{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt \n",
    "import seaborn as sns\n",
    "from rdkit.Chem import PandasTools"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "FILE_LOCATION = Path(\"../data/MalariaData_bioactivity.txt\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/mr/bl2q5rxs0t3d8d8tn7wdcxz80000gp/T/ipykernel_73044/2337347344.py:1: DtypeWarning: Columns (30) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  df = pd.read_table(FILE_LOCATION)\n"
     ]
    }
   ],
   "source": [
    "df = pd.read_table(FILE_LOCATION)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>MOL_CHEMBL_ID</th>\n",
       "      <th>DOWNGRADED</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>STANDARD_INCHI</th>\n",
       "      <th>FULL_MWT</th>\n",
       "      <th>ALOGP</th>\n",
       "      <th>ACD_LOGP</th>\n",
       "      <th>ACD_LOGD</th>\n",
       "      <th>PSA</th>\n",
       "      <th>...</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "      <th>TARGET_CHEMBL_ID</th>\n",
       "      <th>JOURNAL</th>\n",
       "      <th>YEAR</th>\n",
       "      <th>TITLE</th>\n",
       "      <th>PUBMED_ID</th>\n",
       "      <th>DOI</th>\n",
       "      <th>DOC_TYPE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>111</td>\n",
       "      <td>CHEMBL266459</td>\n",
       "      <td>0</td>\n",
       "      <td>[Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C15H14ClNO3.Na/c1-9-7-12(8-13(18)19)1...</td>\n",
       "      <td>313.71</td>\n",
       "      <td>3.93</td>\n",
       "      <td>3.36</td>\n",
       "      <td>0.27</td>\n",
       "      <td>59.3</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 44 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   MOLREGNO MOL_CHEMBL_ID  DOWNGRADED  \\\n",
       "0        23    CHEMBL6206           0   \n",
       "1        23    CHEMBL6206           0   \n",
       "2        23    CHEMBL6206           0   \n",
       "3        23    CHEMBL6206           0   \n",
       "4       111  CHEMBL266459           0   \n",
       "\n",
       "                                 CANONICAL_SMILES  \\\n",
       "0             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "1             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "2             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "3             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "4  [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2   \n",
       "\n",
       "                                      STANDARD_INCHI  FULL_MWT  ALOGP  \\\n",
       "0  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "1  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "2  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "3  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "4  InChI=1S/C15H14ClNO3.Na/c1-9-7-12(8-13(18)19)1...    313.71   3.93   \n",
       "\n",
       "   ACD_LOGP  ACD_LOGD   PSA  ... TARGET_TYPE              PREF_NAME  \\\n",
       "0      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "1      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "2      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "3      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "4      3.36      0.27  59.3  ...    ORGANISM  Plasmodium falciparum   \n",
       "\n",
       "                ORGANISM TARGET_CHEMBL_ID  JOURNAL YEAR  \\\n",
       "0                    NaN     CHEMBL612545      NaN  NaN   \n",
       "1                    NaN     CHEMBL612545      NaN  NaN   \n",
       "2                    NaN     CHEMBL612545      NaN  NaN   \n",
       "3                    NaN     CHEMBL612545      NaN  NaN   \n",
       "4  Plasmodium falciparum        CHEMBL364      NaN  NaN   \n",
       "\n",
       "                       TITLE  PUBMED_ID  DOI  DOC_TYPE  \n",
       "0  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "1  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "2  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "3  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "4  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "\n",
       "[5 rows x 44 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(532413, 44)"
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0         False\n",
       "1         False\n",
       "2         False\n",
       "3         False\n",
       "4         False\n",
       "          ...  \n",
       "532408    False\n",
       "532409    False\n",
       "532410    False\n",
       "532411    False\n",
       "532412    False\n",
       "Length: 532413, dtype: bool"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.duplicated()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop_duplicates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(532413, 44)"
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['MOLREGNO', 'MOL_CHEMBL_ID', 'DOWNGRADED', 'CANONICAL_SMILES',\n",
       "       'STANDARD_INCHI', 'FULL_MWT', 'ALOGP', 'ACD_LOGP', 'ACD_LOGD', 'PSA',\n",
       "       'SRC_DESCRIPTION', 'ASSAY_DESCRIPTION', 'ASSAY_CATEGORY',\n",
       "       'ASSAY_ORGANISM', 'ASSAY_TAX_ID', 'ASSAY_STRAIN', 'ASSAY_CHEMBL_ID',\n",
       "       'ACTIVITY_ID', 'ASSAY_ID', 'DOC_ID', 'RECORD_ID', 'STANDARD_RELATION',\n",
       "       'PUBLISHED_VALUE', 'PUBLISHED_UNITS', 'STANDARD_VALUE',\n",
       "       'STANDARD_UNITS', 'STANDARD_FLAG', 'STANDARD_TYPE', 'ACTIVITY_COMMENT',\n",
       "       'PUBLISHED_TYPE', 'DATA_VALIDITY_COMMENT', 'POTENTIAL_DUPLICATE',\n",
       "       'PUBLISHED_RELATION', 'PCHEMBL_VALUE', 'TARGET_TYPE', 'PREF_NAME',\n",
       "       'ORGANISM', 'TARGET_CHEMBL_ID', 'JOURNAL', 'YEAR', 'TITLE', 'PUBMED_ID',\n",
       "       'DOI', 'DOC_TYPE'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 87,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.int64(63419)"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.PCHEMBL_VALUE.notnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: xlabel='ASSAY_CATEGORY', ylabel='count'>"
      ]
     },
     "execution_count": 89,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.countplot(df.ASSAY_CATEGORY.value_counts())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_df = df[['MOLREGNO', 'CANONICAL_SMILES', 'ASSAY_DESCRIPTION', 'ASSAY_CATEGORY',\n",
    "            'ASSAY_ORGANISM', 'STANDARD_VALUE', 'STANDARD_UNITS', 'PCHEMBL_VALUE', \n",
    "            'TARGET_TYPE', 'PREF_NAME', 'ORGANISM',]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>ASSAY_DESCRIPTION</th>\n",
       "      <th>ASSAY_CATEGORY</th>\n",
       "      <th>ASSAY_ORGANISM</th>\n",
       "      <th>STANDARD_VALUE</th>\n",
       "      <th>STANDARD_UNITS</th>\n",
       "      <th>PCHEMBL_VALUE</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>19952.60</td>\n",
       "      <td>nM</td>\n",
       "      <td>4.70</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>11220.20</td>\n",
       "      <td>nM</td>\n",
       "      <td>4.95</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12589.30</td>\n",
       "      <td>nM</td>\n",
       "      <td>4.90</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10000.00</td>\n",
       "      <td>nM</td>\n",
       "      <td>5.00</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>111</td>\n",
       "      <td>[Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2</td>\n",
       "      <td>PUBCHEM_BIOASSAY: Primary qHTS for delayed dea...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>13115.40</td>\n",
       "      <td>nM</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532408</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>Growth inhibition after 72 hrs of Plasmodium f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>22.20</td>\n",
       "      <td>nM</td>\n",
       "      <td>7.65</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532409</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>GSK_TCMDC: Inhibition of Plasmodium falciparum...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>0.00</td>\n",
       "      <td>%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532410</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>GSK_TCMDC: Inhibition of Plasmodium falciparum...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>100.00</td>\n",
       "      <td>%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532411</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>GSK_TCMDC: Inhibition Frequency Index (IFI). T...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.71</td>\n",
       "      <td>%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532412</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>Growth inhibition after 72 hrs of Plasmodium f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>6.60</td>\n",
       "      <td>nM</td>\n",
       "      <td>8.18</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>532413 rows Ã— 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        MOLREGNO                                   CANONICAL_SMILES  \\\n",
       "0             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "1             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "2             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "3             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "4            111     [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2   \n",
       "...          ...                                                ...   \n",
       "532408   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532409   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532410   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532411   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532412   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "\n",
       "                                        ASSAY_DESCRIPTION ASSAY_CATEGORY  \\\n",
       "0       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "1       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "2       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "3       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "4       PUBCHEM_BIOASSAY: Primary qHTS for delayed dea...   confirmatory   \n",
       "...                                                   ...            ...   \n",
       "532408  Growth inhibition after 72 hrs of Plasmodium f...            NaN   \n",
       "532409  GSK_TCMDC: Inhibition of Plasmodium falciparum...            NaN   \n",
       "532410  GSK_TCMDC: Inhibition of Plasmodium falciparum...            NaN   \n",
       "532411  GSK_TCMDC: Inhibition Frequency Index (IFI). T...            NaN   \n",
       "532412  Growth inhibition after 72 hrs of Plasmodium f...            NaN   \n",
       "\n",
       "               ASSAY_ORGANISM  STANDARD_VALUE STANDARD_UNITS  PCHEMBL_VALUE  \\\n",
       "0                         NaN        19952.60             nM           4.70   \n",
       "1                         NaN        11220.20             nM           4.95   \n",
       "2                         NaN        12589.30             nM           4.90   \n",
       "3                         NaN        10000.00             nM           5.00   \n",
       "4       Plasmodium falciparum        13115.40             nM            NaN   \n",
       "...                       ...             ...            ...            ...   \n",
       "532408  Plasmodium falciparum           22.20             nM           7.65   \n",
       "532409  Plasmodium falciparum            0.00              %            NaN   \n",
       "532410  Plasmodium falciparum          100.00              %            NaN   \n",
       "532411                    NaN            0.71              %            NaN   \n",
       "532412  Plasmodium falciparum            6.60             nM           8.18   \n",
       "\n",
       "       TARGET_TYPE              PREF_NAME               ORGANISM  \n",
       "0        UNCHECKED              Unchecked                    NaN  \n",
       "1        UNCHECKED              Unchecked                    NaN  \n",
       "2        UNCHECKED              Unchecked                    NaN  \n",
       "3        UNCHECKED              Unchecked                    NaN  \n",
       "4         ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "...            ...                    ...                    ...  \n",
       "532408    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "532409    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "532410    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "532411   UNCHECKED              Unchecked                    NaN  \n",
       "532412    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "\n",
       "[532413 rows x 11 columns]"
      ]
     },
     "execution_count": 91,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       " 'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       " 'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       " 'Binding affinity to Plasmodium falciparum spermidine synthase by saturation transfer difference-NMR experiment',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       " 'Inhibition of Plasmodium falciparum thioredoxin reductase by DTNB assay',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of chloroquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of mefloquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artemether',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of quinine',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, ip measured on day 4 postinfection',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of pyrimethamine',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of methylene blue',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of chloroquine',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 1 mg/kg/day, po measured on day 4 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 50 mg/kg/day, ip measured upto day 60 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 100 mg/kg/day, ip measured upto day 60 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 5 mg/kg/day, ip measured upto day 60 postinfection',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of mefloquine',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum FcB1',\n",
       " 'Inhibition of Plasmodium falciparum glutathione S-transferase',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artesunate',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, po measured on day 5 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, po measured on day 4 postinfection',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of premaquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of atovaquone',\n",
       " 'Inhibition of Plasmodium falciparum glutathione reductase by spectrophotometer',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum FcM29',\n",
       " 'Antiplasmodial activity after 24 hrs against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of artemisinin',\n",
       " 'PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP). (Class of assay: confirmatory) ',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum FcM29 assessed as inhibition of parasite growth at 180 nM in presence of 0.87 uM N-acetyl-L-cysteine',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as mortality at 100 mg/kg, po treated 4 days after infection measured on day 7 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum F32',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artemisinin',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of amodiaquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of artesunate',\n",
       " 'Antiplasmodial activity against mefloquine-susceptible Plasmodium falciparum Dd2 assessed as 50% reversant concentration required for mefloquine resistant',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, ip measured on day 5 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as survival at 10 mg/kg, ip treated 4 days before infection measured on day 6 postinfection',\n",
       " 'Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Inhibition of Plasmodium falciparum thioredoxin reductase TrxR assay',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as survival at 10 mg/kg, ip treated 4 days before infection measured on day 9 postinfection',\n",
       " 'Antimicrobial activity against Plasmodium falciparum',\n",
       " 'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       " 'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       " 'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       " 'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       " 'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       " 'NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       " 'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-24 hrs post infection',\n",
       " 'Therapeutic index, ratio of IC50 for concanavalin-stimulated BALB/c mice (Mus musculus) splenocytes to IC50 for Plasmodium falciparum 3D7',\n",
       " 'Therapeutic index, ratio of IC50 for concanavalin-stimulated BALB/c mice (Mus musculus) splenocytes to IC50 for Plasmodium falciparum W2 after 48 hrs',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT K2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-12 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTVo1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Not Plasmodium species',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 36-48 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PA infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as schizont arrest after 48 hrs in chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 96 hrs post invasion by Giemsa staining',\n",
       " 'Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 schizont infected human erythrocytes at 6 uM 96 hrs post infection',\n",
       " 'Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes at 6 uM 96 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTL1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-36 hrs post infection',\n",
       " 'Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT10500 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2',\n",
       " 'Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry',\n",
       " 'In vitro antibacterial activity against gram negative P. aeruginosa DPHP 5263',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-24 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-36 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation after 96 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 0-48 hrs post invasion',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCM29 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-48 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-36 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-48 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free',\n",
       " 'Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Binding constant for PFPK5(P.falciparum) kinase domain',\n",
       " 'Binding constant for PFCDPK1(P.falciparum) kinase domain',\n",
       " 'Displacement of bis-ANS from Plasmodium falciparum 3D7 Hsp90 expressed in Escherichia coli BL21(DE3) assessed as reduction in fluorescence at 100 uM after 30 min by fluorescent monochromator spectrophotometry',\n",
       " 'Relative activity against FM3A cells and Plasmodium falciparum FCR3',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       " 'Inhibition of Plasmodium falciparum recombinant GSK3 expressed in Escherichia coli using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum isolate 208432 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       " 'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       " 'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 80 mg/kg subcutaneous dose ; 5 cured at 60 days post infection',\n",
       " 'Antimalarial activity as survivor number at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 160 mg/kg subcutaneous dose ; 5 cured at 60 days postinfection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hrs',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 320 mg/kg subcutaneous dose ; 5 cured at 60 days post infection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 20 mg/kg subcutaneous dose after 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 40 mg/kg subcutaneous dose ; 5 cured at 60 days post infection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) after 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 640 mg/kg subcutaneous dose ; 5 cured at 60 days postinfection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 80 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Selectivity ratio of growth inhibition against Plasmodium falciparum TM4/8.2(wild-type) and T9/94(mutant)',\n",
       " 'Evaluated for activity of relative to Cycloguanil',\n",
       " 'Evaluated for inhibition constant (Ki wt) against Wild-type dihydrofolate reductase of Plasmodium falciparum',\n",
       " 'Inhibition of Plasmodium falciparum T9/94 mutant',\n",
       " 'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       " 'Evaluated for activity of compound relative to Cycloguanil',\n",
       " 'Ratio of inhibitory constant of mutant by wild-type DHFRs of Plasmodium falciparum',\n",
       " 'Inhibition constant (Ki mut) against A16V+S108T Mutant DHFRs of Plasmodium falciparum',\n",
       " 'Growth inhibition (IC50) against Plasmodium falciparum wild-type TM4/8.2',\n",
       " 'Antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 2.5 to 25 mg/kg',\n",
       " 'Inhibition of Plasmodium falciparum recombinant carbonic anhydrase',\n",
       " 'Ex vivo inhibition of Plasmodium falciparum growth in cultured cells after 48hrs as [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibitory activity against double mutant dihydrofolate reductase (C59R S108N DHFR), relative to trimethoprim',\n",
       " 'Inhibitory activity against wild-type dihydrofolate reductase (S108N DHFR), relative to trimethoprim',\n",
       " 'Inhibitory activity against wild-type dihydrofolate reductase (S108N DHFR)',\n",
       " 'Inhibitory activity against triple mutant dihydrofolate reductase (C59R S108 NI164L DHFR)',\n",
       " 'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NF10 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KC2 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum D2 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum DAN after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum WE2 after 72 hrs by SYBR green assay',\n",
       " 'Inhibitory activity against double mutant dihydrofolate reductase (C59R+S108N DHFR)',\n",
       " 'Inhibition of Plasmodium falciparum DHFR',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KH7 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum LC12 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XE7 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JC9 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XG10 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JF11 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JF6 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JB12 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against transgenic Plasmodium falciparum Dd2 pDT harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum D10 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum HB3 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum GB4 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JC3 after 72 hrs by SYBR green assay',\n",
       " 'Inhibitory activity against Dihydrofolate reductase enzyme purified from Plasmodium berghei.',\n",
       " 'IC50 ratio against Plasmodium falciparum K1CB1/TM4',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JB8 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum LA10 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XB3 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum TF1 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against transgenic Plasmodium falciparum HB3 pDT harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XF12 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum QF5 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JH6 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum WF12 after 72 hrs by SYBR green assay',\n",
       " 'In vitro inhibition of dihydrofolate reductase of Plasmodium berghei',\n",
       " 'Safety ratio as cytotoxicity in vero cells relative to IC50 TM4',\n",
       " 'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum DEV after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NIC after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 7G8 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum AL2 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KB8 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JON after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XD8 after 72 hrs by SYBR green assay',\n",
       " 'Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei',\n",
       " 'Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibitory activity against quadruple mutant dihydrofolate reductase (N51I C59R S108N I164L DHFR), relative to trimethoprim',\n",
       " 'Inhibitory activity against triple mutant dihydrofolate reductase (C59R S108 NI164L DHFR), relative to trimethoprim',\n",
       " 'Compound was tested for its inhibition against dihydrofolate reductase enzyme of Plasmodium berghei',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KC5 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KA6 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum WC4 after 72 hrs by SYBR green assay',\n",
       " 'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       " 'Inhibitory activity against quadruple mutant dihydrofolate reductase (N51I C59R S108N I164L DHFR)',\n",
       " 'Inhibitory activity against dihydrofolate reductase (DHFR) enzyme from Plasmodium berghei',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum AUD after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum TM91C235 by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum KAS3 expressed in Escherichia coli assessed as transfer of [1-14C]acetyl-CoA to [1-14C]acetyl-ACP',\n",
       " 'Therapeutic index, ratio of IC50 for mice (Mus musculus) J774.G8 cells to IC50 for chloroquine-sensitive Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 40 mg/kg subcutaneous dose ; 3 cured at 60 days post infection',\n",
       " 'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 50 uM',\n",
       " 'In Vitro evaluation on percentage inhibition in Heme Oxygenase at concentration 100(uM) of Cell-free parasite Plasmodium yoelii',\n",
       " 'Percentage influence on cellular glutathione reductase activity',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg; 3 survived after 60 days of postinfection',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 5 survived after 60 days of postinfection',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       " 'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum schizonts assessed as change in parasitemia at IC50 concentration treated until all schizonts had burst and invasion was assumed to have occurred by Giemsa staining-based microscopy relative to control',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by lactate dehydrogenase assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs by lactate dehydrogenase assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum schizonts assessed as parasitemia at IC50 concentration treated until all schizonts had burst and invasion was assumed to have occurred by Giemsa staining-based microscopy (Rvb = 8.83%)',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum TM4/8.2 infected Vero cells',\n",
       " 'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (A16V+S108T DHFR) of Plasmodium falciparum.',\n",
       " 'In vitro cytotoxicity against Plasmodium falciparum infected BC cell line.',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum Csl-2 infected BC cells',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum Csl-2 infected KB cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum V1/S infected Vero cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum TM4/8.2 infected BC cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum V1/S infected KB cells',\n",
       " 'Ratio of binding affinity for mutant (C59R+S108N+I164L) to that of wild type dihydrofolate reductase',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase A16V/S108T (T9/94RC17) mutant',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum V1/S infected BC cells',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R/S108N (K1CB1) mutant',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase N51I/C59R/S108N (W2)',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       " 'In vitro cytotoxicity against Plasmodium falciparum infected vero cell line.',\n",
       " 'Ratio of binding affinity for mutant (N51I+C59R+S108N+I164L) to that of wild type dihydrofolate reductase',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase wild type (TM4/8.2)',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum Csl-2 infected Vero cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum TM4/8.2 infected KB cells',\n",
       " 'Ratio of binding affinity for mutant (N51I+C59R+S108N) to that of wild type dihydrofolate reductase',\n",
       " 'Ratio of binding affinity for mutant (A16V+S108T) to that of wild type dihydrofolate reductase',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase CN51I/C59R/S108N/I164L (V1/S) mutant',\n",
       " 'In vitro cytotoxicity against Plasmodium falciparum infected KB cell line',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R+S108N/I164L (Csl-2) mutant',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       " 'Inhibition of FabI',\n",
       " 'Inhibition of FabG at 100 uM',\n",
       " 'Inhibition of FabZ at 100 uM',\n",
       " 'Inhibition of Plasmodium falciparum cyclin-dependent kinase',\n",
       " 'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       " 'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum NF54-R in blood',\n",
       " 'In vitro inhibitory activity against hepatic stages of Plasmodium yoelii yoelii 265 BY',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium falciparum NF54',\n",
       " 'In vitro inhibitory activity against hepatic stages of Plasmodium yoelii yoelii 265 BY; No data',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 rings after 48 hrs by FACS analysis',\n",
       " 'PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid: Hit Validation with Dd2 at 96hr using Flow Cytometry.   (Class of assay: confirmatory) ',\n",
       " 'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       " 'PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid: Hit Validation with 3D7 at 96 hr using Flow Cytometry.   (Class of assay: confirmatory) ',\n",
       " 'PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid: Hit Validation at 96 hr.   (Class of assay: confirmatory) ',\n",
       " 'Inhibition of PSAC-mediated sorbitol uptake in erythrocytes infected with Plasmodium falciparum HB3 at 100 to 5000 uM by osmotic lysis half-time determination assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as reduction of hemozoin formation at IC50 after 48 hrs relative to control',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 10 uM after 15 min by spectrophotometry',\n",
       " 'Inhibition of PSAC-mediated sorbitol uptake in erythrocytes infected with leupeptin resistant-Plasmodium falciparum HB3-leuR1 by osmotic lysis half-time determination assay',\n",
       " 'Minimum inhibitory concentration against schizont maturation of Plasmodium falciparum NF54 ring stage after 40 h',\n",
       " 'Antimalarial activity as survivor number at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Minimum inhibitory concentration against schizont maturation in Plasmodium falciparum NF-54',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Inhibition constant against wild-type PfDHFR (Plasmodium falciparum dihydrofolate reductase)',\n",
       " 'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration; no data',\n",
       " 'Growth inhibition of Plasmodium falciparum Dd2 ring stage infected erythrocytes after 72 hrs by DAPI fluorimetry',\n",
       " 'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Antimalarial activity as inhibition of schizont maturation against Plasmodium malariae Thai after 40 - 70 hrs',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 40 mg/kg; 1 survived after 60 days of postinfection',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'OSM: Inhibition of Plasmodium falciparum 3D7 growth using a SYBR green I fluorescence based assay. GSK Tres Cantos.',\n",
       " 'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR) relative to Pyr.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 320 mg/kg after subcutaneous administration;; no data',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 20 mg/kg.',\n",
       " 'Inhibition of Plasmodium falciparum DHFR assessed as oxidation of NADPH to NADP+ after 15 mins spectrophotometric assay',\n",
       " 'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'In vitro relative antiplasmodial activity (IC50) compared to Pyr against Plasmodium falciparum TM4/8.2 wild-type',\n",
       " 'Antiparasitemia activity against Plasmodium berghei infected mice (Mus musculus) at 30 mg/kg peroral dose for 4 days',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in red blood cells up to 19 uM after 72 hrs by parasitic LDH assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Thermodynamic dissociation constant of compound for mutant S108 Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 3 toxic deaths after 2-5 days of injection',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       " 'Antimalarial activity against Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 40 mg/kg ; 1 cured at 60 days postinjection.',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 1.2 mg/kg/day, po administered 24 hrs post-treatment measured after 4 days',\n",
       " 'Ratio of Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR) to inhibition of wild type dihydrofolate reductase.',\n",
       " 'Inhibitory concentration against cycloguanil sensitive Plasmodium falciparum FJB-D9 ',\n",
       " 'Ratio of Kd to Ki for Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 640 mg/kg ; 1 cured and 2 toxic death',\n",
       " 'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       " 'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       " 'Antimalarial activity against Plasmodium falciparum FC27',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       " 'Ratio of Inhibition of the S108N mutant of dihydrofolate reductase (DHFR) to inhibition of wild type dihydrofolate reductase.',\n",
       " 'Antimalarial activity against mefloquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH assay',\n",
       " 'Anti-malarial activity against Plasmodium falciparum Dd2',\n",
       " 'Inhibitory concentration against cycloguanil sensitive Plasmodium falciparum FJB-D4 ',\n",
       " 'Antiplasmodial activity against Plasmodium vivax',\n",
       " 'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 40 mg/kg after subcutaneous administration; no data',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green fluorescence assay',\n",
       " 'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum K1',\n",
       " 'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose; no data',\n",
       " 'OSM: Inhibition of Plasmodium falciparum 3D7 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       " 'Ratio of IC50 for pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Inhibition of WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Antimalarial activity against chloroquine-susceptible Plasmodium falciparum D10 asexual erythrocyte forms after 48 hrs by parasite LDH assay',\n",
       " 'Inhibitory concentration sensitive Plasmodium falciparum FJB-D9 ',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       " 'Inhibition of Plasmodium falciparum DHFR assessed as oxidation of NADPH to NADP+ at 10 uM after 15 mins spectrophotometric assay',\n",
       " 'Inhibitor constant of compound for Plasmodium falciparum dihydrofolate reductase',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       " 'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum W2; Not determined',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 160 mg/kg ; 5 cured at 60 days postinjection.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       " 'Antiparasitemia activity against Plasmodium berghei infected mice (Mus musculus) at 30 mg/kg subcutaneous dose for 4 days',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single S108T mutation',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in red blood cells after 72 hrs by parasitic LDH assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7A assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 10 nM after 15 min by spectrophotometry',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 5 mg/kg.',\n",
       " 'In vitro minimum inhibitory concentration against Plasmodium falciparum NF54 over 40 hours',\n",
       " 'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1',\n",
       " 'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with quadruple (N51I + C59R + S108N + I164L) mutations',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 1.25 mg/kg.',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235 assessed as inhibition of [3H]hypoxanthine uptake in presence of 1 mM folinic acid',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as parasitemia at 1.2 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs (Rvb = 4.6+/-0.21 %)',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay',\n",
       " 'Selectivity ratio of Ki for human recombinant DHFR to Ki for wild type Plasmodium falciparum DHFR',\n",
       " 'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR) relative to Pyr.',\n",
       " 'Inhibition against Plasmodium falciparum Dd2 in erythrocytes in semiautomated micro dilution assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 1 survived after 60 days of post infection',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as parasitemia at 1.2 mg/kg/day, po administered 24 hrs post-treatment measured after 4 days (Rvb = 56.3+/-0.16 %)',\n",
       " 'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       " 'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-beta2 m null mouse after 7 days',\n",
       " 'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       " 'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes by semiautomated micro dilution',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 in erythrocytes',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 1.2 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs by SYBR green fluorescence assay',\n",
       " 'Antimalarial activity against mefloquine-resistant, chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine uptake in presence of 1 mM folinic acid',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against Plasmodium falciparum FCR3',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Selectivity ratio of IC50 for plasmodium falciparum 3D7A to IC50 for human 5HT2c receptor',\n",
       " 'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       " 'Antimalarial activity as toxic deaths 2-5 days post infection for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antiplasmodial activity (IC50) compared to Pyr against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S108N)',\n",
       " 'Ratio of IC50 for WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 80 mg/kg ; 3 cured at 60 days postinjection.',\n",
       " 'Binding affinity was evaluated as inhibition of recombinant wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg',\n",
       " 'Selectivity ratio of Ki for recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant to Ki for wild type Plasmodium falciparum DHFR',\n",
       " 'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72 hr',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with double (A16V + S108T) mutations',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       " 'Ratio of inhibitions against mutant and wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       " 'Ratio of Kd to Ki for mutant S108 N Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'In vitro inhibition of Plasmodium falciparum HB3 (S108N) culture',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 2.5 mg/kg.',\n",
       " 'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       " 'Binding affinity to recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant by competitive binding assay',\n",
       " 'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       " 'Growth inhibition of Plasmodium falciparum HB3 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single A16V mutation',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       " 'Inhibitor constant of compound for mutant S108 N Plasmodium falciparum in dihydrofolate reductase',\n",
       " 'Inhibitory concentration against multidrug-resistant Plasmodium falciparum Dd2.',\n",
       " 'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 80 mg/kg; 3 survived after 60 days of postinfection',\n",
       " 'Selectivity ratio of IC50 for Plasmodium falciparum Dd2 to IC50 for Plasmodium falciparum 3D7A',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1/S harboring S108N, N51I, C59R, I164L mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human A positive erythrocytes by [3H]hypoxanthine uptake assay in presence of serum in medium',\n",
       " 'Antimalarial activity against Plasmodium falciparum PfV1S0176/N10 infected in immunodeficient HM-IL2Rgamma null mouse after 7 days',\n",
       " 'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum HB3',\n",
       " 'OSM: Inhibition of Plasmodium falciparum K1 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       " 'OSM: HEK293 cytotoxicity assay. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       " 'Ratio of IC50 for pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Ratio of IC50 for WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-IL2Rgamma null mouse after 7 days',\n",
       " 'Ratio of IC50 for WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Ratio of IC50 for WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant to IC50 for Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'In vitro inhibition of Plasmodium falciparum K1 (S108N + C59R) culture',\n",
       " 'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Antimalarial activity against Plasmodium falciparum Mad20',\n",
       " 'Antimalarial activity against liver stages of Plasmodium cynomolgi infected in human HepG2 cells assessed as growth inhibition of hepatic parasite after 3 days',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 10 mg/kg.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 2 toxic deaths after 2-5 days of injection',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 320 mg/kg ; 2 cured and 3 toxic death',\n",
       " 'Antimalarial activity as toxic deaths 2-5 days post infection for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Growth inhibition of Plasmodium falciparum 3D7 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       " 'Binding affinity was evaluated as inhibition of mutant (C59R + S108N) Plasmodium falciparum DHFR-TS.',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Antimalarial activity against Plasmodium falciparum HB3',\n",
       " 'Thermodynamic dissociation constant of compound for Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Inhibition of WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Ratio of IC50 for Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant to IC50 for Plasmodium falciparum D6',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with triple (C59R + S108N + I164L) mutations',\n",
       " 'Compound was tested in vivo for antimalarial activity against Plasmodium berghei in mice (Mus musculus) after 6 days of administration (ED90 is the dose necessary to reduce the percentage of infected cells to 10% of the level found in the infected untreated controls)',\n",
       " 'Antimalarial activity as change in MST for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Binding affinity to wild type Plasmodium falciparum DHFR by competitive binding assay',\n",
       " 'Inhibition of the wild-type dihydrofolate reductase (DHFR)relative to Pyr.',\n",
       " 'Antimalarial activity against Plasmodium falciparum NF54 after 36-40 hrs',\n",
       " 'Ratio of IC50 for pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro',\n",
       " 'DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells.',\n",
       " 'Increase in PfCRT expression in chloroquine-resistant Plasmodium falciparum R1H6/2 by Western blot relative to untreated control',\n",
       " 'Increase in PfCRT expression chloroquine-sensitive Plasmodium falciparum K1Hf by Western blot relative to untreated control',\n",
       " 'Increase in PfCRT expression in chloroquine-sensitive Plasmodium falciparum K1AM by Western blot relative to untreated control',\n",
       " 'Increase in Pgh1 expression in chloroquine-resistant Plasmodium falciparum R1H6/2 by Western blot relative to untreated control',\n",
       " 'Increase in Pgh1 expression chloroquine-sensitive Plasmodium falciparum K1Hf by Western blot relative to untreated control',\n",
       " 'Increase in Pgh1 expression in chloroquine-sensitive Plasmodium falciparum K1AM by Western blot relative to untreated control',\n",
       " 'PUBCHEM_BIOASSAY: Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'PUBCHEM_BIOASSAY: Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'PUBCHEM_BIOASSAY: Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'Percent inhibition of hypoxanthine uptake by Plasmodium berghei',\n",
       " 'Percent inhibition of adenosine uptake by Plasmodium berghei',\n",
       " 'Inhibition of Tween 20-induced beta-hematin formation by colorimetric assay',\n",
       " 'Effective concentration against Plasmodium falciparum W2',\n",
       " 'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by [G-3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of TC50 for hepatocytes to IC50 for Plasmodium yoelii ',\n",
       " 'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs',\n",
       " 'Effective concentration for Plasmodium falciparum 3D7',\n",
       " 'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs',\n",
       " 'Inhibitory concentration IC50 against Plasmodium falciparum K1 by [3H]hypoxanthine uptake over 24 hr',\n",
       " 'Inhibition of [3H]hypoxanthine incorporation in Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine incorporation',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PoW',\n",
       " 'Inhibition of FabZ',\n",
       " 'Inhibition of FabI at 100 uM',\n",
       " 'Antimalarial activity against liver stages of Plasmodium berghei',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in C57BL/6 mouse assessed as reduction of liver infection at 200 mg/kg, ip incubated for 6 hrs prior to sporozoite inoculation measured after 40 hrs by qRT PCR',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum 3D7',\n",
       " 'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       " 'Growth inhibition of chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum-mediated human hemoglobin degradation at 100 uM',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O+ erythrocytes after 72 hrs by SYBR Green-1 fluorescence based assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum DD2 by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum DHOD',\n",
       " 'Antimalarial activity against Plasmodium falciparum DD2 expressing Saccharomyces cerevisiae DHOD by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum NDH2',\n",
       " 'Inhibition of Plasmodium falciparum HGXPRT',\n",
       " 'Ratio of GMP Ki to compound Ki for Plasmodium falciparum HGXPRT',\n",
       " 'Inhibition of Plasmodium vivax HGPRT',\n",
       " 'In vitro inhibition against chloroquine-sensitive Plasmodium falciparum K39; Range 0.1-0.4 uM',\n",
       " 'In vitro inhibition against chloroquine-resistant Plasmodium falciparum V1/S; Range 0.1-0.4 uM',\n",
       " 'Inhibition of Plasmodium falciparum ENR',\n",
       " 'Inhibition of Plasmodium falciparum ENR in presence of triclosan',\n",
       " 'Antiprotozoal activity against Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       " 'Inhibition of FabG',\n",
       " 'Inhibition of Plasmodium falciparum ENR using NADH substrate',\n",
       " 'Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6',\n",
       " 'Inhibition of Plasmodium falciparum FabI',\n",
       " 'HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for Plasmodium falciparum D6',\n",
       " 'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH reporter assay',\n",
       " 'Antiparasitic activity against Plasmodium falciparum K1',\n",
       " 'In vitro antiparasitic activity against chloroquine-resistant Plasmodium falciparum Indochina I',\n",
       " 'Antimalarial activity against Plasmodium falciparum',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 as LDH activity',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 in erythrocytes by LDH reporter assay',\n",
       " 'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 by flow cytometry',\n",
       " 'Selectivity index, ratio for IC50 of rat L6 cells to IC50 of chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Selectivity ratio for IC50 of chloroquine-resistant Plasmodium falciparum K1 over Trypanosoma brucei rhodesiense STIB900',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       " 'Antimalarial activity against erythrocytic stage of Plasmodium falciparum NF54 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counting analysis',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 in erythrocytes by LDH reporter assay',\n",
       " 'Antimalarial activity against chloroquine and pyrimethamine -resistant Plasmodium falciparum K1 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of Plasmodium falciparum recombinant falcipain-2 using Cbz-Leu-Arg-AMC as substrate by standard fluorescence assay',\n",
       " 'In vitro inhibitory activity against Plasmodium falciparum; Not determined',\n",
       " 'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 after 72 hrs by alamar blue assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1 infected in human RBC after 48 hrs by [3H]-hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1 infected in human red blood cells assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FcB1/Colombia infected in human A+ve erythrocytes assessed as inhibition of [G-3H]hypoxanthine uptake preincubated for 24 hrs prior to [G-3H]hypoxanthine addition measured after 18 hrs by liquid scintillation counting',\n",
       " 'Selectivity index, ratio of IC50 for Trypanosoma brucei rhodesiense STIB900 to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 by pLDH activity',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH activity',\n",
       " 'In vitro antiprotozoal activity for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 after 72 hrs by alamar blue assay',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum W2 by pLDH activity',\n",
       " 'In vitro antiparasitic activity against chloroquine-sensitive Plasmodium falciparum Haiti 135',\n",
       " 'Antimalarial activity against drug -sensitive Plasmodium falciparum NF54 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH assay',\n",
       " 'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Plasmodium falciparum NF54',\n",
       " 'In vitro inhibitory activity for Plasmodium falciparum; Not tested',\n",
       " 'Antiprotozoal activity as cell damage against Plasmodium berghei',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected in human erythrocytes after 48 hrs assessed as [3H]hypoxanthine incorporation by liquid scintillation counting',\n",
       " 'Inhibition of Plasmodium falciparum recombinant falcipain-3 by standard fluorescence assay',\n",
       " 'Selectivity ratio of IC50 for Trypanosoma brucei rhodesiense STIB900 to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium berghei schizonts isolated from parasitized erythrocytes infected Wistar rat measured 16 hrs post compound exposure',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH assay',\n",
       " 'In vivo antimalarial activity against Plasmodium falciparum',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 0.1 mg/kg/day',\n",
       " 'The compound was tested for the dose required to cause 50% suppression of Plasmodium berghei growth in mice.',\n",
       " 'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.1-mg/kg/day for 4 days',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 1.0 mg/kg/day',\n",
       " 'Percent parasitaemia in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.5-mg/kg/day after 4 days',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 5 mg/kg/day after 4 days',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 2 mg/kg/day after 4 days',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 5 mg/kg/day',\n",
       " 'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) after 4 days',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 1.0 mg/kg/day after 4 days',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 2 mg/kg/day',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 0.5 mg/kg/day',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 10 mg/kg/day',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at different doses 20 mg/kg/day',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as parasite-specific LDH release after 72 hrs by Malstat assay',\n",
       " 'Antiplasmodial activity against blood stage forms of chloroquine-sensitive Plasmodium falciparum 3D7 assessed as dysfunctional intracellular membrane biosynthesis at IC50 after 72 hrs by electron microscopy',\n",
       " 'Antimalarial activity against erythrocyte stage Plasmodium falciparum 3D7',\n",
       " 'Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant erythrocytic stage of Plasmodium falciparum K1 assessed as inhibition of [3H}hypoxanthine incorporation after 24 hrs by liquid scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 expressing katG',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 with pLN-hrp3-katG-V5 insertion at attB site',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 expressing katG',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 with pLN-hrp3-katG-V5 insertion at attB site',\n",
       " 'Inhibitory concentration (IC50) against chloroquine-sensitive falciparum sierra leone D-8 in human malaria',\n",
       " 'Inhibitory concentration (IC50) against chloroquine-resistant falciparum Indochina W2 in human malaria',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D10',\n",
       " 'HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection',\n",
       " 'Binding affinity to Plasmodium falciparum spermidine synthase by saturation transfer difference-NMR experiment relative to methylthioadenosine',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1 in [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of Plasmodium falciparum falcipain 2 assessed as benzyloxycarbonyl-Phe-Leu-7-amino-4-methylcoumarin substrate hydrolysis after 30 mins by spectrofluorometry analysis',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in erythrocytes assessed as inhibition of sorbitol-induced hemolysis after 15 mins',\n",
       " 'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 after 24 hrs by [3H]hypoxanthine uptake',\n",
       " 'In Vitro evaluation on percentage inhibition in Heme Oxygenase at concentration 100 (uM) of Cell-free parasite Plasmodium yoelii',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by SYBR green assay',\n",
       " 'Chemosensitizing activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes as IC50 ratio chloroquine +/- 500 nM by SYBR green assay',\n",
       " 'Chemosensitizing activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes as IC50 ratio chloroquine +/- 500nM by SYBR green assay',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes by SYBR green assay',\n",
       " 'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'In vitro inhibitory concentration against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 24 hrs as reduced [3H]phenylalanine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum GCO3 after 72 hrs by SYBR green 1 assay',\n",
       " 'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       " 'Antimalarial activity against morfloquine-resistant Plasmodium falciparum TM91C235 assessed as [3H]hypoxanthine incorporation',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       " 'Selectivity index, ratio of IC50 for human MRC5 cells to IC50 for chloroquine-resistant Plasmodium falciparum PFB',\n",
       " 'Antimicrobial activity against Plasmodium vivax at the ring stage measured after 30 hrs by microscopy',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum assessed as resistant isolates',\n",
       " 'Selectivity for chloroquine-resistant Plasmodium falciparum Dd2 over chloroquine-sensitive Plasmodium falciparum HB3 as IC50 ratio by SYBR green assay',\n",
       " 'Concentration required for 50% decrease in IC50 for chloroquine; Not determined',\n",
       " 'Selectivity index, ratio of TC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for Plasmodium falciparum D6',\n",
       " 'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 48 (mg/kg/day) after 4 day',\n",
       " 'Antimicrobial activity against chloroquine-resistant Plasmodium chabaudi ASCQ infected in NIH mice (Mus musculus) at 2.5 mg/kg, perorally administered after 72 hrs post inoculation measured on day 4 post infection',\n",
       " 'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected mice (Mus musculus) macrophage by reporter dye assay',\n",
       " 'Selectivity index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum NF54',\n",
       " 'In vitro inhibitory activity against Chloroquine-sensitive Plasmodium falciparum NF54 as [3H]hypoxanthine incorporation',\n",
       " 'In vitro antimalarial activity as schizont maturation against drug-sensitive Plasmodium falciparum',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human O+ RBC by parasite LDH assay',\n",
       " 'Antiparasitic activity against Plasmodium falciparum K1 infected in rat L6 cells assessed as inhibition of parasite growth preincubated for 48 hrs before [3H]hypoxanthine addition measured after 24 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum FG2 parasite ',\n",
       " 'Antimalarial activity against mefloquine, chloroquine and quinine-resistant Plasmodium falciparum TM91C235',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of IC50 for human HCT116 cells to IC50 for chloroquine-sensitive Plasmodium falciparum FCA 20/ Ghana',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       " 'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected in rat L6 cells',\n",
       " 'Anti-infective activity against Plasmodium falciparum W2 in erythrocytes',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NF54',\n",
       " 'In vitro antimalarial activity against Thai strain of Plasmodium falciparum',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, Ratio of IC50 in Vero cells to IC50 in chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity as reduced parasitaemia after 6 days against Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 50 mg/kg/day intraperitoneal dose',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs',\n",
       " 'Effective subcutaneous dose ED90 against Plasmodium yoelii sspNS',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum L1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Bres infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitemia at 5 mg/kg/day, ip measured on day 5 post-infection by Giemsa staining',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 assessed as inhibition of [3H] hypoxanthine uptake by liquid scintillation counting',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitemia at 1 mg/kg/day, ip measured on day 5 post-infection by Giemsa staining',\n",
       " 'Antimalarial activity after 48 hrs against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       " 'Effect on survival of mice (Mus musculus) infected with Plasmodium berghei at 640 mg/kg, perorally',\n",
       " 'In vitro antimalarial activity against ring stage of chloroquine-resistant Plasmodium falciparum W2 cultured in medium containing 10% human serum assessed as inhibition of parasite growth after 48 hrs by YOYO-1 dye based flow cytometry',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 72 hrs by MSF assay',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       " 'Toxicity in Plasmodium berghei NK-65 infected Swiss Webster mouse at 30 mg/kg, ip QD for 3 days',\n",
       " 'Antiplasmodial potency relative to chloroquine in ferriprotoporphyrin biomineralisation assay',\n",
       " 'Antimalarial activity against Plasmodium berghei NK-65 infected in Swiss Webster mouse assessed as mean survival time at 30 mg/kg, ip QD for 3 days administered 2 hrs post infection',\n",
       " 'Antimalarial activity as mean survival days against Plasmodium berghei NK65 infected ICR mice (Mus musculus) at 30 mg/kg/day peroral dose',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Indochina W2 infected human erythrocytes assessed as uptake of PicoGreen after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in erythrocytes after 48 hrs by SYBR Green 1-based fluorescence assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCM29 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human A+ erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs by scintillation counting',\n",
       " 'Antiplasmodial activity against Plasmodium berghei ANKA infected in mice (Mus musculus) assessed as mice (Mus musculus) survival at 10 mg/kg, intraperitoneal for 5 consecutive days measured on day 14 post parasitic infection',\n",
       " 'Resistance index was measured as the ratio of IC50 of Plasmodium falciparum W-2 clone / IC50 of P. falciparum D-6 clone',\n",
       " 'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 by pLDH assay',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCR-3 infected in human A positive erythrocytes by [3H]-hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 assessed as [3H]hypoxanthine incorporation after 48 hrs by beta-counter',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as host survival time at 100 mg/kg, perorally administered as single dose (Rvb = 6 to 7 days)',\n",
       " 'Inhibition of beta-hematin formation at pH 5.0; active',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium yoelii infected in Swiss mouse assessed as inhibition of beta-hematin formation in plasma after 16 hrs by spectrophotometric analysis',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum K1/Thailand by [3H]hypoxanthine uptake',\n",
       " 'Drug level in chloroquine-sensitive Plasmodium falciparum D6 digestive vacuole assessed as ratio of drug level in vacuole to medium at 5 uM after 1 hr',\n",
       " 'Antimalarial activity against asexual blood stage of Plasmodium falciparum 3D7 after 48 hrs by candle jar method',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum Dd2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235',\n",
       " 'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D6 by ELISA',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 assessed as inhibition of parasite LDH activity after 72 hrs by spectrophotometry',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 infected in human erythrocytes',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCR3 Gambia as 24 hrs [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs by LDH assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum Dd2',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1AM by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1Hf by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibitory activity against beta-hematin formation',\n",
       " 'Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 infected in RBCs by parasitic LDH release assay',\n",
       " 'Antiparasitic activity against chloroquine-resistant Plasmodium falciparum R1H6/2 pretreated with 0.1 uM phenobarbitone for 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine incorporation',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in human erythrocytes after 48 hrs',\n",
       " 'Antimalarial activity as reduced parasitaemia against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) after 4 days',\n",
       " 'Toxicity in Plasmodium berghei infected ICR mice (Mus musculus) dosed intraperitoneally once daily for 4 days by Thompson test',\n",
       " 'Antimalarial schizonticidal activity against Plasmodium falciparum 3D7 infected erythrocytes at 10 ug/ml after 30-39 hrs',\n",
       " 'Selectivity index, ratio of TC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 10 mg/kg, perorally administered through 7% Tween80/3% Ethanol formulation 24 hrs post infection for 3 days measured 96 hrs post infection',\n",
       " 'Antiplasmodial activity against chloroquine-, pyrimethamine-, proguanil-resistant Plasmodium falciparum K1 infected in A-positive human erythrocytes after 72 hrs by SYBR green 1 fluorescence-based method',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in RBC assessed as parasite LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against atovaquone-resistant Plasmodium falciparum TM90C2B',\n",
       " 'Antimalarial activity as inhibition of schizont maturation against Plasmodium falciparum NF54 after 36 - 40 hrs',\n",
       " 'Antimalarial activity against drug-resistant Plasmodium falciparum TM90C2A',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation incubated for 48 hrs prior to [3H]hypoxanthine addition measured after 48 hrs by liquid scintillation counting',\n",
       " 'Antimalarial activity as mean survival time against Plasmodium yoelii N67 infected Swiss mice (Mus musculus)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by 1536-well format based SYBR green assay',\n",
       " 'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       " 'Inhibition of beta-hematin formation using synthetic hemin chloride',\n",
       " 'Inhibitory concentration against Plasmodium falciparum K1 infected erythrocytes',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum C6harboring 7G8 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       " 'Selectivity for chloroquine-resistant Plasmodium falciparum FCB over chloroquine-sensitive Plasmodium falciparum GCO3 as IC50 ratio by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 after 24 hrs by [3H]hypoxanthine uptake',\n",
       " 'Selectivity ratio of IC50 for human HepG2 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7A',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei strain ANKA infected in NMRI mouse assessed as increase in median survival time at 10 mg/kg/day, po administered as single dose measured measured up to 30 days (Rvb = 5 days)',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 by FACS-based assay',\n",
       " 'Antiplasmodial activity growth inhibition of chloroquine-resistant Plasmodium falciparum BHz 26/86 after 72 hrs',\n",
       " 'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum CDC/Indochina III W2',\n",
       " 'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3',\n",
       " 'Selectivity index, ratio of CC50 for human HeLa cells to IC50 for Plasmodium falciparum 3D7 ring stage cells',\n",
       " 'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia dosed in ETPGS formulation 1 day post infection measured 72 hrs post infection',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to ED50 for Plasmodium falciparum W2',\n",
       " 'Antimalarial activity after 24 hrs against Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 3D7 by giemsa stain',\n",
       " 'Selectivity index, ratio of TC50 for human HeLa cells to IC50 for Plasmodium falciparum 3D7',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to IC50 for Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum 7G8 in human erythrocytes by DAPI stain',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei strain ANKA infected in NMRI mouse assessed as increase in median survival time at 10 mg/kg/day, ip administered for 4 days measured up to 30 days (Rvb = 5 to 7 days)',\n",
       " 'In vitro antimalarial activity for Plasmodium falciparum TM91C235',\n",
       " 'Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity as reduced parasitaemia in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 10 mg/kg/day peroral dose then intraperitoneal dose for 4 days',\n",
       " 'Inhibition of Plasmodium falciparum W2 recombinant falcipain-2',\n",
       " 'Antimalarial activity against Plasmodium ovale trophozoite stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-sensitive Plasmodium falciparum D10 to IC50 for chloroquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 intra-erythrocytic form',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Bre1 by hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum assessed as inhibition of merozoite invasion of RBCs at 1 uM after 48 hrs by SYBR green 1 fluorescence-based flow cytometry',\n",
       " 'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 48 (mg/kg/day) after 10 days',\n",
       " 'Antimalarial activity against chloroquine, pyrimethamine, proguanil-resistant Plasmodium falciparum infected in human erythrocytes after 48 hrs by flow cytometry',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 as LDH activity',\n",
       " 'Ratio of IC50 for chloroquine-resistant Plasmodium falciparum W2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Selectivity index ratio of IC50 for human MCF7 cells to IC50 for chloroquine-resistant Plasmodium falciparum FcB1',\n",
       " 'Antiplasmodial activity against Plasmodium berghei NK65 infected in Swiss Webster mice (Mus musculus) assessed as average parasitaemia at 200 mg/kg, perorally administered 1 day after infection measured after 14 days post infection',\n",
       " 'Inhibition of Plasmodium falciparum phosphoethanolamine methyltransferase using phospethanolamine as substrate by radiochemical assay in presence of S-adenosylmethionine',\n",
       " 'Selectivity index, ratio of IC50 for human K562 cells to IC50 for chloroquine, pyrimethamine and proguanil-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in human erythrocytes assessed as inhibition of parasite growth after 24 hrs by Geimsa staining based light microscopic analysis',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 by Malstat LDH activity',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in Sprague-Dawley rat assessed as mean survival days of host at 3 mg/kg, po administered as single dose',\n",
       " 'Antimalarial activity against Plasmodium ovale ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       " 'AUC (0 to 42 days) in Paua New Guinean children with uncomplicated malaria at 10 mg/kg daily for 3 days',\n",
       " 'Antimalarial schizonticidal activity against Plasmodium falciparum 3D7 infected erythrocytes at 0.09 ug/ml after 30-39 hrs',\n",
       " 'Antimalarial activity schizonticidal against Plasmodium falciparum 3D7 infected erythrocytes at 0.05 ug/ml after 30-39 hrs',\n",
       " 'Toxicity in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus)',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 infected human A+ erythrocytes by Makler LDH reporter assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human RBC assessed as inhibition of parasite growth after 72 hrs by lactate dehydrogenase assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes as [3H]hypoxanthine uptake',\n",
       " 'Therapeutic index, Cytotoxicity against human KB cells to Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antimalarial activity after 48 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by pLDH assay',\n",
       " 'In vitro antimalarial activity for Plasmodium falciparum BHz26/86',\n",
       " 'Toxicity in mouse infected with Plasmodium berghei assessed as host survival at 100 mg/kg, po administered QD for 3 days measured on day 28',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 as parasite DNA microfluorimetric assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes',\n",
       " 'Antimalarial activity against Plasmodium falciparum TM91C235',\n",
       " 'Antimalarial activity reduced schizont maturation in Plasmodium berghei at 10 ug/mL after 16 hrs',\n",
       " 'Compound was tested for antimalarial activity in mice (Mus musculus), infected with Plasmodium yoelii NS, activity is expressed as the mortality rate at a concentration of 10 mg/kg. in experiment 1; 5 out of 5',\n",
       " 'Antimalarial activity against Plasmodium falciparum Nigerian',\n",
       " 'Antiparasitic activity against Plasmodium falciparum W2',\n",
       " 'Antimalarial activity as parasitaemia against Plasmodium berghei ANKA infected Swiss albino mice (Mus musculus) at 100 uM/kg intraperitoneal dose after 3 days',\n",
       " 'Antimalarial activity against erythrocytic stage of chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]-hypoxanthine incorporation incubated for 48 hrs prior to [3H]-hypoxanthine addition measured after 24 hrs by liquid scintillation counting',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against Plasmodium berghei str. ANKA infected in NMRI mouse assessed as mean survival days at 100 mg/kg, po qd for 4 days (Rvb = 7 days)',\n",
       " 'Antiplasmodial activity against Plasmodium berghei liver stage form transfected in human Huh-7 cells assessed as cell viability after 48 hrs by luciferase reporter gene assay',\n",
       " 'Antimalarial activity against multidrug-resistant and atovaquone-sensitive Plasmodium falciparum TM91C235',\n",
       " 'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 3',\n",
       " 'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum D2',\n",
       " 'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) expressed as mean survival time at 20 mg/kg',\n",
       " 'Antimalarial activity against Plasmodium falciparum infected in human O+ erythrocytes after 48 hrs by HRP2-ELISA method',\n",
       " 'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 25 mg/kg peroral dose (experiment 3); Not determined',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 assessed as inhibition of schizont maturation at 0.25 ug/ml after 36-40 hrs relative to control',\n",
       " 'Compound was tested for antimalarial activity in mice (Mus musculus), infected with Plasmodium yoelii NS, activity is expressed as the mortality rate at a concentration of 10 mg/kg. in experiment 2; 5 out of 5',\n",
       " 'Antimalarial activity against Plasmodium yoelii nigeriensis infected mice (Mus musculus) by oral dose',\n",
       " 'Compound was tested for antimalarial activity in mice (Mus musculus), infected with Plasmodium berghei N., activity is expressed as the mortality rate at a concentration of 10 mg/kg. in experiment 2; 5 out of 5',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by SYBR green 1 fluorescence-based method',\n",
       " 'Inhibition of 1-monooleoyl glycerol induced beta-hematin formation',\n",
       " 'Antiplasmodial activity as reduced parasitaemia against Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 10 mg/kg peroral dose',\n",
       " 'Antimalarial activity after 48 hrs against Plasmodium falciparum NF54 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Inhibitory concentration against Plasmodium falciparum D6 infected erythrocytes',\n",
       " 'Association constant with ferriprotoporphyrin IX.',\n",
       " 'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 in human erythrocytes by DAPI stain',\n",
       " 'Resistance index as ratio of IC50 for Plasmodium falciparum FcB1 and Thai strains',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 after 3 days by SYBR green I assay',\n",
       " 'Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes (stage 4 & 5)',\n",
       " 'In vitro growth inhibition against Plasmodium falciparum',\n",
       " 'Antimicrobial activity against Plasmodium falciparum harboring HFP-tagged Pfs16 protein after 48 hrs',\n",
       " 'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       " 'Antigametocyte activity against ring stage Plasmodium falciparum D10 assessed as inhibition of parasite growth at 50 nM after 1 to 8 hrs',\n",
       " 'Selective toxicity- EC50 value of FM3A / EC50 value of Plasmodium falciparum',\n",
       " 'Antimalarial activity against chloroquine,pyrimethamine-resistant Plasmodium falciparum K1 after 24 hrs',\n",
       " 'Antigametocyte activity against drug-resistant ring stage Plasmodium falciparum Dd2 schizonts assessed as inhibition of parasite growth at 50 nM after 1 to 8 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum W2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum PA infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 as LDH activity after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 8425 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Inhibitory concentration against chloroquine-sensitive Plasmodium falciparum',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 infected in human erythrocytes after 72 hrs by lactate dehydrogenase assay',\n",
       " 'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after oral administration',\n",
       " 'Antimalarial activity against drug-resistant Plasmodium falciparum D6 infected in Aotus lemurinus lemurinus monkey',\n",
       " 'Inhibition of Plasmodium falciparum GP1',\n",
       " 'Antimalarial activity as reduced parasitaemia against Plasmodium berghei NK65 infected ICR mice (Mus musculus) at 30 mg/kg/day peroral dose at day 4',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-IL2Rgamma null mouse assessed as decreased parasitemia at 50 mg/kg, po for 4 days after 28 days',\n",
       " 'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 24 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       " 'Antimalarial activity against Plasmodium falciparum PA assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antiplasmodial activity against drug resistant Plasmodium falciparum Dd2 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       " 'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum African D6',\n",
       " 'Selectivity index, ratio of CC50 for african green monkey Vero C1008 cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum T9-96 infected Rhesus positive human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum F32-Tanzania by [3H]hypoxanthine uptake',\n",
       " 'Anti-protozoal activity against Plasmodium falciparum K1 IEF stage after 72 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Selectivity ratio of IC50 for Plasmodium falciparum C235 to IC50 for Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium falciparum C235 containing mdr1 transporter gene assessed as growth inhibition after 72 hrs by SYBR Green 1-based fluorescence assay',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as parasite growth inhibition after 72 hrs by MSF assay',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine incorporation',\n",
       " 'Growth inhibition of Plasmodium vivax isolate 4 assessed as parasite LDH synthesis after 48 hrs by double-site Plasmodium LDH antigen capture enzyme-linked immunosorbent assay',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 10 mg/kg/day after 4 days',\n",
       " 'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 72 hrs by LDH assay',\n",
       " 'Resistant index. ratio of EC50 for chloroquine, mefloquine, pyrimethamine and atovaquone-resistant Plasmodium falciparum TM90-C2B to EC50 for chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by fluorometric method',\n",
       " 'Number of Plasmodium berghei infected mice died on day 16 at 160 mg/kg',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Ratio of EC50 for rat L6 cells to EC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in African green monkey (Cercopithecus aethiops) Vero cells after 72 hrs by twofold serial dilution method',\n",
       " 'Inhibition of Plasmodium falciparum falcipain-2 after 12 hrs by fluorescence spectroscopy-based on-bead assay',\n",
       " 'Antimicrobial activity against fast-growing synchronous Plasmodium vivax by microscopy',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antimicrobial activity against slow-growing synchronous Plasmodium vivax by microscopy',\n",
       " 'Growth inhibition of chloroquine-sensitive Plasmodium falciparum F32',\n",
       " 'Number of Plasmodium berghei infected mice died on day 25 at 640 mg/kg',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by pLDH reporter assay',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected in Swiss mouse assessed as survival at 10 mg/kg, ip qd for 5 days coadministered with ritonavir 40 mg/kg, po',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 10 mg/kg, perorally administered once daily for 3 days',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) assessed as reduction in parasitemia at 48 mg/kg, intraperitoneally after 3 days measured on day 4',\n",
       " 'Effective dose was determined in vivo for 90% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration',\n",
       " 'Antimalarial activity against erythrocyte stages of chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes by lactate dehydrogenase assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by FACS analysis in presence of 10 % human serum',\n",
       " 'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as cure rat at 3 mg/kg, perorally administered for 3 days post infection measured after 30 days',\n",
       " 'Antimalarial activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of IC50 for human HepG2 cells to IC50 for chloroquine, pyrimethamine, and mefloquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K14 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiprotozoal activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-sensitive ring stage plasmodium falciparum 3D7 infected in erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human RBCs after 72 hrs by parasite lactate dehydrogenase assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human O positive erythrocytes under low oxygen atmosphere after 72 hrs by spectrophotometric analysis',\n",
       " 'Compound was evaluated for uM concentration.',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected in ip dosed Swiss albino mouse assessed as suppression of parasitemia measured on day 4 post infection by Giemsa staining',\n",
       " 'Resistant index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum W2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Selectivity index, ratio of CC50 for african green monkey Vero C1008 cells to IC50 for Plasmodium falciparum 3D7',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana in human erythrocytes after 72 hrs by Malstat assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum HB3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity as reduced schizont maturation in Plasmodium berghei ANKA infected mice (Mus musculus) at 5 mg/kg/day peroral dose over 4 days',\n",
       " 'Resistance index as IC50 for Plasmodium falciparum K1 and Thai strains',\n",
       " 'Antiparasitic activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum Nigerian assessed as [3H]hypoxanthine uptake after 48 hrs by liquid scintillation counting',\n",
       " 'Antiplasmodial activity against Plasmodium berghei NK65 infected in Swiss Webster mice (Mus musculus) assessed as average parasitaemia at 200 mg/kg, perorally administered 1 day after infection measured after 10 days post infection',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 72 hrs by SYBR green 1 fluorescence-based method',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by DAPI staining method',\n",
       " 'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered subcutaneously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human red blood cells after 72 hrs by parasite lactate dehydrogenase assay',\n",
       " 'Antimalarial activity in mice (Mus musculus), infected with Plasmodium berghei N. activity is expressed as the percent of parasitaemia observed in mice (Mus musculus) at end of 4-day test at a concentration of 1 mg/kg in experiment 2',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 20 mg/kg/day after 4 days',\n",
       " 'Selectivity ratio of IC50 for human HepG2 cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Number of Plasmodium berghei infected mice died on day 18 at 160 mg/kg',\n",
       " 'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 0.2 uM treated for 48 hrs',\n",
       " 'Inhibition of Plasmodium falciparum K1 as [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial potency relative to chloroquine',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in Sprague-Dawley rat assessed as reduction in parasitemia at 30 mg/kg, po administered as 4 doses measured on day 4 post-infection by flow cytometry',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum HB3 by [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NF54 infected in human erythrocytes assessed as decrease in parasitemia measured on day 3 post-treatment by geimsa staining (Rvb = 2.18 +/- 0.17%)',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 by Malstat LDH activity',\n",
       " 'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 (CDC/Sierra Leone I)',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 after 24 hrs',\n",
       " 'Inhibitory activity against Plasmodium falciparum W2',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 ring-stage infected in human erythrocytes after 48 hrs by [3H]hypoxanthine assay',\n",
       " 'Growth inhibition of chloroquine-resistant Plasmodium falciparum KI',\n",
       " 'Antimalarial activity against Plasmodium vinckei petteri infected in CD mice (Mus musculus) assessed as inhibition of parasitaemia dosed daily for 4 days measured on day 5',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Thai after 24 hrs by semiautomated micro dilution assay',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum FcB1',\n",
       " 'Antimalarial activity against Plasmodium falciparum assessed as parasite growth inhibition after 48 hrs by [3H]hypoxanthin incorporation assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against wild type early trophozoite stage of Plasmodium falciparum D6 in human red blood cells assessed as [3H]hypoxanthine uptake after 96 hrs',\n",
       " 'Effect on survival of CD1 mice (Mus musculus) infected with Plasmodium berghei KBG173 at 4 mg/kg/day, peroral',\n",
       " 'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival time at 30 mg/kg, po administered as quadruple dose regimen',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 48 mg/kg/day orally',\n",
       " 'Antiplasmodial activity against Plasmodium berghei NK65 infected in Swiss Webster mice (Mus musculus) assessed as average parasitaemia at 200 mg/kg, perorally administered 1 day after infection measured after 7 days post infection',\n",
       " 'Antiprotozoal activity against Plasmodium falciparum',\n",
       " 'Selectivity index, ratio of IC50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum FCR3/Gambia',\n",
       " 'Survival rate in Plasmodium berghei NK65 infected JCL-ICR mice (Mus musculus) at 50 mg/kg body weight after 14 days',\n",
       " 'Antimalarial activity against Plasmodium falciparum FCM29 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 assessed as parasite growth inhibition after 72 hrs by MSF assay',\n",
       " 'Antimalarial activity against chloroquine sensitive Plasmodium falciparum FCR-3',\n",
       " 'Antimalarial activity against chloroquine resistant, mefloquine sensitive Plasmodium falciparum W2 infected in human erythrocytes by [3H]-hypoxanthine incorporation assay',\n",
       " 'In vitro efficacy for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against mefloquine-resistant, chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against drug-resistant Plasmodium falciparum TM91C235',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 3D7 infected in erythrocytes after 72 hrs by syber green 1 assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 48 hrs by SYBR green 1-based fluorescence assay',\n",
       " 'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 48 hrs prior to [3H] hypoxanthine addition measured after 24 hrs by liquid scintillation counting',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in RBC assessed as plasmodial LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum W2',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1Hf in presence of 5 uM verapamil by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by beta liquid scintillation counting method',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1AM pretreated with 0.1 uM phenobarbitone for 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of Plasmodium falciparum in HRP2 ELISA',\n",
       " 'Antimalarial activity in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) as reduced parasitaemia at 10 mg/kg initial oral dose and further intraperitoneal dose after 4 days',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium yoelii N67 infected in Swiss mice (Mus musculus) assessed as inhibition of parasitaemia at 10 mg/kg, perorally administered for 4 days measured on day 4 post-infection',\n",
       " 'Ability to associate with ferriprotoporphyrin IX',\n",
       " 'Antimalarial activity against drug-sensitive Plasmodium falciparum 3D7 after 24 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in type A rhesus-positive human erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by scintillation counting',\n",
       " 'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       " 'Resistance index, ratio IC50 for chloroquine-resistant Plasmodium falciparum Dd2 to IC50 for chloroquine-sensitive Plasmodium falciparum HB3',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 after 72 hrs',\n",
       " 'Selectivity index, ratio of CC50 for human MRC5 cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antiprotozoal activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3 assessed as SYBR Green 1 fluorescence emission after 72 hrs',\n",
       " 'Selectivity index, ratio of IC50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) erythrocytes at 10 uM after 18 hrs as reduced hemoglobin hydrolysis',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 72 hrs by parasite lactate dehydrogenase assay',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 20 mg/kg/day',\n",
       " 'Antimicrobial activity against Plasmodium falciparum harboring CVMNT genotype after 72 hrs by SYBR green I assay',\n",
       " 'Inhibition of Plasmodium falciparum falcipain 3 using substrate benzoxycarbonyl-Leu-Arg-7-amino-4-methyl-coumarin preincubated for 30 mins before substrate addition by fluorescence assay',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 30 mg/kg, po administered as single dose after 72 hrs by flow cytometry',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by SYBR green 1 assay',\n",
       " 'Growth inhibition of chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of ring stage parasite growth at IC50 after 6 hr by [3H]hypoxanthine incorporation assay',\n",
       " 'Growth inhibitory concentration against Plasmodium falciparum NF54',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum FcB1 to IC50 for drug-sensitive Plasmodium falciparum 3D7',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 5 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs',\n",
       " 'Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum VS1',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum PFB to IC50 for chloroquine-sensitive Plasmodium falciparum FC32',\n",
       " 'Inhibition of hydrogen peroxide-mediated haem detoxification in Plasmodium falciparum',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as reduction in parasitemia measured between day 1 and day 2 relative to control',\n",
       " 'Antimalarial activity against GFP-tagged Plasmodium berghei ANKA infected in NMRI mouse assessed as mouse survival at 30 mg/kg, po QD administered 24 hrs post infection for 3 days measured on day 30 post infection',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in po dosed NMRI mouse assessed as reduction in parasitemia administered as single dose after 72 hrs by flow cytometry',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 10 mg/kg, po administered as single dose after 72 hrs by flow cytometry',\n",
       " 'Reversal of chloroquine-resistance in Plasmodium chabaudi infected in mouse at 10 mg/kg, po coadministered with chloroquine 3 mg/kg, iv administered for 3 consecutive days measured on day 4',\n",
       " 'Ratio of cytotoxicity against rat L6 cells to IC50 for chloroquine-resistant Plasmodium falciparum NF54',\n",
       " 'Antiplasmodial activity as reduced parasitaemia against chloroquine-resistant Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 10 mg/kg/day peroral dose after 4 days',\n",
       " 'Antimalarial activity as schizonticidal activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Inhibition of Plasmodium falciparum 3D7',\n",
       " 'Antigametocyte activity against Plasmodium falciparum D10 trophozoites assessed as inhibition of parasite growth at 50 nM after 1 to 8 hrs',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected erythrocytes by MSF assay',\n",
       " 'Percent parasitemia after 0.75 mg/kg dose',\n",
       " 'Antimalarial activity against Plasmodium berghei infected ICR mice (Mus musculus) daily intraperitoneal dose for 4 days by Thompson test',\n",
       " 'Antimalarial activity against transgenic Plasmodium falciparum 3D7 infected in human A positive erythrocytes after 72 hrs by luciferase reporter gene assay',\n",
       " 'Antimalarial activity in mice (Mus musculus), infected with Plasmodium berghei N. activity is expressed as the percent of parasitaemia observed in mice (Mus musculus) at end of 4-day test at a concentration of 10 mg/kg in experiment 1',\n",
       " 'Antimalarial activity against Plasmodium vivax with >50% parasites at ring stage infected in human erythrocytes assessed as growth inhibition after 30 to 50 hrs by microscopic analysis using giemsa staining',\n",
       " 'Antimalarial activity against chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against Plasmodium knowlesi infected in rhesus monkey RBC assessed as [3H]-hypoxanthine incorporation after 12 hrs by scintillation counting',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as survival time at 3 mg/kg, perorally administered for 3 days post infection',\n",
       " 'Antimalarial activity against chloroquine, pyrimethamine, and mefloquine-resistant Plasmodium falciparum Dd2 infected in human O positive red blood cells assessed as inhibition of [3H]-hypoxanthine uptake after 48 hrs',\n",
       " 'In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       " 'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1 ring stage after 72 hrs by SYBP Green fluorescence-based assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum FAC8',\n",
       " 'Antiplasmodial activity against chloroquinone-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against Plasmodium berghei str. ANKA infected in NMRI mouse assessed as mean survival days at 10 mg/kg, po qd for 4 days (Rvb = 7 days)',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in Sprague-Dawley rat assessed as reduction in parasitemia at 3 mg/kg, po administered as single dose measured on day 3 post-infection by flow cytometry',\n",
       " 'Antiplasmodial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       " ...]"
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(new_df.ASSAY_DESCRIPTION.unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['nM',\n",
       " nan,\n",
       " '%',\n",
       " 'ug.mL-1',\n",
       " 'ng/ml',\n",
       " 'days',\n",
       " 'mg kg-1 day-1',\n",
       " 'um',\n",
       " 'mg Kg-1',\n",
       " 'mg kg-1',\n",
       " 'day',\n",
       " 'mg.kg-1',\n",
       " 'ug ml-1',\n",
       " 'nM hr',\n",
       " 'mg kg-1 day-1 x 5',\n",
       " 'mg/kg/day',\n",
       " 'mg ml-1',\n",
       " 'uM kg-1',\n",
       " 'ng ml-1',\n",
       " 'umol.kg-1',\n",
       " 'mL.min-1.kg-1',\n",
       " \"10'-8mol\",\n",
       " 'milliequivalent',\n",
       " 'uM',\n",
       " 'L.kg-1',\n",
       " 'molar ratio',\n",
       " 'hr',\n",
       " 'ug well-1',\n",
       " 'uM well-1',\n",
       " 'Cures/total',\n",
       " 'min-1',\n",
       " 's-1',\n",
       " 'M-1 s-1',\n",
       " 'ng.hr/ml',\n",
       " 'hr.ng/ml',\n",
       " 'mg kg-1 day-1 x 4',\n",
       " 'MST',\n",
       " 'nM g-1',\n",
       " 'ml/min',\n",
       " 'l',\n",
       " 'ng hr ml-1',\n",
       " 'uM ml-1',\n",
       " 'pM mg-1',\n",
       " 'nM hr-1 mg-1',\n",
       " 'mU mg-1',\n",
       " 'nM mg-1',\n",
       " 'mg mg-1',\n",
       " 'hr-1',\n",
       " \"10'6/M\",\n",
       " \"10'7/M\",\n",
       " 'mmHg',\n",
       " 'uM hr',\n",
       " 'min',\n",
       " 'uL min-1 mg-1',\n",
       " \"10'5/M\",\n",
       " 'ug',\n",
       " 'M-1 min-1',\n",
       " 'uM.min',\n",
       " 'cpm/uL',\n",
       " 'mL.min-1.g-1',\n",
       " 'nm/s',\n",
       " '10-6 cm/s',\n",
       " '%,%',\n",
       " 'g']"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(new_df.STANDARD_UNITS.unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.int64(266106)"
      ]
     },
     "execution_count": 94,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.MOLREGNO.duplicated().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.float64(1263969.659520729)"
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_df[\"STANDARD_VALUE\"].aggregate(\"mean\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    nM\n",
       "1    nM\n",
       "2    nM\n",
       "3    nM\n",
       "4    nM\n",
       "Name: STANDARD_UNITS, dtype: object"
      ]
     },
     "execution_count": 96,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "su = new_df['STANDARD_UNITS']\n",
    "\n",
    "su.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [],
   "source": [
    "units_df = pd.DataFrame(df[df[\"STANDARD_UNITS\"].notnull()].groupby(\"MOLREGNO\")[\"STANDARD_UNITS\"].unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "units_df[\"No Units\"] = units_df['STANDARD_UNITS'].apply(lambda x: len(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 264366 entries, 23 to 1540450\n",
      "Data columns (total 2 columns):\n",
      " #   Column          Non-Null Count   Dtype \n",
      "---  ------          --------------   ----- \n",
      " 0   STANDARD_UNITS  264366 non-null  object\n",
      " 1   No Units        264366 non-null  int64 \n",
      "dtypes: int64(1), object(1)\n",
      "memory usage: 6.1+ MB\n"
     ]
    }
   ],
   "source": [
    "units_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [],
   "source": [
    "units_df.rename(columns={\"No Units\": \"no_units\"}, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>STANDARD_UNITS</th>\n",
       "      <th>no_units</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>[nM]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>[nM]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>[nM]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>[nM]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>[nM, %, ug.mL-1, ng/ml]</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1531021</th>\n",
       "      <td>[ug.mL-1]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1531022</th>\n",
       "      <td>[ug.mL-1]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1531023</th>\n",
       "      <td>[ug.mL-1]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1531024</th>\n",
       "      <td>[ug.mL-1]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1540450</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>264366 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   STANDARD_UNITS  no_units\n",
       "MOLREGNO                                   \n",
       "23                           [nM]         1\n",
       "111                          [nM]         1\n",
       "146                          [nM]         1\n",
       "147                          [nM]         1\n",
       "148       [nM, %, ug.mL-1, ng/ml]         4\n",
       "...                           ...       ...\n",
       "1531021                 [ug.mL-1]         1\n",
       "1531022                 [ug.mL-1]         1\n",
       "1531023                 [ug.mL-1]         1\n",
       "1531024                 [ug.mL-1]         1\n",
       "1540450                   [%, nM]         2\n",
       "\n",
       "[264366 rows x 2 columns]"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "units_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>STANDARD_UNITS</th>\n",
       "      <th>no_units</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>[nM, %, ug.mL-1, ng/ml]</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>[nM, %, ug.mL-1]</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1024</th>\n",
       "      <td>[nM, %]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529184</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529185</th>\n",
       "      <td>[nM, %]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529186</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529187</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1540450</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>22824 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   STANDARD_UNITS  no_units\n",
       "MOLREGNO                                   \n",
       "148       [nM, %, ug.mL-1, ng/ml]         4\n",
       "236                       [%, nM]         2\n",
       "241              [nM, %, ug.mL-1]         3\n",
       "322                       [%, nM]         2\n",
       "1024                      [nM, %]         2\n",
       "...                           ...       ...\n",
       "1529184                   [%, nM]         2\n",
       "1529185                   [nM, %]         2\n",
       "1529186                   [%, nM]         2\n",
       "1529187                   [%, nM]         2\n",
       "1540450                   [%, nM]         2\n",
       "\n",
       "[22824 rows x 2 columns]"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "units_df.query(\"no_units != 1\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>STANDARD_UNITS</th>\n",
       "      <th>no_units</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>[nM, %, ug.mL-1, ng/ml]</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>[nM, %, ug.mL-1]</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1024</th>\n",
       "      <td>[nM, %]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529184</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529185</th>\n",
       "      <td>[nM, %]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529186</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529187</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1540450</th>\n",
       "      <td>[%, nM]</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>26830 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   STANDARD_UNITS  no_units\n",
       "MOLREGNO                                   \n",
       "148       [nM, %, ug.mL-1, ng/ml]         4\n",
       "236                       [%, nM]         2\n",
       "241              [nM, %, ug.mL-1]         3\n",
       "322                       [%, nM]         2\n",
       "1024                      [nM, %]         2\n",
       "...                           ...       ...\n",
       "1529184                   [%, nM]         2\n",
       "1529185                   [nM, %]         2\n",
       "1529186                   [%, nM]         2\n",
       "1529187                   [%, nM]         2\n",
       "1540450                   [%, nM]         2\n",
       "\n",
       "[26830 rows x 2 columns]"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "units_df[units_df.STANDARD_UNITS.apply(lambda x: \"%\" in x)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "no_units\n",
       "1     241542\n",
       "2      21629\n",
       "3        980\n",
       "4        130\n",
       "5         58\n",
       "6         10\n",
       "9          3\n",
       "7          3\n",
       "10         3\n",
       "8          2\n",
       "11         2\n",
       "15         1\n",
       "25         1\n",
       "14         1\n",
       "12         1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "n_units_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<BarContainer object of 15 artists>"
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "n_units_count = units_df.no_units.value_counts()\n",
    "plt.bar(n_units_count.index, height=n_units_count.values, )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>STANDARD_UNITS</th>\n",
       "      <th>no_units</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2080</th>\n",
       "      <td>[nM, ug.mL-1, days, %, um, mg Kg-1, mg kg-1 da...</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6579</th>\n",
       "      <td>[nM, %, ug.mL-1, mg kg-1, day, days, mg.kg-1, ...</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6936</th>\n",
       "      <td>[nM, ug.mL-1, mg kg-1 day-1, %, mg.kg-1, days,...</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9459</th>\n",
       "      <td>[%, ug.mL-1, nM, days, um]</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10389</th>\n",
       "      <td>[ug.mL-1, nM, days, day, umol.kg-1, %, mg/kg/d...</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1203056</th>\n",
       "      <td>[mL.min-1.g-1, ug.mL-1, hr, %, nM]</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1264978</th>\n",
       "      <td>[day, mg kg-1, mg.kg-1, nM, %]</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1281805</th>\n",
       "      <td>[nM, uM.min, mg kg-1, mg.kg-1, hr]</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1348407</th>\n",
       "      <td>[%, nM, day, mg kg-1, mg.kg-1]</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1386335</th>\n",
       "      <td>[uL min-1 mg-1, min, ug.mL-1, %, nM]</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>85 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             STANDARD_UNITS  no_units\n",
       "MOLREGNO                                                             \n",
       "2080      [nM, ug.mL-1, days, %, um, mg Kg-1, mg kg-1 da...         8\n",
       "6579      [nM, %, ug.mL-1, mg kg-1, day, days, mg.kg-1, ...        25\n",
       "6936      [nM, ug.mL-1, mg kg-1 day-1, %, mg.kg-1, days,...        15\n",
       "9459                             [%, ug.mL-1, nM, days, um]         5\n",
       "10389     [ug.mL-1, nM, days, day, umol.kg-1, %, mg/kg/d...        10\n",
       "...                                                     ...       ...\n",
       "1203056                  [mL.min-1.g-1, ug.mL-1, hr, %, nM]         5\n",
       "1264978                      [day, mg kg-1, mg.kg-1, nM, %]         5\n",
       "1281805                  [nM, uM.min, mg kg-1, mg.kg-1, hr]         5\n",
       "1348407                      [%, nM, day, mg kg-1, mg.kg-1]         5\n",
       "1386335                [uL min-1 mg-1, min, ug.mL-1, %, nM]         5\n",
       "\n",
       "[85 rows x 2 columns]"
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "units_df.query(\"no_units > 4\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>MOL_CHEMBL_ID</th>\n",
       "      <th>DOWNGRADED</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>STANDARD_INCHI</th>\n",
       "      <th>FULL_MWT</th>\n",
       "      <th>ALOGP</th>\n",
       "      <th>ACD_LOGP</th>\n",
       "      <th>ACD_LOGD</th>\n",
       "      <th>PSA</th>\n",
       "      <th>...</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "      <th>TARGET_CHEMBL_ID</th>\n",
       "      <th>JOURNAL</th>\n",
       "      <th>YEAR</th>\n",
       "      <th>TITLE</th>\n",
       "      <th>PUBMED_ID</th>\n",
       "      <th>DOI</th>\n",
       "      <th>DOC_TYPE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>542</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>SINGLE PROTEIN</td>\n",
       "      <td>Dihydrofolate reductase</td>\n",
       "      <td>Plasmodium falciparum K1</td>\n",
       "      <td>CHEMBL1939</td>\n",
       "      <td>J. Med. Chem.</td>\n",
       "      <td>2004.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15293997.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>543</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum (isolate K1 / Thailand)</td>\n",
       "      <td>Plasmodium falciparum K1</td>\n",
       "      <td>CHEMBL612856</td>\n",
       "      <td>Bioorg. Med. Chem. Lett.</td>\n",
       "      <td>2005.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15780626.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>544</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium berghei</td>\n",
       "      <td>Plasmodium berghei</td>\n",
       "      <td>CHEMBL612653</td>\n",
       "      <td>J. Med. Chem.</td>\n",
       "      <td>1984.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6502605.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum (isolate K1 / Thailand)</td>\n",
       "      <td>Plasmodium falciparum K1</td>\n",
       "      <td>CHEMBL612856</td>\n",
       "      <td>Bioorg. Med. Chem. Lett.</td>\n",
       "      <td>2005.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15878272.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Science</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20813948.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>794</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Antimicrob. Agents Chemother.</td>\n",
       "      <td>2007.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>17875995.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>795</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Antimicrob. Agents Chemother.</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20350951.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>796</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>SINGLE PROTEIN</td>\n",
       "      <td>Dihydrofolate reductase</td>\n",
       "      <td>Plasmodium falciparum K1</td>\n",
       "      <td>CHEMBL1939</td>\n",
       "      <td>J. Med. Chem.</td>\n",
       "      <td>2002.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>11881993.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>797</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>Bioorg. Med. Chem. Lett.</td>\n",
       "      <td>2008.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18039570.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>798</th>\n",
       "      <td>2080</td>\n",
       "      <td>CHEMBL36</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1nc(N)nc(N)c1c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...</td>\n",
       "      <td>248.71</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.75</td>\n",
       "      <td>2.55</td>\n",
       "      <td>77.81</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Antimicrob. Agents Chemother.</td>\n",
       "      <td>2007.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>17875995.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>257 rows Ã— 44 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     MOLREGNO MOL_CHEMBL_ID  DOWNGRADED              CANONICAL_SMILES  \\\n",
       "542      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "543      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "544      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "545      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "546      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "..        ...           ...         ...                           ...   \n",
       "794      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "795      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "796      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "797      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "798      2080      CHEMBL36           0  CCc1nc(N)nc(N)c1c2ccc(Cl)cc2   \n",
       "\n",
       "                                        STANDARD_INCHI  FULL_MWT  ALOGP  \\\n",
       "542  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "543  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "544  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "545  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "546  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "..                                                 ...       ...    ...   \n",
       "794  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "795  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "796  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "797  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "798  InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)1...    248.71   2.75   \n",
       "\n",
       "     ACD_LOGP  ACD_LOGD    PSA  ...     TARGET_TYPE  \\\n",
       "542      2.75      2.55  77.81  ...  SINGLE PROTEIN   \n",
       "543      2.75      2.55  77.81  ...        ORGANISM   \n",
       "544      2.75      2.55  77.81  ...        ORGANISM   \n",
       "545      2.75      2.55  77.81  ...        ORGANISM   \n",
       "546      2.75      2.55  77.81  ...       UNCHECKED   \n",
       "..        ...       ...    ...  ...             ...   \n",
       "794      2.75      2.55  77.81  ...       UNCHECKED   \n",
       "795      2.75      2.55  77.81  ...       UNCHECKED   \n",
       "796      2.75      2.55  77.81  ...  SINGLE PROTEIN   \n",
       "797      2.75      2.55  77.81  ...        ORGANISM   \n",
       "798      2.75      2.55  77.81  ...       UNCHECKED   \n",
       "\n",
       "                                         PREF_NAME                  ORGANISM  \\\n",
       "542                        Dihydrofolate reductase  Plasmodium falciparum K1   \n",
       "543  Plasmodium falciparum (isolate K1 / Thailand)  Plasmodium falciparum K1   \n",
       "544                             Plasmodium berghei        Plasmodium berghei   \n",
       "545  Plasmodium falciparum (isolate K1 / Thailand)  Plasmodium falciparum K1   \n",
       "546                                      Unchecked                       NaN   \n",
       "..                                             ...                       ...   \n",
       "794                                      Unchecked                       NaN   \n",
       "795                                      Unchecked                       NaN   \n",
       "796                        Dihydrofolate reductase  Plasmodium falciparum K1   \n",
       "797                          Plasmodium falciparum     Plasmodium falciparum   \n",
       "798                                      Unchecked                       NaN   \n",
       "\n",
       "    TARGET_CHEMBL_ID                        JOURNAL    YEAR TITLE   PUBMED_ID  \\\n",
       "542       CHEMBL1939                  J. Med. Chem.  2004.0   NaN  15293997.0   \n",
       "543     CHEMBL612856       Bioorg. Med. Chem. Lett.  2005.0   NaN  15780626.0   \n",
       "544     CHEMBL612653                  J. Med. Chem.  1984.0   NaN   6502605.0   \n",
       "545     CHEMBL612856       Bioorg. Med. Chem. Lett.  2005.0   NaN  15878272.0   \n",
       "546     CHEMBL612545                        Science  2010.0   NaN  20813948.0   \n",
       "..               ...                            ...     ...   ...         ...   \n",
       "794     CHEMBL612545  Antimicrob. Agents Chemother.  2007.0   NaN  17875995.0   \n",
       "795     CHEMBL612545  Antimicrob. Agents Chemother.  2010.0   NaN  20350951.0   \n",
       "796       CHEMBL1939                  J. Med. Chem.  2002.0   NaN  11881993.0   \n",
       "797        CHEMBL364       Bioorg. Med. Chem. Lett.  2008.0   NaN  18039570.0   \n",
       "798     CHEMBL612545  Antimicrob. Agents Chemother.  2007.0   NaN  17875995.0   \n",
       "\n",
       "     DOI     DOC_TYPE  \n",
       "542  NaN  PUBLICATION  \n",
       "543  NaN  PUBLICATION  \n",
       "544  NaN  PUBLICATION  \n",
       "545  NaN  PUBLICATION  \n",
       "546  NaN  PUBLICATION  \n",
       "..   ...          ...  \n",
       "794  NaN  PUBLICATION  \n",
       "795  NaN  PUBLICATION  \n",
       "796  NaN  PUBLICATION  \n",
       "797  NaN  PUBLICATION  \n",
       "798  NaN  PUBLICATION  \n",
       "\n",
       "[257 rows x 44 columns]"
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.query(\"MOLREGNO == 2080\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "DOC_TYPE\n",
       "DATASET        343366\n",
       "PUBLICATION    189047\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 117,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.DOC_TYPE.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "STANDARD_UNITS\n",
       "nM               326679\n",
       "%                  7695\n",
       "ug.mL-1            5766\n",
       "uM                 1050\n",
       "hr                  248\n",
       "mL.min-1.g-1        234\n",
       "day                  65\n",
       "nm/s                 16\n",
       "10-6 cm/s            10\n",
       "uL min-1 mg-1         7\n",
       "min                   7\n",
       "%,%                   3\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 120,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.query(\"DOC_TYPE == 'DATASET'\")[\"STANDARD_UNITS\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "STANDARD_UNITS\n",
       "%                    80021\n",
       "nM                   72203\n",
       "ug.mL-1               5315\n",
       "days                  3317\n",
       "mg.kg-1                593\n",
       "day                    502\n",
       "mg kg-1                409\n",
       "um                     315\n",
       "mg kg-1 day-1          244\n",
       "ng ml-1                200\n",
       "uM well-1              104\n",
       "Cures/total             94\n",
       "mg/kg/day               79\n",
       "hr                      70\n",
       "ug ml-1                 58\n",
       "mg kg-1 day-1 x 5       46\n",
       "uM                      40\n",
       "umol.kg-1               39\n",
       "ug well-1               24\n",
       "ng.hr/ml                23\n",
       "uM kg-1                 23\n",
       "ng/ml                   20\n",
       "milliequivalent         20\n",
       "mg Kg-1                 12\n",
       "pM mg-1                 12\n",
       "min-1                   11\n",
       "M-1 s-1                 10\n",
       "s-1                     10\n",
       "mg ml-1                  9\n",
       "L.kg-1                   9\n",
       "mL.min-1.kg-1            9\n",
       "cpm/uL                   8\n",
       "molar ratio              8\n",
       "nM hr                    6\n",
       "mU mg-1                  6\n",
       "l                        6\n",
       "mg kg-1 day-1 x 4        6\n",
       "10'-8mol                 4\n",
       "ml/min                   4\n",
       "nM hr-1 mg-1             4\n",
       "nM mg-1                  3\n",
       "uM.min                   3\n",
       "10'5/M                   3\n",
       "M-1 min-1                3\n",
       "mg mg-1                  3\n",
       "g                        2\n",
       "10'7/M                   2\n",
       "mmHg                     2\n",
       "hr-1                     2\n",
       "hr.ng/ml                 1\n",
       "uM ml-1                  1\n",
       "ng hr ml-1               1\n",
       "MST                      1\n",
       "nM g-1                   1\n",
       "10'6/M                   1\n",
       "ug                       1\n",
       "uM hr                    1\n",
       "min                      1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.query(\"DOC_TYPE == 'PUBLICATION'\")[\"STANDARD_UNITS\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>MOL_CHEMBL_ID</th>\n",
       "      <th>DOWNGRADED</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>STANDARD_INCHI</th>\n",
       "      <th>FULL_MWT</th>\n",
       "      <th>ALOGP</th>\n",
       "      <th>ACD_LOGP</th>\n",
       "      <th>ACD_LOGD</th>\n",
       "      <th>PSA</th>\n",
       "      <th>...</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "      <th>TARGET_CHEMBL_ID</th>\n",
       "      <th>JOURNAL</th>\n",
       "      <th>YEAR</th>\n",
       "      <th>TITLE</th>\n",
       "      <th>PUBMED_ID</th>\n",
       "      <th>DOI</th>\n",
       "      <th>DOC_TYPE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>148</td>\n",
       "      <td>CHEMBL6246</td>\n",
       "      <td>0</td>\n",
       "      <td>Oc1cc2C(=O)Oc3c(O)c(O)cc4C(=O)Oc(c1O)c2c34</td>\n",
       "      <td>InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7...</td>\n",
       "      <td>302.19</td>\n",
       "      <td>1.58</td>\n",
       "      <td>0.24</td>\n",
       "      <td>-3.38</td>\n",
       "      <td>133.52</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium vinckei petteri</td>\n",
       "      <td>Plasmodium vinckei petteri</td>\n",
       "      <td>CHEMBL613012</td>\n",
       "      <td>Antimicrob. Agents Chemother.</td>\n",
       "      <td>2009.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>19015354.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>148</td>\n",
       "      <td>CHEMBL6246</td>\n",
       "      <td>0</td>\n",
       "      <td>Oc1cc2C(=O)Oc3c(O)c(O)cc4C(=O)Oc(c1O)c2c34</td>\n",
       "      <td>InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7...</td>\n",
       "      <td>302.19</td>\n",
       "      <td>1.58</td>\n",
       "      <td>0.24</td>\n",
       "      <td>-3.38</td>\n",
       "      <td>133.52</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium vinckei petteri</td>\n",
       "      <td>Plasmodium vinckei petteri</td>\n",
       "      <td>CHEMBL613012</td>\n",
       "      <td>Antimicrob. Agents Chemother.</td>\n",
       "      <td>2009.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>19015354.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>236</td>\n",
       "      <td>CHEMBL6229</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1cc2c(Sc3nnc(N)s3)ncnc2s1</td>\n",
       "      <td>InChI=1S/C10H9N5S3/c1-2-5-3-6-7(16-5)12-4-13-8...</td>\n",
       "      <td>295.41</td>\n",
       "      <td>2.85</td>\n",
       "      <td>2.81</td>\n",
       "      <td>2.81</td>\n",
       "      <td>159.36</td>\n",
       "      <td>...</td>\n",
       "      <td>CELL-LINE</td>\n",
       "      <td>HepG2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>CHEMBL395</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>236</td>\n",
       "      <td>CHEMBL6229</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1cc2c(Sc3nnc(N)s3)ncnc2s1</td>\n",
       "      <td>InChI=1S/C10H9N5S3/c1-2-5-3-6-7(16-5)12-4-13-8...</td>\n",
       "      <td>295.41</td>\n",
       "      <td>2.85</td>\n",
       "      <td>2.81</td>\n",
       "      <td>2.81</td>\n",
       "      <td>159.36</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>236</td>\n",
       "      <td>CHEMBL6229</td>\n",
       "      <td>0</td>\n",
       "      <td>CCc1cc2c(Sc3nnc(N)s3)ncnc2s1</td>\n",
       "      <td>InChI=1S/C10H9N5S3/c1-2-5-3-6-7(16-5)12-4-13-8...</td>\n",
       "      <td>295.41</td>\n",
       "      <td>2.85</td>\n",
       "      <td>2.81</td>\n",
       "      <td>2.81</td>\n",
       "      <td>159.36</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532402</th>\n",
       "      <td>1540450</td>\n",
       "      <td>CHEMBL2364559</td>\n",
       "      <td>0</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...</td>\n",
       "      <td>360.88</td>\n",
       "      <td>2.73</td>\n",
       "      <td>2.82</td>\n",
       "      <td>0.98</td>\n",
       "      <td>45.59</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532407</th>\n",
       "      <td>1540450</td>\n",
       "      <td>CHEMBL2364559</td>\n",
       "      <td>0</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...</td>\n",
       "      <td>360.88</td>\n",
       "      <td>2.73</td>\n",
       "      <td>2.82</td>\n",
       "      <td>0.98</td>\n",
       "      <td>45.59</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532409</th>\n",
       "      <td>1540450</td>\n",
       "      <td>CHEMBL2364559</td>\n",
       "      <td>0</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...</td>\n",
       "      <td>360.88</td>\n",
       "      <td>2.73</td>\n",
       "      <td>2.82</td>\n",
       "      <td>0.98</td>\n",
       "      <td>45.59</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532410</th>\n",
       "      <td>1540450</td>\n",
       "      <td>CHEMBL2364559</td>\n",
       "      <td>0</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...</td>\n",
       "      <td>360.88</td>\n",
       "      <td>2.73</td>\n",
       "      <td>2.82</td>\n",
       "      <td>0.98</td>\n",
       "      <td>45.59</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532411</th>\n",
       "      <td>1540450</td>\n",
       "      <td>CHEMBL2364559</td>\n",
       "      <td>0</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...</td>\n",
       "      <td>360.88</td>\n",
       "      <td>2.73</td>\n",
       "      <td>2.82</td>\n",
       "      <td>0.98</td>\n",
       "      <td>45.59</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>Nature</td>\n",
       "      <td>2010.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20485427.0</td>\n",
       "      <td>10.1038/nature09107</td>\n",
       "      <td>PUBLICATION</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>87716 rows Ã— 44 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        MOLREGNO  MOL_CHEMBL_ID  DOWNGRADED  \\\n",
       "23           148     CHEMBL6246           0   \n",
       "57           148     CHEMBL6246           0   \n",
       "68           236     CHEMBL6229           0   \n",
       "69           236     CHEMBL6229           0   \n",
       "71           236     CHEMBL6229           0   \n",
       "...          ...            ...         ...   \n",
       "532402   1540450  CHEMBL2364559           0   \n",
       "532407   1540450  CHEMBL2364559           0   \n",
       "532409   1540450  CHEMBL2364559           0   \n",
       "532410   1540450  CHEMBL2364559           0   \n",
       "532411   1540450  CHEMBL2364559           0   \n",
       "\n",
       "                                         CANONICAL_SMILES  \\\n",
       "23             Oc1cc2C(=O)Oc3c(O)c(O)cc4C(=O)Oc(c1O)c2c34   \n",
       "57             Oc1cc2C(=O)Oc3c(O)c(O)cc4C(=O)Oc(c1O)c2c34   \n",
       "68                           CCc1cc2c(Sc3nnc(N)s3)ncnc2s1   \n",
       "69                           CCc1cc2c(Sc3nnc(N)s3)ncnc2s1   \n",
       "71                           CCc1cc2c(Sc3nnc(N)s3)ncnc2s1   \n",
       "...                                                   ...   \n",
       "532402  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532407  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532409  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532410  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532411  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "\n",
       "                                           STANDARD_INCHI  FULL_MWT  ALOGP  \\\n",
       "23      InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7...    302.19   1.58   \n",
       "57      InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7...    302.19   1.58   \n",
       "68      InChI=1S/C10H9N5S3/c1-2-5-3-6-7(16-5)12-4-13-8...    295.41   2.85   \n",
       "69      InChI=1S/C10H9N5S3/c1-2-5-3-6-7(16-5)12-4-13-8...    295.41   2.85   \n",
       "71      InChI=1S/C10H9N5S3/c1-2-5-3-6-7(16-5)12-4-13-8...    295.41   2.85   \n",
       "...                                                   ...       ...    ...   \n",
       "532402  InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...    360.88   2.73   \n",
       "532407  InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...    360.88   2.73   \n",
       "532409  InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...    360.88   2.73   \n",
       "532410  InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...    360.88   2.73   \n",
       "532411  InChI=1S/C20H24N2O2.ClH/c1-3-13-12-22-9-7-14(1...    360.88   2.73   \n",
       "\n",
       "        ACD_LOGP  ACD_LOGD     PSA  ... TARGET_TYPE  \\\n",
       "23          0.24     -3.38  133.52  ...    ORGANISM   \n",
       "57          0.24     -3.38  133.52  ...    ORGANISM   \n",
       "68          2.81      2.81  159.36  ...   CELL-LINE   \n",
       "69          2.81      2.81  159.36  ...    ORGANISM   \n",
       "71          2.81      2.81  159.36  ...   UNCHECKED   \n",
       "...          ...       ...     ...  ...         ...   \n",
       "532402      2.82      0.98   45.59  ...   UNCHECKED   \n",
       "532407      2.82      0.98   45.59  ...    ORGANISM   \n",
       "532409      2.82      0.98   45.59  ...    ORGANISM   \n",
       "532410      2.82      0.98   45.59  ...    ORGANISM   \n",
       "532411      2.82      0.98   45.59  ...   UNCHECKED   \n",
       "\n",
       "                         PREF_NAME                    ORGANISM  \\\n",
       "23      Plasmodium vinckei petteri  Plasmodium vinckei petteri   \n",
       "57      Plasmodium vinckei petteri  Plasmodium vinckei petteri   \n",
       "68                           HepG2                Homo sapiens   \n",
       "69           Plasmodium falciparum       Plasmodium falciparum   \n",
       "71                       Unchecked                         NaN   \n",
       "...                            ...                         ...   \n",
       "532402                   Unchecked                         NaN   \n",
       "532407       Plasmodium falciparum       Plasmodium falciparum   \n",
       "532409       Plasmodium falciparum       Plasmodium falciparum   \n",
       "532410       Plasmodium falciparum       Plasmodium falciparum   \n",
       "532411                   Unchecked                         NaN   \n",
       "\n",
       "       TARGET_CHEMBL_ID                        JOURNAL    YEAR TITLE  \\\n",
       "23         CHEMBL613012  Antimicrob. Agents Chemother.  2009.0   NaN   \n",
       "57         CHEMBL613012  Antimicrob. Agents Chemother.  2009.0   NaN   \n",
       "68            CHEMBL395                         Nature  2010.0   NaN   \n",
       "69            CHEMBL364                         Nature  2010.0   NaN   \n",
       "71         CHEMBL612545                         Nature  2010.0   NaN   \n",
       "...                 ...                            ...     ...   ...   \n",
       "532402     CHEMBL612545                         Nature  2010.0   NaN   \n",
       "532407        CHEMBL364                         Nature  2010.0   NaN   \n",
       "532409        CHEMBL364                         Nature  2010.0   NaN   \n",
       "532410        CHEMBL364                         Nature  2010.0   NaN   \n",
       "532411     CHEMBL612545                         Nature  2010.0   NaN   \n",
       "\n",
       "         PUBMED_ID                  DOI     DOC_TYPE  \n",
       "23      19015354.0                  NaN  PUBLICATION  \n",
       "57      19015354.0                  NaN  PUBLICATION  \n",
       "68      20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "69      20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "71      20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "...            ...                  ...          ...  \n",
       "532402  20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "532407  20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "532409  20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "532410  20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "532411  20485427.0  10.1038/nature09107  PUBLICATION  \n",
       "\n",
       "[87716 rows x 44 columns]"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.query(\"STANDARD_UNITS == '%'\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "units_df = units_df.join(\n",
    "    pd.DataFrame(df[df[\"STANDARD_UNITS\"].notnull()].groupby(\n",
    "        \"MOLREGNO\"\n",
    "        )[\"ASSAY_DESCRIPTION\"].unique()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[array(['Inhibition of Plasmodium falciparum thioredoxin reductase by DTNB assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, ip measured on day 4 postinfection',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum FcB1',\n",
       "        'Inhibition of Plasmodium falciparum glutathione S-transferase',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Inhibition of Plasmodium falciparum glutathione reductase by spectrophotometer',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum FcM29',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP). (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial activity against mefloquine-susceptible Plasmodium falciparum Dd2 assessed as 50% reversant concentration required for mefloquine resistant',\n",
       "        'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, ip measured on day 5 postinfection',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum thioredoxin reductase TrxR assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-24 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT K2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-12 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTVo1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Not Plasmodium species',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 36-48 hrs post infection',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PA infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTL1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-36 hrs post infection',\n",
       "        'Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT10500 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry',\n",
       "        'In vitro antibacterial activity against gram negative P. aeruginosa DPHP 5263',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-24 hrs post infection',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-36 hrs post infection',\n",
       "        'Antimalarial activity as 3rd generation after 96 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 0-48 hrs post invasion',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCM29 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-48 hrs post infection',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-36 hrs post infection',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-48 hrs post infection',\n",
       "        'Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free',\n",
       "        'Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Displacement of bis-ANS from Plasmodium falciparum 3D7 Hsp90 expressed in Escherichia coli BL21(DE3) assessed as reduction in fluorescence at 100 uM after 30 min by fluorescent monochromator spectrophotometry',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Inhibition of Plasmodium falciparum recombinant GSK3 expressed in Escherichia coli using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum isolate 208432 infected in human erythrocytes after 48 hrs by flow-cytometry'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Antimalarial activity as survivor number at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72 hr',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hrs',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72 hr',\n",
       "        'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 20 mg/kg subcutaneous dose after 72 hr',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) after 72 hr',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 80 mg/kg subcutaneous dose over 72 hr',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'Inhibitory activity against wild-type dihydrofolate reductase (S108N DHFR)',\n",
       "        'Inhibitory activity against triple mutant dihydrofolate reductase (C59R S108 NI164L DHFR)',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum NF10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum KC2 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D2 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum DAN after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum WE2 after 72 hrs by SYBR green assay',\n",
       "        'Inhibitory activity against double mutant dihydrofolate reductase (C59R+S108N DHFR)',\n",
       "        'Inhibition of Plasmodium falciparum DHFR',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum KH7 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum LC12 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum XE7 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JC9 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum XG10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JF11 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JF6 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JB12 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against transgenic Plasmodium falciparum Dd2 pDT harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JC3 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Inhibitory activity against Dihydrofolate reductase enzyme purified from Plasmodium berghei.',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JB8 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum LA10 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum XB3 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum TF1 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against transgenic Plasmodium falciparum HB3 pDT harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum XF12 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum QF5 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JH6 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum WF12 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'In vitro inhibition of dihydrofolate reductase of Plasmodium berghei',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum DEV after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum NIC after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       "        'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum AL2 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum KB8 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum JON after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum XD8 after 72 hrs by SYBR green assay',\n",
       "        'Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay',\n",
       "        'Compound was tested for its inhibition against dihydrofolate reductase enzyme of Plasmodium berghei',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum KC5 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum KA6 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum WC4 after 72 hrs by SYBR green assay',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibitory activity against quadruple mutant dihydrofolate reductase (N51I C59R S108N I164L DHFR)',\n",
       "        'Inhibitory activity against dihydrofolate reductase (DHFR) enzyme from Plasmodium berghei',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum AUD after 72 hrs by SYBR green assay'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 50 uM',\n",
       "        'In Vitro evaluation on percentage inhibition in Heme Oxygenase at concentration 100(uM) of Cell-free parasite Plasmodium yoelii'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg.',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg; 3 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum schizonts assessed as change in parasitemia at IC50 concentration treated until all schizonts had burst and invasion was assumed to have occurred by Giemsa staining-based microscopy relative to control',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by lactate dehydrogenase assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs by lactate dehydrogenase assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum schizonts assessed as parasitemia at IC50 concentration treated until all schizonts had burst and invasion was assumed to have occurred by Giemsa staining-based microscopy (Rvb = 8.83%)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 10 uM after 15 min by spectrophotometry',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'Minimum inhibitory concentration against schizont maturation of Plasmodium falciparum NF54 ring stage after 40 h',\n",
       "        'Antimalarial activity as survivor number at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       "        'Minimum inhibitory concentration against schizont maturation in Plasmodium falciparum NF-54',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Inhibition constant against wild-type PfDHFR (Plasmodium falciparum dihydrofolate reductase)',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Growth inhibition of Plasmodium falciparum Dd2 ring stage infected erythrocytes after 72 hrs by DAPI fluorimetry',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity as inhibition of schizont maturation against Plasmodium malariae Thai after 40 - 70 hrs',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 40 mg/kg; 1 survived after 60 days of postinfection',\n",
       "        'OSM: Inhibition of Plasmodium falciparum 3D7 growth using a SYBR green I fluorescence based assay. GSK Tres Cantos.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 20 mg/kg.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Inhibition of Plasmodium falciparum DHFR assessed as oxidation of NADPH to NADP+ after 15 mins spectrophotometric assay',\n",
       "        'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'Antiparasitemia activity against Plasmodium berghei infected mice (Mus musculus) at 30 mg/kg peroral dose for 4 days',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibitory concentration against cycloguanil sensitive Plasmodium falciparum FJB-D9 ',\n",
       "        'In vitro cytotoxicity against Plasmodium falciparum infected vero cell line.',\n",
       "        'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase wild type (TM4/8.2)',\n",
       "        'Antimalarial activity against Plasmodium falciparum FC27',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH assay',\n",
       "        'Anti-malarial activity against Plasmodium falciparum Dd2',\n",
       "        'Inhibitory concentration against cycloguanil sensitive Plasmodium falciparum FJB-D4 ',\n",
       "        'Antiplasmodial activity against Plasmodium vivax',\n",
       "        'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum K1',\n",
       "        'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'OSM: Inhibition of Plasmodium falciparum 3D7 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       "        'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Inhibition of WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Antimalarial activity against chloroquine-susceptible Plasmodium falciparum D10 asexual erythrocyte forms after 48 hrs by parasite LDH assay',\n",
       "        'Inhibitory concentration sensitive Plasmodium falciparum FJB-D9 ',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       "        'Inhibition of Plasmodium falciparum DHFR assessed as oxidation of NADPH to NADP+ at 10 uM after 15 mins spectrophotometric assay',\n",
       "        'Inhibitor constant of compound for Plasmodium falciparum dihydrofolate reductase',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antiparasitemia activity against Plasmodium berghei infected mice (Mus musculus) at 30 mg/kg subcutaneous dose for 4 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single S108T mutation',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in red blood cells after 72 hrs by parasitic LDH assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7A assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 10 nM after 15 min by spectrophotometry',\n",
       "        'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 5 mg/kg.',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'In vitro minimum inhibitory concentration against Plasmodium falciparum NF54 over 40 hours',\n",
       "        'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with quadruple (N51I + C59R + S108N + I164L) mutations',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase CN51I/C59R/S108N/I164L (V1/S) mutant',\n",
       "        'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 1.25 mg/kg.',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as parasitemia at 1.2 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs (Rvb = 4.6+/-0.21 %)',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase N51I/C59R/S108N (W2)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Inhibition against Plasmodium falciparum Dd2 in erythrocytes in semiautomated micro dilution assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-beta2 m null mouse after 7 days',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes by semiautomated micro dilution',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 in erythrocytes',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 1.2 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hr',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       "        'Antimalarial activity as toxic deaths 2-5 days post infection for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hr',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vitro cytotoxicity against Plasmodium falciparum infected KB cell line',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Binding affinity was evaluated as inhibition of recombinant wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg',\n",
       "        'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72 hr',\n",
       "        'In vitro cytotoxicity against Plasmodium falciparum infected BC cell line.',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with double (A16V + S108T) mutations',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R+S108N/I164L (Csl-2) mutant',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'In vitro inhibition of Plasmodium falciparum HB3 (S108N) culture',\n",
       "        'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 2.5 mg/kg.',\n",
       "        'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Binding affinity to recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant by competitive binding assay',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Growth inhibition of Plasmodium falciparum HB3 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single A16V mutation',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibitor constant of compound for mutant S108 N Plasmodium falciparum in dihydrofolate reductase',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 80 mg/kg subcutaneous dose over 72 hr',\n",
       "        'Inhibitory concentration against multidrug-resistant Plasmodium falciparum Dd2.',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1/S harboring S108N, N51I, C59R, I164L mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human A positive erythrocytes by [3H]hypoxanthine uptake assay in presence of serum in medium',\n",
       "        'Inhibition of Plasmodium falciparum DHFR',\n",
       "        'Antimalarial activity against Plasmodium falciparum PfV1S0176/N10 infected in immunodeficient HM-IL2Rgamma null mouse after 7 days',\n",
       "        'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum HB3',\n",
       "        'OSM: Inhibition of Plasmodium falciparum K1 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       "        'OSM: HEK293 cytotoxicity assay. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       "        'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-IL2Rgamma null mouse after 7 days',\n",
       "        'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.',\n",
       "        'In vitro inhibition of Plasmodium falciparum K1 (S108N + C59R) culture',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       "        'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 20 mg/kg subcutaneous dose after 72 hr',\n",
       "        'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Antimalarial activity against Plasmodium falciparum Mad20',\n",
       "        'Antimalarial activity against liver stages of Plasmodium cynomolgi infected in human HepG2 cells assessed as growth inhibition of hepatic parasite after 3 days',\n",
       "        'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 10 mg/kg.',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antimalarial activity as toxic deaths 2-5 days post infection for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as reduction of hemozoin formation at IC50 after 48 hrs relative to control',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Growth inhibition of Plasmodium falciparum 3D7 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       "        'Binding affinity was evaluated as inhibition of mutant (C59R + S108N) Plasmodium falciparum DHFR-TS.',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with triple (C59R + S108N + I164L) mutations',\n",
       "        'Compound was tested in vivo for antimalarial activity against Plasmodium berghei in mice (Mus musculus) after 6 days of administration (ED90 is the dose necessary to reduce the percentage of infected cells to 10% of the level found in the infected untreated controls)',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antimalarial activity as change in MST for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72 hr',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Binding affinity to wild type Plasmodium falciparum DHFR by competitive binding assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54 after 36-40 hrs'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Tween 20-induced beta-hematin formation by colorimetric assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Effective concentration against Plasmodium falciparum W2',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Percent inhibition of adenosine uptake by Plasmodium berghei',\n",
       "        'Percent inhibition of hypoxanthine uptake by Plasmodium berghei',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs',\n",
       "        'Effective concentration for Plasmodium falciparum 3D7',\n",
       "        'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Inhibition of Plasmodium falciparum cyclin-dependent kinase',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PoW',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'Inhibition of FabZ',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antimalarial activity against liver stages of Plasmodium berghei',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in C57BL/6 mouse assessed as reduction of liver infection at 200 mg/kg, ip incubated for 6 hrs prior to sporozoite inoculation measured after 40 hrs by qRT PCR'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum ENR',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of triclosan',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'Antiprotozoal activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Inhibition of FabG',\n",
       "        'Inhibition of Plasmodium falciparum ENR using NADH substrate',\n",
       "        'Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate',\n",
       "        'Inhibition of FabZ',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Inhibition of FabI',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'Inhibition of Plasmodium falciparum FabI'], dtype=object),\n",
       " array(['Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antiparasitic activity against Plasmodium falciparum K1',\n",
       "        'In vitro antiparasitic activity against chloroquine-resistant Plasmodium falciparum Indochina I',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antimalarial activity against erythrocytic stage of Plasmodium falciparum NF54 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counting analysis',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine -resistant Plasmodium falciparum K1 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected in human RBC after 48 hrs by [3H]-hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected in human red blood cells assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       "        'In vitro antiprotozoal activity for Plasmodium falciparum K1',\n",
       "        'In vitro antiparasitic activity against chloroquine-sensitive Plasmodium falciparum Haiti 135',\n",
       "        'Antimalarial activity against drug -sensitive Plasmodium falciparum NF54 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected in human erythrocytes after 48 hrs assessed as [3H]hypoxanthine incorporation by liquid scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium berghei schizonts isolated from parasitized erythrocytes infected Wistar rat measured 16 hrs post compound exposure'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium falciparum',\n",
       "        'The compound was tested for the dose required to cause 50% suppression of Plasmodium berghei growth in mice.',\n",
       "        'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.1-mg/kg/day for 4 days',\n",
       "        'Percent parasitaemia in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.5-mg/kg/day after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 5 mg/kg/day after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 2 mg/kg/day after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 1.0 mg/kg/day after 4 days'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum Dd2 expressing katG',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 with pLN-hrp3-katG-V5 insertion at attB site',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 expressing katG',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 with pLN-hrp3-katG-V5 insertion at attB site'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In Vitro evaluation on percentage inhibition in Heme Oxygenase at concentration 100 (uM) of Cell-free parasite Plasmodium yoelii',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 50 uM'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 24 hrs as reduced [3H]phenylalanine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum GCO3 after 72 hrs by SYBR green 1 assay',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        ...,\n",
       "        'Antimalarial activity against chloroquine, pyrimethamine and cycloguanil-resistant Plasmodium falciparum VS1 after 24 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef schizont form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 rings after 48 hrs by FACS analysis'],\n",
       "       dtype=object),\n",
       " array(['50% effective dose against Plasmodium yoelii in mice (Mus musculus)',\n",
       "        '90% effective dose against Plasmodium yoelii in mice (Mus musculus)',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        '50% effective dose for antimalarial activity (in vivo) against Plasmodium berghei',\n",
       "        '90% effective dose against Plasmodium yoelii in mice (Mus musculus)',\n",
       "        '50% effective dose against Plasmodium yoelii in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        '50% effective dose against Plasmodium yoelii in mice (Mus musculus)',\n",
       "        '90% effective dose against Plasmodium yoelii in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        '50% effective dose against Plasmodium yoelii in mice (Mus musculus)',\n",
       "        '90% effective dose against Plasmodium yoelii in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        '90% effective dose against Plasmodium yoelii in mice (Mus musculus)',\n",
       "        '50% effective dose against Plasmodium yoelii in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum FC27',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum in 20 mM FeCl3',\n",
       "        'Growth inhibition after 6 hrs in chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium vinckei petteri infected intraperitoneally dosed Swiss Albino mice (Mus musculus)',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimicrobial activity against Plasmodium falciparum FCC1/HN',\n",
       "        'Antimicrobial activity against wild type Plasmodium falciparum HB3 infected in erythrocytes assessed as growth inhibition after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Mad20',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as [35S]Met/Cys incorporation by SYBR green based fluorescence assay',\n",
       "        'Growth inhibition of Plasmodium falciparum as reduced [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum CAMP by semiautomated micro dilution assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as plasmodial LDH activity',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54 infected mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium vinckei petteri infected subcutaneously dosed Swiss Albino mice (Mus musculus)',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCK by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91C235',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum F32',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine uptake by microculture radioisotope technique',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against chloroquine-resistant, pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs',\n",
       "        'Inhibition of Plasmodium falciparum ATPase6 expressed in Xenopus oocytes',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected in human blood by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum FCB in human erythrocytes by DAPI stain',\n",
       "        'Antimalarial activity against chloroquine-resistant, mefloquine-susceptible Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counter',\n",
       "        'Antimicrobial activity against leupeptin resistant-Plasmodium falciparum HB3-leuR1 mutant infected in erythrocytes assessed as growth inhibition after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Parasite viability index for Plasmodium falciparum Indochina W2 by [3H]hypoxanthine uptake',\n",
       "        'Antiprotozoal activity against chloroquine-, pyrimethamine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine incorporation assay',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium berghei KBG173 ',\n",
       "        'Antimalarial activity in Plasmodium falciparum Indochina W2',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vivo effective dose for antimalarial activity by peroral dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 after 48 hrs by pLDH assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'In vitro antimalarial activity against the Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 in human erythrocytes by DAPI stain',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum (Ghana)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 after 48 hrs by LDH reporter assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M3 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone 1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected mice (Mus musculus) by peroral dose',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH assay',\n",
       "        'Antiparasitic activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant (Smith) isolates of Plasmodium falciparum at dose 160 mg/kg in mice (Mus musculus)',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum by [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       "        'Antiprotozoal activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Inhibitory concentration against Plasmodium falciparum K1 infected erythrocytes',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       "        'Inhibition of Plasmodium falciparum ATP6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 infected erythrocytes',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 3 against Plasmodium berghei infected MORO mice (Mus musculus) at 100 mg/kg subcutaneous dose',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 by pLDH activity',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum RKL9 infected in human erythrocyte after 48 h by SYBR-Green-1 assay',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum African D6',\n",
       "        'Antimalarial activity against chloroquine,mefloquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 after 72 hrs by alamar blue assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte after 48 h by SYBR-Green-1 assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum NF54',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 35 uM treated for 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 48 hrs',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH activity',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M4 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium yoelii nigeriensis infected mice (Mus musculus) by oral dose',\n",
       "        'Antimalarial activity as growth inhibition of Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum W2 Indochina relative to QHS',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 4 hrs',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'Antimalarial activity against Plasmodium vinckei petteri infected orally dosed Swiss Albino mice (Mus musculus)',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected mice (Mus musculus) macrophage by reporter dye assay',\n",
       "        'In vitro antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Inhibitory concentration (IC50) against chloroquine-resistant falciparum Indochina W2 in human malaria',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using CAM promoter driven expressing ATP4 I398F/P990R mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum African D6',\n",
       "        'In vitro anti-malarial activity against Plasmodium berghei',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and expressing parental ATP4 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum 7G8 in human erythrocytes by DAPI stain',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing ATP4 I398F/P990R mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum D6 (Sierra Leone) after 24 to 60 hrs by [G-H3]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 5 nM after 15 min by spectrophotometry',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7A assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       "        'Compound was tested in vitro Antimalarial activity against Plasmodium berghei in infected mice (Mus musculus) administered intraperitoneally',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected in erythrocytes by LDH assay',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum W2 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as reduction of hemozoin formation at IC50 after 48 hrs relative to control',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH release assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs as [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in RBC assessed as parasite LDH activity after 72 hrs',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after oral dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'Drug uptake in human type-A erythrocytes infected with Plasmodium falciparum D6 at 3.55 uM after 2 hrs by LC-MS analysis',\n",
       "        'Antimalarial activity Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity against CQ-resistant Plasmodium falciparum 3D7 blood stage form after 48 hrs by FACSort cytometry',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasite replication incubated for 62 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive and mefloquine-resistant Plasmodium falciparum D6',\n",
       "        'In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in red blood cells after 72 hrs by parasitic LDH assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 after 72 hrs by alamar blue assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum FcB1',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef by hypoxanthine uptake assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 infected mice (Mus musculus)',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 in human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Growth inhibition of Plasmodium falciparum ring stage in infected erythrocytes by DAPI growth assay',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Antimalarial activity against chloroquine- and mefloquine-resistant Plasmodium falciparum W2-Mef infected in human O-positive erythrocytes assessed as inhibition of schizonts growth after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine, pyrimethamine-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of parasitemia after 48 hrs by Giemsa staining',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 70 uM treated for 48 hrs',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 Indochina',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as LDH activity after 72 hrs by malstat reagent method',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 after 72 hrs by pLDH assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum resistant W-2',\n",
       "        'In vitro antimalarial activity against ring stage of chloroquine-resistant Plasmodium falciparum W2 cultured in medium containing 10% human serum assessed as inhibition of parasite growth after 48 hrs by YOYO-1 dye based flow cytometry',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'Anti-infective activity against Plasmodium falciparum D6 infected red blood cells',\n",
       "        'Antimalarial activity against Plasmodium yoelii nigeriensis infected subcutaneously dosed mice (Mus musculus)',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg)',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone 2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 48 mg/kg/day intramuscular.',\n",
       "        'Mean of EC50 values for FM3A cells/ mean of EC50 values for Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2/Indochina by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum C235',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Indochina W2 after 24 to 60 hrs by [G-H3]hypoxanthine uptake ',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54 by [3H]hypoxanthine incorporation assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs by SYBR green fluorescence assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH release',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum (Experiment 2)',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing wild type ATP4 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Inhibitory concentration (IC50) against chloroquine-sensitive falciparum sierra leone D-8 in human malaria',\n",
       "        'Antimalarial activity against Plasmodium falciparum W-2 Indochina in human malaria',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum V1/S',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 72 hrs by LDH assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after subcutaneous dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 after 48 hrs by pLDH assay',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania after 1000 days',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) by intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 infected in human erythrocytes after 72 hrs by lactate dehydrogenase assay',\n",
       "        'Growth inhibition of Plasmodium falciparum 3D7 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 Indochina',\n",
       "        'Antimalarial activity against Plasmodium berghei K173 in mice (Mus musculus) by peroral administration using peanut oil',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 48 hrs as LDH reporter activity',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef schizont form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Antiprotozoal activity against Plasmodium falciparum K1 infected in human erythrocytes at 4.8 ug/m after 72 hrs by [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by pLDH assay',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum D6 (Sierra Leone) relative to QHS',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 after 72 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 Africa in human malaria',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by pLDH reporter assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by fluorescence assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6 clone after 48 hrs',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 synchronized ring stage parasites infected in erythrocytes assessed as reduction in parasitemia after 48 hrs by Giemsa staining',\n",
       "        'Growth inhibition of Plasmodium falciparum Dd2 ring stage infected erythrocytes after 72 hrs by DAPI fluorimetry',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 24 mg/kg/day intramuscular.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH assay',\n",
       "        'Antimalarial activity against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum RCS',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 (Thailand) assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in RBC assessed as plasmodial LDH activity after 72 hrs',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in RBC assessed as plasmodial LDH activity after 72 hrs',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei NF54 infected mice (Mus musculus)',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 by Malstat LDH activity',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 3D7 after 72 hrs by malaria SYBR Green I-based fluorescence assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum D6',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 48 hrs',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 (Sierra Leone I)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs by LDH assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 as [3H]hypoxanthine uptake',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg)',\n",
       "        'Inhibition of Plasmodium falciparum D6 (Sierra Leone) by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH reporter assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum D6 in LDH release assay',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcM29',\n",
       "        'OSM: Inhibition of Plasmodium falciparum 3D7 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       "        'Anti-malarial activity against Plasmodium falciparum Dd2',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 in erythrocytes after 72 hrs by LDH activity',\n",
       "        'In vitro inhibition of Plasmodium falciparum K1 (0.0008 ug/mL)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D2',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after oral administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 in erythrocytes after 72 hrs by LDH activity',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Compound was tested in vitro Antimalarial activity against Plasmodium berghei in infected mice (Mus musculus) administered per orally',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH release assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 9 uM treated for 48 hrs',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH release assay',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 20 mg/kg dose as mean survival time',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 40 mg/kg dose as mean survival time',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 100 mg/kg, perorally administered 1 day post-infection measured 3 day post-infection',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 infected in human red blood cells assessed as 3H-hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum infected in human O+ erythrocytes after 48 hrs by HRP2-ELISA method',\n",
       "        'Antimalarial activity against Plasmodium yoelii infected Swiss mice (Mus musculus) at 48 mg/kg Intramuscular dose',\n",
       "        'In vitro EC50 against chloroquine susceptible Plasmodium falciparum by [3H]hypoxanthine incorporation',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'Antimalarial activity after 24 hrs against Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day',\n",
       "        'Growth inhibition of Plasmodium falciparum HB3 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 3 against Plasmodium berghei infected MORO mice (Mus musculus) at 100 mg/kg peroral dose',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 as LDH activity after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 harboring pfATP6 263E mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg)',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine- and mefloquine-resistant Plasmodium falciparum W2-Mef infected in human O-positive erythrocytes assessed as inhibition of trophozoites growth after 48 hrs',\n",
       "        'Inhibitory concentration against Plasmodium berghei',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mice (Mus musculus) assessed as increase in survival of mice (Mus musculus) at 100 uM/kg',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 in erythrocytes by LDH reporter assay',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 in human erythrocytes by DAPI stain',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after oral administration.',\n",
       "        'In vitro antimalarial activity in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 in [3H]hypoxanthine incorporation microculture radioisotope assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro activity as 50% reduction in parasite growth against Plasmodium falciparum by [3H]hypoxanthine uptake ',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 assessed as growth inhibition after 72 hrs by DAPI staining',\n",
       "        'In vitro inhibition of Plasmodium falciparum in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 infected erythrocytes',\n",
       "        'Antiplasmodial activity against chloroquine-resistant blood-stage Plasmodium falciparum W2 after 48 hrs by flow cytometric analysis',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W-2',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes assessed as reduction in parasitaemia after 48 hrs by FACS',\n",
       "        'Inhibition of Plasmodium falciparum NDH2',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake relative to gedunin',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCB1-R/Colombia by [3H]hypoxanthine uptake',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after oral administration.',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone 1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against Plasmodium falciparum DD2 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum FcM29-Cameroon by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity as reduced parasitaemia against multidrug-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 1 uM treated for 96 hrs',\n",
       "        'Inhibition of Plasmodium falciparum DHOD',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 640(mg/kg); Survival beyond 60 days is considered curative',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum D-8',\n",
       "        'Antimalarial activity against drug-sensitive Plasmodium falciparum FCR3 infected human erythrocytes after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum W-2',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration',\n",
       "        'Antimalarial activity against erythrocytic stage of chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]-hypoxanthine incorporation incubated for 48 hrs prior to [3H]-hypoxanthine addition measured after 24 hrs by liquid scintillation counting',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 Sierra Leone',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity in Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR-3 infected in human erythrocytes after 72 hrs by lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef ring form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected in human erythrocytes after 48 hrs assessed as [3H]hypoxanthine incorporation by liquid scintillation counting',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 assessed as LDH activity after 72 hrs by malstat reagent method',\n",
       "        'Inhibition of Plasmodium falciparum ATP6 expressed in Xenopus laevis oocytes',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 in parasite LDH assay',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum isolate 208432 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by malaria SYBR Green I-based fluorescence assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in RBC assessed as parasite LDH activity after 72 hrs',\n",
       "        'Antimalarial activity as reduced parasitaemia after 3 days against Plasmodium berghei infected NMRI mice (Mus musculus) at 100 mg/kg peroral dose',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 as LDH activity',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in red blood cells after 72 hrs by parasitic LDH assay',\n",
       "        'Antimalarial activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum D6 as LDH activity by Makler method',\n",
       "        'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration',\n",
       "        'Antimalarial activity against Plasmodium yoelii infected Swiss mice (Mus musculus) at 24 mg/kg intramuscular dose',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes assessed as reduction in parasitemia after 48 hrs by flow cytometry analysis',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against Chloroquine-sensitive Plasmodium falciparum NF54 as [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 18 uM treated for 48 hrs',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 mg/kg)',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by DAPI staining method',\n",
       "        'In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'Antimalarial activity as parasitaemia against Plasmodium berghei ANKA infected Swiss albino mice (Mus musculus) at 100 uM/kg intraperitoneal dose after 3 days',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum W2',\n",
       "        'In vitro inhibitory activity against Plasmodium falciparum (sierra leone clone)',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 by Malstat LDH activity',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum Nigeria',\n",
       "        'OSM: HEK293 cytotoxicity assay. Duplicate point single experiment at 120 uM. Avery Group, Griffith.',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum (Experiment 1)',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 as [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3 by pLDH reporter assay',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 by pLDH assay',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day',\n",
       "        'Inhibitory concentration against chloroquine-sensitive Plasmodium falciparum D-8',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using CAM promoter driven expressing ATP4 D1247Y mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum FcM29',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Africa',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium berghei SERCA',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake relative to gedunin',\n",
       "        'Antimalarial activity against mefloquine, chloroquine and quinine-resistant Plasmodium falciparum TM91C235',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum K1 infected human erythrocytes after 72 hrs',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1 as [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as plasmodial LDH activity after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as plasmodial LDH activity after 72 hrs',\n",
       "        'OSM: Inhibition of Plasmodium falciparum K1 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in terms of survival days when administered subcutaneously in mice (Mus musculus)',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M3 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 18 uM treated for 48 hrs',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 9 uM treated for 48 hrs',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum HB3 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'Antimalarial activity against chloroquine- and mefloquine-resistant Plasmodium falciparum W2-Mef infected in human O-positive erythrocytes assessed as inhibition of ring-stage parasite growth after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCB infected in human A-positive type erythrocytes after 72 hrs by SRB assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6 infected in RBCs by parasitic LDH release assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by DAPI staining method',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes assessed as [3H]hypoxanthine incorporation after 24 hrs by liquid scintillation and luminescence counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 harboring pfATP6 263E mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 as LDH activity',\n",
       "        'Antimalarial activity against chloroquine- and mefloquine-resistant Plasmodium falciparum W2-Mef infected in human O-positive erythrocytes after 48 hrs',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 infected erythrocytes by LDH assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH reporter assay',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 as LDH activity',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone 1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone 1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone 2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 in parasite LDH assay',\n",
       "        'Relative potency was determined in vitro in paratized human whole blood against drug resistant strain of Plasmodium falciparum strain-Sierra Leone(D-6)',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 3D7 after 72 hrs by fluorescence assay',\n",
       "        'Antimalarial activity (100 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'In vitro inhibition against Plasmodium falciparum; range 0.004-0.02 uM',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef assessed as DNA positive erythrocytes by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 assessed as plasmodial LDH activity',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as growth inhibition after 72 hrs by DAPI staining',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 in human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum W2 by pLDH activity',\n",
       "        'Antiplasmodial activity against CQ-resistant Plasmodium falciparum W2 blood stage form after 48 hrs by FACSort cytometry',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 infected in human erythrocytes',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as parasitaemia at 9 uM after 48 hrs by rhodamine 123 staining',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against multi drug-resistant Plasmodium falciparum K1 assessed as [3H]hypoxanthine uptake after 18 hrs by microculture radioisotope technique',\n",
       "        'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 0.1 uM treated for 96 hrs',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum W2 in LDH release assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing ATP4 D1247Y mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 infected in RBCs by parasitic LDH release assay',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 after 72 hrs by pLDH assay',\n",
       "        'Antimalarial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum W2 as LDH activity by Makler method',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 by microplate assay',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 40 mg/kg dose as mean survival time after 60 days',\n",
       "        'Antiplasmodial activity against atovaquone-resistant Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum 106/1 in human erythrocytes by DAPI stain',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum.',\n",
       "        'Antimalarial activity against Plasmodium falciparum DD2 expressing Saccharomyces cerevisiae DHOD by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity (100 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Antiplasmodial activity against chloroquine, pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'Relative potency was determined in vitro in paratized human whole blood against drug resistant strain of Plasmodium falciparum strain-Indochina(W-2)',\n",
       "        'Anti-infective activity against Plasmodium falciparum W2 in erythrocytes',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Smith by semiautomated micro dilution assay',\n",
       "        'Antimalarial activity after 24 hrs against Plasmodium falciparum W2 infected in type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 in erythrocytes by LDH reporter assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum Indochina W2',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in terms of survival days when administered orally in mice (Mus musculus)',\n",
       "        'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after oral administration for 4 days',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after intravenous administration for 4 days',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after intravenous administration determined as parasite suppression at 10 mg/kg',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after oral administration determined as parasite suppression at 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after oral administration for 4 days',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after intravenous administration determined as parasite suppression at 10 mg/kg',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after intravenous administration for 4 days',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after oral administration determined as parasite suppression at 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after oral administration for 4 days',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after oral administration determined as parasite suppression at 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after intravenous administration for 4 days',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) infected with Plasmodium berghei NY malaria parasite after intravenous administration determined as parasite suppression at 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum K1 (EC50).',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'MMV: CRC and MIC90 against Mtb (nonreplicating)',\n",
       "        'MMV: CRC and MIC90 against Mtb (replicating)',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Cytotoxicity CRC and LD50 against HepG2',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).'],\n",
       "       dtype=object),\n",
       " array(['PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 160 mg/kg',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 640 mg/kg',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg',\n",
       "        'Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 160 mg/kg',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'In vitro inhibition of multidrug-resistant Plasmodium falciparum K1',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6.',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 160 mg/kg',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 640 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6.',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 640 mg/kg',\n",
       "        'In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against mefloquine-susceptible Plasmodium falciparum CDC Indochina 3 W2 after 48 hrs by [3H]hypoxanthine uptake assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum KT1 gametocytes',\n",
       "        'Antimalarial activity against Plasmodium yoelii 265 sporozoites in primary mice (Mus musculus) hepatocytes after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 40 mg/kg dose administered subcutaneously',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum CDC Sierra Leone 1 D6 after 48 hrs by [3H]hypoxanthine uptake assay',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii yoelii',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes (stage 2 & 3)',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum F32 after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium cynomolgi sporozoites infected in Rhesus monkey assessed as delay in detection of parasites in blood at 1.78 mg/kg/day, po administered for three consecutive days before infection',\n",
       "        'Antimalarial activity was evaluated against Plasmodium berghei in female CD1 mice (Mus musculus) (20-25g)',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg',\n",
       "        'Inhibition of Plasmodium falciparum phosphoethanolamine methyltransferase using phospethanolamine as substrate by radiochemical assay in presence of S-adenosylmethionine',\n",
       "        'Mean survival time which expresses the antimalarial activity of compound was measured against Pseudomonas berghei in mice (Mus musculus) at Delta MST 80 mg/kg dose',\n",
       "        'Prophylatic antimalarial activity against Plasmodium berghei infected Exoerythrocytic mouse model',\n",
       "        'Antimalarial activity against Plasmodium yoelii 265 BY liver stage sporozoites in primary mice (Mus musculus) hepatocytes at 38.6 uM after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 160 mg/kg dose administered subcutaneously; toxic',\n",
       "        'Antimalarial activity after 10 days against Plasmodium berghei ANKA infected Anopheles stephensi at 50 uM/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 0.1 mg/kg/day after 7 days (x7); cured 0 of 2',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 asexual gametocytes',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against liver-stage GFP expressing Plasmodium berghei sporozoites infected in human HuH7 cells assessed as inhibition of parasite schizonts development after 48 hrs by FACS analysis',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FcB1 after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against sporozoites stage of Plasmodium cynomolgi infected in Rhesus monkey assessed as delay in patency at 1.78 mg/kg/day, po administered one day before infection, on day of infection and one day post infection',\n",
       "        'Antiplasmodial activity against Plasmodium berghei liver stage form transfected in human Huh-7 cells assessed as cell viability after 48 hrs by luciferase reporter gene assay',\n",
       "        'Antiplasmodial activity against Plasmodium cynomolgi sporozoites infected in Rhesus monkey assessed as duration for detection of parasites in blood at 1.78 mg/kg/day, po administered for three consecutive days before infection (Rvb = 8 days)',\n",
       "        'Antiplasmodial activity against chloroquine-resistant blood stage Plasmodium falciparum W2 after 48 hrs by FACS analysis',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes (stage 4 & 5)',\n",
       "        'Antiplasmodial activity against Plasmodium berghei ANKA infected in BALB/c mice (Mus musculus) assessed as parasite-transmission to Anopheles stephensi after feeding on infected mice (Mus musculus) at 50 umol/kg, intraperitoneally administered 4 days after infection measured 10 days after 2 hrs of mosquito feeding by transmission-blocking activity assay relative to control',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 assessed as inhibition of [3H] hypoxanthine uptake by liquid scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum KT3 gametocytes',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH assay',\n",
       "        'Effective concentration for gametocidal activity against Plasmodium falciparum FDL-HD',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine incorporation assay',\n",
       "        'Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 0.316 mg/kg/day after 7 days; cured 0 of 2',\n",
       "        'Antiplasmodial activity against liver stage of Plasmodium berghei expressing GFP-Luc infected in HuH7 cells incubated at 1 hr prior to infection followed by compound replenisment at 24 hrs post-infection measured after 48 hrs by Alamar blue assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 assessed as plasmodial LDH activity',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as plasmodial LDH activity',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium berghei ANKA infected in BALB/c mice (Mus musculus) assessed as parasite-transmission to Anopheles stephensi after feeding on infected mice (Mus musculus) at 10 umol/kg, intraperitoneally administered 4 days after infection measured 10 days after 2 hrs of mosquito feeding by transmission-blocking activity assay relative to control',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 640 mg/kg dose administered subcutaneously; toxic',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum F32 assessed as suppression of parasitemia after 4 hrs by Giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 320 mg/kg dose administered subcutaneously; toxic',\n",
       "        'Mean survival time which expresses the antimalarial activity of compound was measured against Pseudomonas berghei in mice (Mus musculus) at 40 mg/kg dose',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum FcB1/Columbia assessed as suppression of parasitemia after 4 hrs by Giemsa staining',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FcM29 after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 gametocytes assessed as suppression of parasitemia after 4 hrs by Giemsa staining',\n",
       "        'Radical curative antimalarial activity against Plasmodium cynomolgi in Rhesus monkeys (Macaca mulatta) at 1 mg/kg/day over 7 days; cured 1 of 2',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum F32 after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes after 48 hrs by microscopy',\n",
       "        'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium cynomolgi M infected in rhesus monkey administered as po qd for 7 days',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 80 mg/kg dose administered subcutaneously; active',\n",
       "        'Antimalarial activity after 10 days against Plasmodium berghei ANKA infected Anopheles stephensi at 10 uM/kg',\n",
       "        'Mean survival time which expresses the antimalarial activity of compound was measured against Pseudomonas berghei in mice (Mus musculus) at 20 mg/kg dose',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii 265 BY infected in Swiss mouse after 48 hrs by fluorescence microscopy',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FcB1/Columbia after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Gametocytocidal activity against Plasmodium berghei ANKA 25R/10 infected in Balb/C mouse assessed as infected mosquitoes at 15 mg/kg, ip after 2 hrs feed Anopheles stephensi mosquitoes for 2 hrs on compound treated animals measured after 10 days post feed by stereomicroscopy (Rvb = 80%)',\n",
       "        'Antimalarial activity against liver stages of Plasmodium berghei',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 assessed as suppression of parasitemia after 4 hrs by Giemsa staining',\n",
       "        'Gametocytocidal activity as infected mosquitoes against Plasmodium berghei at 10 uM/kg',\n",
       "        'Antimalarial activity against Plasmodium cynomolgi infected in rhesus monkey assessed as delay in patency time at 1.78 mg/kg, po administered one day before infection, on day of infection followed by 1 day post infection'],\n",
       "       dtype=object),\n",
       " array(['Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 0.316 mg/kg/day after 7 days; cured 0 of 2',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 320 mg/kg dose administered subcutaneously; active',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 640 mg/kg dose administered subcutaneously; cure/1toxic',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 40 mg/kg dose administered subcutaneously',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 80 mg/kg dose administered subcutaneously',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 160 mg/kg dose administered subcutaneously; active',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 20 mg/kg dose administered subcutaneously',\n",
       "        'Antimalarial activity against Plasmodium cynomolgi M infected in rhesus monkey administered as po qd for 7 days',\n",
       "        'Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 1 mg/kg/day after 7 days; cured 0 of 2',\n",
       "        'Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 10.0 mg/kg/day after 7 days; cured 2 of 2'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum HDAC1',\n",
       "        'Antimalarial activity against sPlasmodium falciparum VS/1 assessed as parasite growth inhibition after 48 hrs by standard growth inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as parasite growth inhibition after 48 hrs by standard growth inhibition assay',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum D6 infected in Aotus lemurinus lemurinus monkey',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM90C2A by hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in O+ human erythrocytes by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 after 72 hrs by alamar blue assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as parasite growth inhibition after 48 hrs by standard growth inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 after 72 hrs by alamar blue assay',\n",
       "        'Inhibition of HDAC in Plasmodium falciparum 3D7 by fluorescent activity assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by hypoxanthine uptake',\n",
       "        'Antimalarial activity against ring stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCB1 assessed as parasite growth inhibition after 48 hrs by standard growth inhibition assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against ring stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91C235 by hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 assessed as parasite growth inhibition after 48 hrs by standard growth inhibition assay',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum W2',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum TM90C2A',\n",
       "        'Inhibition of Plasmodium falciparum 3D7 histone deacetylase infected in human erythrocytes assessed as alteration of histone H3 acetylation after 3.5 hrs by SDS-PAGE',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in O+ human erythrocytes by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity against Plasmodium falciparum infected in mouse RAW264.7 cells',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 by hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH reporter assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in O+ human erythrocytes by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 after 48 hrs by LDH reporter assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in O+ human erythrocytes by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       "        'Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 CDY mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 T76K1 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7A infected in type A rhesus-positive human erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium yoelii infected in CD-1 mouse assessed as efficacy at 160 mg/kg, ip',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 36-48 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by microtiter plate scintillation counting',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 SND mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium yoelii infected in CD-1 mouse assessed as efficacy at 40 mg/kg, ip',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011003 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 C6 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium berghei KBG-173 infected in sc dosed mouse administered bid for 3 days',\n",
       "        'Antimalarial activity after 96hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum 3BA6 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of Plasmodium falciparum in HRP2 ELISA',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 24-36 hrs post infection',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235 assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by microtiter plate scintillation counting',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011017 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity against Plasmodium berghei KBG173 infected in mouse assessed as mouse survival time at 5 mg/kg, iv BID administered on day 3, 4 and 5 post infection',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum 7G8 T76K1 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3BA6 SDD with CRT and MDR1 mutation after 96 hrs in [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum 3BA6 CDY mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96hrs against Plasmodium falciparum GCO3 C2 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 C4 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 C1 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs by SYBR green fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7A infected in human A-positive erythrocytes assessed as inhibition of [3H]-hypoxanthine incorporation after 48 hrs by semi-automated microdilution technique',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in type A rhesus-positive human erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium berghei KBG173 infected in mouse assessed as mouse survival time at 15 mg/kg, iv BID administered on day 3, 4 and 5 post infection',\n",
       "        'Antimalarial activity against Plasmodium yoelii infected in CD-1 mouse assessed as efficacy at 40 mg/kg, po after 2 hrs',\n",
       "        'Antiplasmodial activity after 120 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 SDD mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolates assessed as parasite growth inhibition after 72 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011008 isolate in HRP2 ELISA',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 12-48 hrs post infection',\n",
       "        'Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry',\n",
       "        'Antimalarial activity against chloroquine/pyrimethamine-resistant Plasmodium falciparum W2 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-,pyrimethamine-resistant Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by microtiter plate scintillation counting',\n",
       "        'Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free',\n",
       "        'Antiplasmodial activity after 48 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96 hrs at 100 nM dosed 0-48 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum W2 infected in human A-positive erythrocytes assessed as inhibition of [3H]-hypoxanthine incorporation after 48 hrs by semi-automated microdilution technique',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green fluorescence assay',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 0-24 hrs post infection',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 12-24 hrs post infection',\n",
       "        'Antiplasmodial activity after 96 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry',\n",
       "        'Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes assessed after 96hrs at 100 nM dosed 12-36 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum after 68 hrs',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum TM91C235 assessed as [3H]hypoxanthine incorporation after 48 hrs',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum 7G8 C1 mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96 hrs at 100 nM dosed 0-12 hrs post infection',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum 3BA6 SND mutant CRT/MDR1 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity after 72 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium yoelii infected in CD-1 mouse assessed as efficacy at 160 mg/kg, po after 2 hrs',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 24-48 hrs post infection',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011022 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 0-36 hrs post infection',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium vivax assessed as effect on cure rate after 28 days'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) at 150 mg/kg/day intraperitoneal dose over 4 days',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 by [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant synchronous Plasmodium falciparum K1 infected human A+ erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine incorporation',\n",
       "        'Reduced parasitemia in Plasmodium berghei ANKA infected CD1 mice (Mus musculus) at 150 mg/kg peroral dose after 4 days',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected human A+ erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D10 infected human A+ erythrocytes in Makler LDH reporter assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 infected human A+ erythrocytes by Makler LDH reporter assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'Antimalarial activity against Plasmodium chabaudi AS infected CD1 mice (Mus musculus) assessed as suppression of parasitaemia at 50mg/kg, perorally after 4 days',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Inhibition of beta-hematin formation',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium chabaudi AS infected CD1 mice (Mus musculus) at 50 mg/kg/day peroral dose',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7A assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 100 mg/kg subcutaneous dose (experiment 2)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg subcutaneous dose (expt 2)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 100 mg/kg subcutaneous dose (expt 1)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 1)',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum HB3',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg subcutaneous dose (experiment 1)',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum W2',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 100 mg/kg subcutaneous dose (expt 3)',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum BHz26/86',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum D6',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg subcutaneous dose (expt 3)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 2)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum HB3',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum BHz26/86',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg subcutaneous dose (experiment 1)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg subcutaneous dose (expt 2)',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 1)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 100 mg/kg subcutaneous dose (expt 1)',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum D6',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg subcutaneous dose (expt 3)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 100 mg/kg subcutaneous dose (experiment 2)',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 2)'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 1)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 2)',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei schizonts isolated from parasitized erythrocytes infected Wistar rat measured 16 hrs post compound exposure',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected human erythrocytes after 48 hrs as [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake measured from 1 to 2 hrs',\n",
       "        'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs',\n",
       "        'Antimalarial activity against liver stages of Plasmodium berghei 17XNL infected in human Hepa1-6 cells assessed as reduction in liver parasite load at 10 uM/L incubated for 1 hr prior to sporozoite inoculation measured after 46 to 48 hrs by fluorescence microscope',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring HFP-tagged Pfs16 protein after 48 hrs',\n",
       "        'Antimicrobial activity against Plasmodium falciparum at ring stage',\n",
       "        'Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes assessed as reduction in [3H]-chloroquine uptake after 1.5 to 2 hrs',\n",
       "        'Antimalarial activity against chloroquine resistant, mefloquine sensitive Plasmodium falciparum W2 infected in human erythrocytes by [3H]-hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10',\n",
       "        'Antimicrobial activity against Plasmodium vivax at trophozoite stage',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Activity of Plasmodium falciparum NDH2 expressed in Escherichia coli by Michaelis-Menten plot',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Michaelis menton constant against Plasmodium falciparum glutathione reductase',\n",
       "        'Catalysis constant against Plasmodium falciparum glutathione reductase',\n",
       "        'Ratio of Catalysis constant Michaelis menton constant of Plasmodium falciparum glutathione reductase',\n",
       "        'In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 80 mg/kg dose administered subcutaneously; active',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 640 mg/kg dose administered subcutaneously; toxic',\n",
       "        'Antimalarial activity against Plasmodium cynomolgi M infected in rhesus monkey administered as po qd for 7 days',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 320 mg/kg dose administered subcutaneously; active/4 toxic',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 160 mg/kg dose administered subcutaneously; active/1 toxic',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 20 mg/kg dose administered subcutaneously',\n",
       "        'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) at 40 mg/kg dose administered subcutaneously; active'],\n",
       "       dtype=object),\n",
       " array(['Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 1 mg/kg/day after 7 days; cured 1 of 1',\n",
       "        'Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 3.16 mg/kg/day after 7 days; cured 0 of 1',\n",
       "        'Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 0.316 mg/kg/day after 7 days; cured 3 of 3',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Radical curative antimalarial activity against Plasmodium cynomolgi in Rhesus monkeys (Macaca mulatta) at 0.1 mg/kg/day over 7 days; cured 5 of 5'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 (Indochina)',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 3 against Plasmodium berghei infected MORO mice (Mus musculus) at 100 mg/kg subcutaneous dose',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 3 against Plasmodium berghei infected MORO mice (Mus musculus) at 100 mg/kg peroral dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against erythrocytic stage of chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by FACS method',\n",
       "        'Antimalarial activity against erythrocytic stage of chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by FACS method',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against erythrocytic stage of chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by spectrophotometry',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against erythrocytic stage of chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by spectrophotometry'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antimalarial activity against chloroquine sensitive Plasmodium falciparum HB3 after 72 hrs by SYBP Green I dye staining',\n",
       "        'Antimalarial activity against chloroquine resistant Plasmodium falciparum Dd2 after 72 hrs by SYBP Green I dye staining',\n",
       "        'Inhibition of Tween 20-induced beta-hematin formation by colorimetric assay',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg); Experiment I',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg); Experiment I',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 (Indochina)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg); Survival beyond 60 days is considered curative; Experiment II; Survival beyond 60 days is considered curative (C)',\n",
       "        'Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg); Experiment II',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 640(mg/kg); Experiment I',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 3 against Plasmodium berghei infected MORO mice (Mus musculus) at 100 mg/kg subcutaneous dose',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in terms of survival days when administered orally in mice (Mus musculus)',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium berghei KBG173 ',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 640(mg/kg); Experiment II; Survival beyond 60 days is considered curative (C)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg); Experiment II',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 100 mg/kg, perorally administered 1 day post-infection measured 3 day post-infection',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in terms of survival days when administered subcutaneously in mice (Mus musculus)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 (mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 (mg/kg); Experiment II; active (A)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg); Experiment I',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 3 against Plasmodium berghei infected MORO mice (Mus musculus) at 100 mg/kg peroral dose',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg); Experiment I'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 at 100 uM by SYBR green assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by FACS analysis in presence of 10 % human serum',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 after 48 hrs by SYBR green assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs',\n",
       "        'Reduction in Plasmodium falciparum FCK2 in human blood cell culture after 96 hrs',\n",
       "        'Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimalarial activity against trophozoite stage of chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs'],\n",
       "       dtype=object),\n",
       " array(['Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       "        'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'In vitro inhibition of Plasmodium falciparum K1 (S108N + C59R) culture',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R+S108N/I164L (Csl-2) mutant',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase wild type (TM4/8.2)',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase CN51I/C59R/S108N/I164L (V1/S) mutant',\n",
       "        'Binding affinity was evaluated as inhibition of mutant (C59R + S108N) Plasmodium falciparum DHFR-TS.',\n",
       "        'Inhibitory activity against recombinant wild type (WT) Plasmodium falciparum DHFR-TS',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Binding affinity was evaluated as inhibition of recombinant wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase N51I/C59R/S108N (W2)',\n",
       "        'In vitro inhibition of Plasmodium falciparum HB3 (S108N) culture',\n",
       "        'Inhibitory activity against mutant Plasmodium falciparum DHFR-TS',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition constant against Plasmodium falciparum dihydrofolate reductase'],\n",
       "       dtype=object),\n",
       " array(['Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       "        'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vivo inhibition of Plasmodium falciparum infected male Swiss albino mice (Mus musculus) by intraperitoneal dose',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium vivax infected in human assessed as clearance of peripheral parasitemia at total dose of 30 mg/kg administered as three daily doses measured within 24 hrs post dose',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum TM6 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium vivax with >50% parasites at ring stage infected in human erythrocytes assessed as growth inhibition after 30 to 50 hrs by microscopic analysis using giemsa staining',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites by microscopy',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium vivax at the ring stage infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 106/1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum 3D7',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Tmax in children with uncomplicated malaria assessed as desethylamodiaquine at 10 mg/kg, po administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured after 30 hrs by microscopy',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum PH3',\n",
       "        'Toxicity in children with malaria under 2 years of age assessed as incidence of fever administered with 250 mg sulfalene/12.5 mg pyrimethamine on first day followed by compound treatment at <=15 mg/kg/day,perorally',\n",
       "        'Toxicity in children with malaria assessed as incidence of rashes at >19 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against Plasmodium falciparum trophozoites by microscopy treated during ring stage',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium vivax by Giemsa staining',\n",
       "        'Toxicity in patient infected with chloroquine-resistant Plasmodium vivax assessed as occurrence of vomitting at total dose of 30 mg/kg administered as three daily doses measured 30 minutes post dose',\n",
       "        'AUC (0-120 hrs) in Ugandan children patient with uncomplicated malaria assessed as desethylamodiaquine level at 10 mg/kg, perorally qd on first 2 days and then 5 mg/kg, perorally on third day co-administered with artesunate at 4 mg/kg, perorally bid for 3 days',\n",
       "        'Toxicity in children with malaria assessed as incidence of rashes at 17-19 mg/kg/day, perorally and cotreated with Sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Inhibition of Tween 20-induced beta-hematin formation by colorimetric assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum HB',\n",
       "        'Toxicity in children with malaria assessed as incidence of vomiting at 17-19 mg/kg/day, perorally and cotreated with Sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Toxicity in children with malaria assessed as incidence of vomiting at >19 mg/kg/day, perorally and cotreated with Sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against Plasmodium falciparum THAI',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum VS/1 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage by microscopy',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as inhibition of parasite growth after 48 hrs by [3H]hypoxanthine reuptake assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 24 hrs by semiautomated micro dilution assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum V1/S',\n",
       "        'ST_JUDE: Growth inhibition of to Toxoplasma gondii, in human U-2OS cells, as measured by luciferase.',\n",
       "        'Antimalarial activity against Plasmodium falciparum trophozoites infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) perorally dosed daily over 4 days',\n",
       "        'AUC in Gabonian malarial children aged 6 months to 10 years assessed as desethylamodiaquine level at 30 mg/kg measured on third day post dose',\n",
       "        'Cmax in Ugandan children patient with uncomplicated malaria assessed as desethylamodiaquine level at 10 mg/kg, perorally qd on first 2 days and then 5 mg/kg, perorally on third day co-administered with artesunate at 4 mg/kg, perorally bid for 3 days',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimicrobial activity against Plasmodium falciparum 3D7 by DAPI growth inhibition assay',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'Antimalarial activity as ED100 in peripheral blood against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human forskin fibroblast cells (BJ)',\n",
       "        'Toxicity in children with malaria over 2 years of age assessed as incidence of rashes at >=15 mg/kg/day, perorally co-treated with 500 mg sulfalene/25 mg pyrimethamine',\n",
       "        'Antimalarial activity against Plasmodium ovale ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum SB-A6',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'Inhibition of beta-hematin formation as molar equivalent relative to hemin causing blockade in BHIA',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) as reduced parasitaemia at 10 mg/kg initial oral dose and further intraperitoneal dose after 4 days',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii NS peroral dosage',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum K1/Thailand by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FC27',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum T996',\n",
       "        'Toxicity in children with malaria assessed as febrile incidence at 15-17 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 7G8-mdr7G8',\n",
       "        'Toxicity in children with malaria assessed as febrile incidence at 17-19 mg/kg/day, perorally and cotreated with Sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM4',\n",
       "        'Antimalarial activity against Plasmodium vivax trophozoites infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'Toxicity in children with malaria assessed as incidence of rashes at <15 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity against Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'ST_JUDE: Cytotoxicity using Alamar Blue to measure viability of Leishmania major',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 assessed as inhibition of parasite LDH activity after 72 hrs by spectrophotometry',\n",
       "        'ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye',\n",
       "        'In vitro antimalarial activity against Plasmodium yoelii NS in peter 4-day assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Toxicity in children with malaria assessed as incidence of vomiting at <15 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'AUC (0-8 hrs) in Ugandan children patient with uncomplicated malaria at 10 mg/kg, perorally qd on first 2 days and then 5 mg/kg, perorally on third day co-administered with artesunate at 4 mg/kg, perorally bid for 3 days',\n",
       "        'Cmax in children with uncomplicated malaria assessed as desethylamodiaquine at 10 mg/kg, po administered as single dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Toxicity in children with malaria over 2 years of age assessed as incidence of fever at >=15 mg/kg/day, perorally co-treated with 500 mg sulfalene/25 mg pyrimethamine',\n",
       "        'Toxicity in children with malaria assessed as febrile incidence at <15 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Toxicity in children with malaria assessed as incidence of rashes at 15-17 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity against Plasmodium falciparum GC03',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as inhibition of parasite LDH activity after 72 hrs by spectrophotometry',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium vivax infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human epithelial embryonic kidney cells (HEK293)',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Thai after 24 hrs by semiautomated micro dilution assay',\n",
       "        'Toxicity in children with malaria under 2 years of age assessed as incidence of rashes administered with 250 mg sulfalene/12.5 mg pyrimethamine on first day followed by compound treatment at <=15 mg/kg/day,perorally',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum TM4',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against Plasmodium malariae trophozoite stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'Toxicity in children with malaria assessed as incidence of vomiting at 15-17 mg/kg/day, perorally and cotreated with Sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Toxicity in children with malaria over 2 years of age assessed as incidence of itching at >=15 mg/kg/day, perorally co-treated with 500 mg sulfalene/25 mg pyrimethamine',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum Dd2',\n",
       "        'Antimalarial activity against Plasmodium falciparum PH3 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'Inhibition of beta-hematin formation by BHIA assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum at the ring stage infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1R after 24 hrs by semiautomated micro dilution assay',\n",
       "        'AUC (0-infinity) in Ugandan children patient with uncomplicated malaria assessed as desethylamodiaquine level at 10 mg/kg, perorally qd on first 2 days and then 5 mg/kg, perorally on third day co-administered with artesunate at 4 mg/kg, perorally bid for 3 days',\n",
       "        'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Toxicity in children with malaria under 2 years of age assessed as incidence of itching administered with 250 mg sulfalene/12.5 mg pyrimethamine on first day followed by compound treatment at <=15 mg/kg/day,perorally',\n",
       "        'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum by [3H]hypoxanthine incorporation',\n",
       "        'Change in mean survival time of trophozoite-induced Plasmodium berghei infection after 20 mg/kg subcutaneous dose',\n",
       "        'AUC in Nigerian human adult malaria patient assessed as desethylamodiaquine level at 25 mg/kg measured on third day post dose',\n",
       "        'Antimicrobial activity against Plasmodium falciparum at the ring stage by microscopy',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium vivax infected in human assessed as clearance of peripheral parasitemia at total dose of 30 mg/kg administered as three daily doses measured 48 hrs post dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum DD2',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum RSA11',\n",
       "        'Antimalarial activity against Plasmodium berghei NK-65 infected in ICR mouse assessed as host survival at 30 mg/kg, po administered at 72, 96 and 120 hrs post infection measured on day 17 post infection by Thompson test',\n",
       "        'Antimalarial activity against Plasmodium falciparum T9-96',\n",
       "        'Antimalarial activity against chloroquine-Resistant Plasmodium vivax infected in human assessed as parasite recurrence rate at total dose of 30 mg/kg administered as three daily doses measured on day 28 post dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured within 30 hrs by microscopy',\n",
       "        'Antimalarial activity as reduced parasitaemia in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 10 mg/kg/day peroral dose then intraperitoneal dose for 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) perorally dosed daily for 4 days',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum THAI',\n",
       "        'Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        \"ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human Burkitt''s lymphoma lymphoblast cells (Raji)\",\n",
       "        'Toxicity in children with malaria over 2 years of age assessed as incidence of vomiting at >=15 mg/kg/day, perorally co-treated with 500 mg sulfalene/25 mg pyrimethamine',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'Toxicity in children with malaria over 2 years of age assessed as incidence of headache at >=15 mg/kg/day, perorally co-treated with 500 mg sulfalene/25 mg pyrimethamine',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human RBCs after 72 hrs by parasite lactate dehydrogenase assay',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured after 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium malariae ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Toxicity in children with malaria under 2 years of age assessed as incidence of vomiting administered with 250 mg sulfalene/12.5 mg pyrimethamine on first day followed by compound treatment at <=15 mg/kg/day,perorally',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected in human erythrocytes after 72 hrs by spectrophotometry based Malstat method',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum V1/S',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the trophozoites by microscopy treated during ring stage',\n",
       "        'Antimalarial activity against chloroquine-susceptible Plasmodium falciparum 3D7 assessed as inhibition of parasite growth after 48 hrs by [3H]hypoxanthine reuptake assay',\n",
       "        'ST_JUDE: Cytotoxicity against Plasmodium falciparum D10 transfected with yeast DHOD',\n",
       "        'Half life in Ugandan children patient with uncomplicated malaria assessed as desethylamodiaquine level at 10 mg/kg,perorallyqd on first 2 days and then 5 mg/kg,perorallyon third day co-administered with artesunate at 4 mg/kg,perorallybid for 3 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum TM6',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Primary phase half life in children with uncomplicated malaria assessed as desethylamodiaquine at 10 mg/kg, po administered as single dose',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum THAI/Thailand as [3H]hypoxanthine uptake after 24 hrs by semi-automated micro dilution',\n",
       "        'In vivo inhibition of Plasmodium falciparum infected male Swiss albino mice (Mus musculus) by oral dose',\n",
       "        'Antiparasitic activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum V1/S',\n",
       "        'Antimalarial activity against ring stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Half life in Ugandan children patient with uncomplicated malaria at 10 mg/kg,perorally qd on first 2 days and then 5 mg/kg,perorally on third day co-administered with artesunate at 4 mg/kg,perorally bid for 3 days',\n",
       "        'Change in mean survival time of trophozoite-induced Plasmodium berghei infection after 40 mg/kg subcutaneous dose',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum J164',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PH3',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM4 infected in human A positive erythrocytes assessed as inhibition of [G-3H]-hypoxanthine uptake after 24 hrs by liquid scintillation counting',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as [3H]hypoxanthine incorporation after 24 hrs by scintillation counting',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human RBCs after 72 hrs by parasite lactate dehydrogenase assay',\n",
       "        'Toxicity in children with malaria under 2 years of age assessed as incidence of headache administered with 250 mg sulfalene/12.5 mg pyrimethamine on first day followed by compound treatment at <=15 mg/kg/day,perorally',\n",
       "        'Toxicity in children with malaria assessed as febrile incidence at >19 mg/kg/day, perorally and co-treated with sulfadoxine and pyrimethamine during intermittent preventive treatment to prevent malaria in children regimen',\n",
       "        'Antimalarial activity as minimal concentration for parasite elimination at day 23 against Plasmodium yoelii 17X peroral inoculated CD1 mice (Mus musculus) dosed 1 hrs post infection then daily for 4 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum Dd2',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by Geimsa staining',\n",
       "        'Inhibition of Plasmodium falciparum phosphoethanolamine methyltransferase using phospethanolamine as substrate by radiochemical assay in presence of S-adenosylmethionine',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured within 30 hrs by microscopy',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcB1R/Colombia by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 34-1/E',\n",
       "        'ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human epithelial hepatocellular carcinoma cells (HepG2)',\n",
       "        'ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of Trypanosoma brucei',\n",
       "        'AUC (0-infinity) in Ugandan children patient with uncomplicated malaria at 10 mg/kg, perorally qd on first 2 days and then 5 mg/kg, perorally on third day co-administered with artesunate at 4 mg/kg, perorally bid for 3 days',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against ring stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Cmax in Ugandan children patient with uncomplicated malaria at 10 mg/kg, perorally qd on first 2 days and then 5 mg/kg, perorally on third day co-administered with artesunate at 4 mg/kg, perorally bid for 3 days',\n",
       "        'AUC in children with uncomplicated malaria assessed as desethylamodiaquine at 10 mg/kg, po administered as single dose',\n",
       "        'Terminal half life in children with uncomplicated malaria assessed as desethylamodiaquine at 10 mg/kg, po administered as single dose',\n",
       "        'Toxicity in patient infected with chloroquine-resistant Plasmodium vivax assessed as occurrence of anemia at total dose of 30 mg/kg administered as three daily doses measured 7 days post dose',\n",
       "        'Toxicity in human infected with chloroquine-Resistant Plasmodium vivax assessed as occurrence of nausea at total dose of 30 mg/kg administered as three daily doses'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium falciparum NF54 in mice (Mus musculus) by intravenous dose',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54 infected mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum NF54 in mice (Mus musculus) by peroral dose'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium falciparum NF54 in mice (Mus musculus) by intravenous dose',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum NF54 in mice (Mus musculus) by peroral dose',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54 infected mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Binding constant for PFCDPK1(P.falciparum) kinase domain',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Binding constant for PFPK5(P.falciparum) kinase domain',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against 3000 Plasmodium berghei NK65 liver stage sporozoites infected in 12 wk old C57BL/6 mouse assessed as delay in prepatent period at 5 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 5 days by microscopic analysis',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in human HepG2 cells after 48 hrs by RT-PCR',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 12 wk old C57BL/6 mouse assessed as prepatent period at 5 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 5 days by microscopic analysis'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against liver stages of Plasmodium berghei 17XNL infected in human Hepa1-6 cells assessed as reduction in liver parasite load at 10 uM/L incubated for 1 hr prior to sporozoite inoculation measured after 46 to 48 hrs by fluorescence microscope',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii 17XNL infected in Swiss Webster mouse assessed as reduction in liver parasite load at 25 mg/kg, po co-administered with 12.5 mg/kg ritonavir incubated for 6 hrs prior to sporozoite inoculation measured after 18 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii 17XNL infected in Swiss Webster mouse assessed as reduction in liver parasite load at 100 mg/kg, po co-administered with 50 mg/kg ritonavir incubated for 6 hrs prior to sporozoite inoculation measured after 18 hrs',\n",
       "        'Antimalarial activity against chloroquine resistant, mefloquine sensitive Plasmodium falciparum W2 infected in human erythrocytes by [3H]-hypoxanthine incorporation assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring HFP-tagged Pfs16 protein after 48 hrs'],\n",
       "       dtype=object),\n",
       " array(['in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration',\n",
       "        'In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control',\n",
       "        'Antimalarial activity in vitro',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'Inhibitory concentration against Plasmodium berghei',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R/S108N (K1CB1) mutant',\n",
       "        'Binding affinity to recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant by competitive binding assay',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase A16V/S108T (T9/94RC17) mutant',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (A16V+S108T DHFR) of Plasmodium falciparum.',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Binding affinity was evaluated as inhibition of mutant (C59R + S108N) Plasmodium falciparum DHFR-TS.',\n",
       "        'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.',\n",
       "        'Inhibition of Plasmodium falciparum T9/94 mutant',\n",
       "        'Evaluated for inhibition constant (Ki wt) against Wild-type dihydrofolate reductase of Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase wild type (TM4/8.2)',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 in erythrocytes',\n",
       "        'Inhibition constant (Ki mut) against A16V+S108T Mutant DHFRs of Plasmodium falciparum',\n",
       "        'Minimum inhibitory concentration against Plasmodium falciparum NF-54 after 40 hrs',\n",
       "        'Binding affinity to wild type Plasmodium falciparum DHFR by competitive binding assay',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum K1',\n",
       "        'In vitro minimum inhibiting concentration for schizont maturation from ring stage parasite over 40 hrs',\n",
       "        'In vitro cytotoxicity against Plasmodium falciparum infected KB cell line',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Inhibitory concentration against multidrug-resistant Plasmodium falciparum Dd2.',\n",
       "        'Antimalarial activity against chloroquine and cycloguanil-resistant Plasmodium falciparum FCR-3/Gambia ring stage infected in human red blood cells assessed as inhibition of [3H]-hypoxanthine incorporation incubated 24 hrs before addition of [3H]-hypoxanthine measured after 24 hrs',\n",
       "        'Anti-malarial activity against Plasmodium falciparum Dd2',\n",
       "        'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with quadruple (N51I + C59R + S108N + I164L) mutations',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase N51I/C59R/S108N (W2)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes by semiautomated micro dilution',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with double (A16V + S108T) mutations',\n",
       "        'Inhibition constant against wild-type PfDHFR (Plasmodium falciparum dihydrofolate reductase)',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single A16V mutation',\n",
       "        'Inhibition against Plasmodium falciparum Dd2 in erythrocytes in semiautomated micro dilution assay',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R+S108N/I164L (Csl-2) mutant',\n",
       "        'In vitro cytotoxicity against Plasmodium falciparum infected BC cell line.',\n",
       "        'In vitro cytotoxicity against Plasmodium falciparum infected vero cell line.',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single S108T mutation',\n",
       "        'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase CN51I/C59R/S108N/I164L (V1/S) mutant',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with triple (C59R + S108N + I164L) mutations',\n",
       "        'Binding affinity was evaluated as inhibition of recombinant wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       "        'Growth inhibition (IC50) against Plasmodium falciparum wild-type TM4/8.2'],\n",
       "       dtype=object),\n",
       " array(['In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after oral administration.',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after oral administration.'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity in vitro',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity in vitro',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration'],\n",
       "       dtype=object),\n",
       " array(['In vivo 90% effective dose tested against Plasmodium berghei NK 65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'In vivo 50% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration',\n",
       "        'In vivo 90% effective dose tested against Plasmodium berghei NK65 infected mice (Mus musculus), after intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 0.1 uM using Leu-AMC as a substrate by spectrophotometer',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Leu-AMC as a substrate by spectrophotometer',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 0.1 uM using Leu-AMC as a substrate by spectrophotometer in presence of 1 nM CoCl2',\n",
       "        'Inhibitory activity for Plasmodium falciparum Zinc aminopeptidase',\n",
       "        'Inhibition of Plasmodium falciparum recombinant AM1 using Leu-pNA as substrate',\n",
       "        'Inhibition of Plasmodium falciparum recombinant M1-aminopeptidase expressed in Escherichia coli after 40 mins uisng fluorigenic substrate L-Leucyl-7-amido-40-methylcoumarin by fluorescence spectrophotometry',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Leu-AMC as a substrate by spectrophotometer in presence of 1 nM CoCl2',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected-erythrocytes after 72 hrs by SYBR green fluorescence method',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human O positive erythrocytes under low oxygen atmosphere after 72 hrs by spectrophotometric analysis',\n",
       "        'Inhibitory activity against Plasmodium falciparum FcB1',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 harboring tPfAP-M17 gene at 0.1 uM using Leu-AMC as a substrate by spectrophotometer in presence of 1 nM CoCl2',\n",
       "        'Antimalarial activity as inhibition of Plasmodium falciparum 3D7 replication in medium + isoleucine after 65 hrs',\n",
       "        'Antimalarial activity as inhibition of Plasmodium falciparum 3D7 replication in medium with all amino acids after 65 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       "        'Inhibition of alanyl aminopeptidase activity in Plasmodium falciparum 3D7 at 0.1 uM using Ala-AMC as a substrate by spectrophotometer',\n",
       "        'Inhibition of alanyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Ala-AMC as a substrate by spectrophotometer'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration.',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 640 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 2',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 40 mg/kg after subcutaneous administration',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration;'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 1',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 1',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 320 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 4',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 3',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 640 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 4',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 4',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 4'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 40 mg/kg after subcutaneous administration',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 80 mg/kg after subcutaneous administration',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 2',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 640 mg/kg after subcutaneous administration; No. of mice (Mus musculus) surviving after 60 days 3',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 320 mg/kg after subcutaneous administration;'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 20 mg/kg after subcutaneous administration.',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 40 mg/kg after subcutaneous administration',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'Dose that causes 50% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Dose that causes 90% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.'],\n",
       "       dtype=object),\n",
       " array(['Dose that causes 50% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.',\n",
       "        'Dose that causes 90% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['Dose that causes 90% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.',\n",
       "        'Dose that causes 50% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Dose that causes 90% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.',\n",
       "        'Dose that causes 50% suppression of Plasmodium berghei parasitaemia in the treated mice (Mus musculus) compared to untreated controls.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Not Plasmodium species'], dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in erythrocytes assessed as inhibition of sorbitol-induced hemolysis after 15 mins',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 assessed as inhibition of [3H] hypoxanthine uptake by liquid scintillation counting',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by FACS-based assay',\n",
       "        'Inhibition of Plasmodium falciparum falcipain 2 assessed as benzyloxycarbonyl-Phe-Leu-7-amino-4-methylcoumarin substrate hydrolysis after 30 mins by spectrofluorometry analysis',\n",
       "        'In vitro antiplasmodial activity against Plasmodium falciparum D10',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 by FACS-based assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 by FACS-based assay',\n",
       "        'Antiplasmodial activity against drug resistant Plasmodium falciparum Dd2 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 ring stage cells assessed as reduction parasitemia by Malstat assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 5',\n",
       "        'In vivo effective dose was evaluated against Plasmodium berghei N by sub cutaneous administration in mice (Mus musculus)',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 11',\n",
       "        'In vivo effective dose was evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by subcutaneous administration in mice (Mus musculus)',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by subcutaneous administration in mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'In vivo effective dose was evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 12',\n",
       "        'In vivo effective dose was evaluated against Plasmodium berghei N by subcutaneous administration in mice (Mus musculus)',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 10',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 11',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4'],\n",
       "       dtype=object),\n",
       " array(['Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by subcutaneous administration in mice (Mus musculus)',\n",
       "        'In vivo effective dose was evaluated against Plasmodium berghei N by sub cutaneous administration in mice (Mus musculus)',\n",
       "        'In vivo effective dose was evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 11',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 5',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose was evaluated against Plasmodium berghei N by sub cutaneous administration in mice (Mus musculus)',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by per oral administration in mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 11',\n",
       "        'In vivo effective dose evaluated against Plasmodium berghei N by subcutaneous administration in mice (Mus musculus)',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Percent survival of mice (Mus musculus) after 20 days post infection of malarial parasite in out of 5 mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 in mice (Mus musculus) by intraperitoneal route at a concentration of 35.5 uM/kg at day 4',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum GHA infected in human erythrocytes after 72 hrs using malstat staining by spectrophotometry',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum GHA strain infected in human erythrocytes after 72 hrs by spectrophotometry',\n",
       "        'Inhibition of Plasmodium falciparum GHA strain PDE assessed as inhibition of cGMP hydrolysis at 20 uM after 6 hrs by time resolved fluorescence resonance energy transfer-based assay'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum GHA strain infected in human erythrocytes after 72 hrs by spectrophotometry',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum GHA infected in human erythrocytes after 72 hrs using malstat staining by spectrophotometry',\n",
       "        'Inhibition of Plasmodium falciparum GHA strain PDE assessed as inhibition of cGMP hydrolysis at 20 uM after 6 hrs by time resolved fluorescence resonance energy transfer-based assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of FabG',\n",
       "        'Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.25 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Inhibition of FabI'], dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in terms of survival days when administered orally in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vivo evaluation for antimalarial activity against Plasmodium berghei in terms of survival days when administered subcutaneously in mice (Mus musculus)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered subcutaneously in mice (Mus musculus)',\n",
       "        'In vivo evaluation for antimalarial activity against Plasmodium berghei in percentage when administered orally in mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Toxicity in patient with malaria assessed as incidence of increase in bilirubin at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235 assessed as inhibition of [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 320 mg/kg, po administered as single dose',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum F32-Tanzania by [3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 5 mg/kg, po administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 30 mg/kg, perorally administered as single dose 24 hrs post infection for 1 day measured 72 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 100 mg/kg, perorally administered as single dose 24 hrs post infection for 1 day measured 72 hrs post infection',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum PFB Brazil by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3C10 containing 2 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3C20 containing 2 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum D6 infected in Aotus lemurinus lemurinus monkey',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using CAM promoter driven expressing ATP4 D1247Y mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 by hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 3 times 30 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6',\n",
       "        'Effective subcutaneous dose ED90 against Plasmodium yoelii sspNS',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum D-8',\n",
       "        'Antimalarial activity against Plasmodium falciparum trophozoites infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 24 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM91C235 by SYBR Green I-based fluorescence assay',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum TM91C235',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A7 containing 4 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing wild type ATP4 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing ATP4 I398F/P990R mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 80 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as [35S]Met/Cys incorporation by SYBR green based fluorescence assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of rash at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and expressing parental ATP4 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 10 mg/kg, perorally administered through 7% Tween80/3% Ethanol formulation 24 hrs post infection for 3 days measured 96 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef assessed as DNA positive erythrocytes by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 40 mg/kg, po administered as single dose',\n",
       "        'Toxicity in patient with malaria assessed as incidence of diarrhea at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using CAM promoter driven expressing ATP4 I398F/P990R mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolates assessed as parasite growth inhibition after 72 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay',\n",
       "        'Antimalarial activity Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in ICR mice (Mus musculus) assessed as delay in mortality at 160 mg/kg, perorally for 3 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity after 24 hrs against Plasmodium falciparum W2 infected in type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 72 hrs by MSF assay',\n",
       "        'Antimalarial activity against ring stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity against Plasmodium malariae ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A3 containing 1 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 infected erythrocytes',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM90C2A assessed as inhibition of [3H]hypoxanthine incorporation by liquid scintillation spectrometry',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 10 mg/kg, perorally administered as single dose 24 hrs post infection for 1 day measured 72 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive and mefloquine-resistant Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine incorporation by liquid scintillation spectrometry',\n",
       "        'Growth inhibition of Plasmodium falciparum 3D7 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       "        'Antimicrobial activity against Plasmodium vivax harboring amplified Pvmdr1 gene',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring single copy of Pfmdr1 gene',\n",
       "        'Antimicrobial activity against drug pre-treated Plasmodium falciparum clone W2AL80 containing 3 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM90C2A',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 in MSF assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abnormal retinal fluoroscein at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef by hypoxanthine uptake assay',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 100 mg/kg, perorally administered as single dose 24 hrs post infection for 1 day measured 72 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 30 mg/kg, perorally administered through 7% Tween80/3% Ethanol formulation 24 hrs post infection for 3 days measured 96 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia dosed in 7% Tween80/3% ethanol formulation 1 day post infection measured 72 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia dosed in ETPGS formulation 1 day post infection measured 72 hrs post infection',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abnormal dreams at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes after 72 hrs by MSF assay',\n",
       "        'Antimalarial activity against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum RCS',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Indochina W2 after 24 to 60 hrs by [G-H3]hypoxanthine uptake ',\n",
       "        'Inhibition of Plasmodium falciparum 3D7',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the trophozoites by microscopy treated during ring stage',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of musculoskeletal injury at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       "        'Toxicity in patient with malaria assessed as incidence of somnolence at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 infected erythrocytes',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Effective dose EC50 against Plasmodium berghei N in a mice (Mus musculus) malaria model after oral dose',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum W2 Indochina relative to QHS',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine incorporation after 24 hrs by microtiter plate scintillation counting',\n",
       "        'Antimalarial activity against chloroquine-resistant, mefloquine-susceptible Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A12 containing 2 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of Plasmodium falciparum F32A',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs by SYBR green fluorescence assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum at the ring stage by microscopy',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage by microscopy',\n",
       "        'Inhibitory concentration against chloroquine-sensitive Plasmodium falciparum D-8',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring amplified Pfmdr1 gene',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium vivax at the ring stage infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef ring form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'Minimum inhibitory concentration (IC99) against Plasmodium falciparum K1 infected erythrocytes',\n",
       "        'Antimicrobial activity against Plasmodium falciparum at ring stage',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 160 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Toxicity in patient with malaria assessed as incidence of dizziness at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Smith by semiautomated micro dilution assay',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 160 mg/kg, po administered as single dose',\n",
       "        'Antimalarial activity against chloroquine,mefloquine-sensitive Plasmodium falciparum D6',\n",
       "        'Toxicity in patient with malaria assessed as incidence of arthralgia at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W-2',\n",
       "        'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum by [3H]hypoxanthine incorporation',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring NGFSDD genotype after 72 hrs by SYBR green I assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abnormal coordination at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of upper respiratory tract infection at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of headache at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 3 times 30 mg/kg, perorally',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 100 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake relative to gedunin',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3C18 containing 3 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured within 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2',\n",
       "        'Inhibition of Plasmodium falciparum cyclin-dependent kinase',\n",
       "        'Toxicity in patient with malaria assessed as incidence of viral infection at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum Mad20',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 in human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of phayngitis at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of vertigo at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum CAMP by semiautomated micro dilution assay',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing ATP4 D1247Y mutant after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after oral administration',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 20 mg/kg, po administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against ring stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured after 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake relative to gedunin',\n",
       "        'Antimalarial activity against mefloquine-resistant and chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as mice (Mus musculus) survival days at 3 mg/kg, perorally daily once for 3 consecutive days measured after 4 days post-infection',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 20 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 160 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 20 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 10 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 5 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium falciparum C235',\n",
       "        'Toxicity in patient with malaria assessed as incidence of pigmentation of retinal epithelium at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3C1 containing 3 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 10 mg/kg, perorally administered as single dose as single dose 24 hrs post infection for 1 day measured 72 hrs post infection',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A26 containing 3 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 as [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 as [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 100 mg/kg, perorally administered as single dose',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 10 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'Inhibition of Plasmodium falciparum FCM29',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 30 mg/kg, perorally administered as single dose 24 hrs post infection for 1 day measured 72 hrs post infection',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A17 containing 2 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 30 mg/kg/day peroral dose after 4 days',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimicrobial activity against Plasmodium falciparum 3D7 by DAPI growth inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 10 mg/kg, perorally administered through 7% Tween80/3% Ethanol formulation 24 hrs post infection for 3 days measured 96 hrs post infection',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 Sierra Leone',\n",
       "        'Antimalarial activity against Plasmodium malariae trophozoite stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as resistant isolates',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green fluorescence assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured after 30 hrs by microscopy',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum W2 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring NDFCDY genotype after 72 hrs by SYBR green I assay',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum D6 (Sierra Leone) relative to QHS',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antimalarial activity against Plasmodium vivax with >50% parasites at ring stage infected in human erythrocytes assessed as growth inhibition after 30 to 50 hrs by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium vivax infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium vivax trophozoites infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimicrobial activity against Plasmodium falciparum trophozoites by microscopy treated during ring stage',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 3 times 30 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antimicrobial activity against Plasmodium vivax harboring single copy of Pvmdr1 gene',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 30 mg/kg, perorally administered through 7% Tween80/3% Ethanol formulation 24 hrs post infection for 3 days measured 96 hrs post infection',\n",
       "        'Antimalarial activity against chloroquine-sensitive and mefloquine-resistant Plasmodium falciparum D6 by SYBR Green I-based fluorescence assay',\n",
       "        'Growth inhibition of Plasmodium falciparum Dd2 ring stage infected erythrocytes after 72 hrs by DAPI fluorimetry',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as curing of parasitaemia at 3 mg/kg, perorally daily once for 3 consecutive days measured after 30 days post-infection',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring NDFCDD genotype after 72 hrs by SYBR green I assay',\n",
       "        'Antimalarial activity against mefloquine, chloroquine and quinine-resistant Plasmodium falciparum TM91C235',\n",
       "        'Antimalarial activity against early trophozoite-stage Plasmodium falciparum 3D7 infected in erythrocyte assessed as reduction in parasite hemoglobin content at 5 times IC50 after 8 hrs',\n",
       "        'Antimalarial activity against morfloquine-resistant Plasmodium falciparum TM91C235 assessed as [3H]hypoxanthine incorporation',\n",
       "        'Toxicity in patient with malaria assessed as incidence of depression at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'Antimalarial activity against atovaquone-resistant Plasmodium falciparum TM90C2B',\n",
       "        'Antimalarial activity against blood stage of Plasmodium berghei NK65 infected in po dosed rat assessed as inhibition of parasite growth',\n",
       "        'Toxicity in patient with malaria assessed as incidence of increase in serum creatinine at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of fungal dermatitis at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of vomiting at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of nausea at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum D6 (Sierra Leone) after 24 to 60 hrs by [G-H3]hypoxanthine uptake',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 80 mg/kg, po administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum FC27',\n",
       "        'Growth inhibition of chloroquine-resistant Plasmodium falciparum KI',\n",
       "        'Antimalarial activity after 24 hrs against Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 in human erythrocytes after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium falciparum in HRP2 ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium ovale ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 320 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Inhibition of Tween 20-induced beta-hematin formation by colorimetric assay',\n",
       "        'Antimalarial activity against chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W2',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 3 times 30 mg/kg, perorally measured up to 30 days postinfection',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 40 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as cure rat at 3 mg/kg, perorally administered for 3 days post infection measured after 30 days',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by SYBR green I-based assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against multidrug-resistant and atovaquone-sensitive Plasmodium falciparum TM91C235',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs by lactate dehydrogenase assay',\n",
       "        'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 100 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs',\n",
       "        'In vitro sensitivity for Plasmodium falciparum FcB1R',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235 after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium falciparum HB3 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 in MSF assay',\n",
       "        'Antimalarial activity against chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine incorporation by liquid scintillation spectrometry',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum isolate 208432 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Inhibition of hydrogen peroxide-mediated haem detoxification in Plasmodium falciparum',\n",
       "        'Antimicrobial activity against Plasmodium vivax at trophozoite stage',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A8 containing 3 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W2 infected in human O-positive erythrocytes assessed as inhibition of parasite growth by [3H]hypoxanthine incorporation assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abdominal pain at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Inhibition of Plasmodium falciparum FCR3',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 80 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Toxicity in patient with malaria assessed as incidence of gastroentertis at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum African D6',\n",
       "        'Antimicrobial activity against compound-sensitive Plasmodium falciparum clone W2 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against drug-resistant Plasmodium falciparum TM90C2A',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 320 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM91C235 assessed as inhibition of [3H]hypoxanthine incorporation by liquid scintillation spectrometry',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum FAC8',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 10 mg/kg, po administered as single dose',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured within 30 hrs by microscopy',\n",
       "        'Antimalarial activity against mefloquine-resistant, chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasite growth inhibition after 48 hrs by [3H]hypoxanthin incorporation assay',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites by microscopy',\n",
       "        'Antimalarial activity against blood stage of Plasmodium berghei NK65 infected in po dosed rat assessed as minimum curative dose',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium vivax by Giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 100 mg/kg/day peroral dose after 4 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef schizont form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Inhibition of Plasmodium falciparum GP1',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA NK65 infected in po dosed Swiss Webster mouse assessed as reduction of parasitemia level administered qd for 4 days measured 24 hrs after last dose by light microscopic analysis',\n",
       "        'Inhibitory activity against Plasmodium falciparum K1',\n",
       "        'Effective subcutaneous dose ED50 against Plasmodium yoelii sspNS',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 100 mg/kg, perorally administered as single dose measured up to 30 days postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as host survival at 40 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimicrobial activity against Plasmodium falciparum subclone 3A1 containing 1 copy number of pfmdr1-containing amplicon on chromosome 5 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as reduction of parasitaemia level at 3 mg/kg, perorally daily once for 3 consecutive days measured after 4 days post-infection',\n",
       "        'Inhibitory activity against Plasmodium falciparum NF54',\n",
       "        'Inhibition of Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay',\n",
       "        'Inhibition of Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91C235 by hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM90C2A by hypoxanthine uptake',\n",
       "        'Growth inhibition of chloroquine-sensitive Plasmodium falciparum D10',\n",
       "        'Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum at the ring stage infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mouse assessed as complete cure at 5 mg/kg, po administered as single dose measured on day 31',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Toxicity in patient with malaria assessed as incidence of insomnia at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by SYBR green I-based assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Toxicity in patient with malaria assessed as incidence of back pain at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).. (Class of assay: confirmatory) [Related PubChem assays: 2170 (Confirmation screen (PFM18AAP inhibitors).), 1855 (Summary AID.)]'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against liver stages of Plasmodium yoelii infected in mouse assessed as protection against parasitic infection at 50 mg/kg, po after 7 days',\n",
       "        'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii assessed as inhibition of cytochrome bc1 complex',\n",
       "        'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of [3H]hypoxanthine incorporation in Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum 3D7'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 60 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 30 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 10 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 20 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 50 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 40 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 300 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 50 mg/kg.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 40 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose'],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time of Plasmodium berghei infected mice (Mus musculus) after administration of single dose of 640 mg/kg intravenously',\n",
       "        'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       "        'Mean survival time of Plasmodium berghei infected mice (Mus musculus) after administration of single dose of 320 g/kg intravenously',\n",
       "        'HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection',\n",
       "        'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       "        'Mean survival time of Plasmodium berghei infected mice (Mus musculus) after administration of single dose of 160 mg/kg intravenously',\n",
       "        'Mean survival time of Plasmodium berghei infected mice (Mus musculus) after administration of single dose of 40 mg/kg intravenously',\n",
       "        'Mean survival time of Plasmodium berghei infected mice (Mus musculus) after administration of single dose of 80 mg/kg intravenously',\n",
       "        'Mean survival time of Plasmodium berghei infected mice (Mus musculus) after administration of single dose of 20 mg/kg intravenously'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium cynomolgi M infected in rhesus monkey administered as po qd for 7 days',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 in human erythrocytes after 24 hrs',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Mean reduction in parasitaemia of Plasmodium berghei ANKA suppressive test in mice (Mus musculus) (in vivo) at 25 mg/kg scheduled for 4 days',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in human HepG2 cells after 48 hrs by RT-PCR',\n",
       "        'Inhibition of Plasmodium falciparum 3D7 in erythrocytes',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was determined against Leishmania donovani in hamsters',\n",
       "        'Antiparasitic activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity was determined against Leishmania donovani in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum 3D7 infected in O-positive human erythrocytes after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in O-positive human erythrocytes assessed as growth inhibition by LDH assay',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 harboring tPfAP-M17 gene at 10 uM using Leu-AMC as a substrate by spectrophotometer in presence of 1 nM CoCl2',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Leu-AMC as a substrate by spectrophotometer'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of alanyl aminopeptidase activity in Plasmodium falciparum 3D7 at 0.1 uM using Ala-AMC as a substrate by spectrophotometer',\n",
       "        'Inhibition of alanyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Ala-AMC as a substrate by spectrophotometer',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 0.1 uM using Leu-AMC as a substrate by spectrophotometer in presence of 1 nM CoCl2',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in O-positive human erythrocytes assessed as growth inhibition by LDH assay',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Leu-AMC as a substrate by spectrophotometer',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 10 uM using Leu-AMC as a substrate by spectrophotometer in presence of 1 nM CoCl2',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 infected in O-positive human erythrocytes after 72 hrs',\n",
       "        'Inhibition of leucyl aminopeptidase activity in Plasmodium falciparum 3D7 at 0.1 uM using Leu-AMC as a substrate by spectrophotometer'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum ENR in presence of quercetin',\n",
       "        'Inhibition of Plasmodium falciparum ENR',\n",
       "        'Inhibition of Plasmodium falciparum enoyl-acyl carrier protein reductase',\n",
       "        'Antiparasitic activity against Plasmodium falciparum in RBCs',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 by reduced [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of quercetin',\n",
       "        'Inhibition of Plasmodium falciparum ENR enzymatic activity',\n",
       "        'Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.05 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry',\n",
       "        'Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs',\n",
       "        'Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of EGC',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake',\n",
       "        'DNDI: Cytotoxicity against L-6 rat myoblasts from skeletal muscle cells',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of EGCG',\n",
       "        'Inhibition of Plasmodium falciparum recombinant enoyl ACP reductase expressed in BL21 (DE3) cells with respect to crotonyl CoA',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of ECG by dilution assay',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'Inhibition of Plasmodium falciparum FabI by spectrophotometric analysis',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCK2',\n",
       "        'Inhibition of Plasmodium falciparum recombinant FabI',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of butein',\n",
       "        'Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of ECG',\n",
       "        'Inhibition of Plasmodium falciparum enoyl-acyl carrier protein reductase expressed in Escherichia coli BL21(DE3) by spectrophotometry',\n",
       "        'Inhibition of PfENR enzymatic activity',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of EGCG by dilution assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite growth',\n",
       "        'DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro.',\n",
       "        'Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of EGCG',\n",
       "        'Inhibition of Plasmodium falciparum FabI',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of EGC by dilution assay',\n",
       "        'Inhibition of Plasmodium falciparum recombinant FabI A217V mutant',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of ECG',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of butein by dilution assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 assessed as inhibition of parasite growth',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry',\n",
       "        'Antimalarial activity after 48 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of drug-sensitive Plasmodium falciparum 3D7 after 72 hrs',\n",
       "        'Inhibition of Plasmodium falciparum recombinant enoyl ACP reductase expressed in BL21 (DE3) cells',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of EGC',\n",
       "        'Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of butein',\n",
       "        'Antimalarial activity after 96hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake',\n",
       "        'Inhibition of drug-resistant Plasmodium falciparum Dd2 after 72 hrs',\n",
       "        'Inhibition of Plasmodium falciparum enoyl-ACP reductase assessed as oxidation of NADH to NAD+ after 10 mins by spectrophotometric analysis',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of quercetin by dilution assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 by reduced [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei K137 after peroral dose',\n",
       "        'Mean time for 90% reduction in parasitaemia at a dose of 10 mg/kg/day after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)',\n",
       "        'Time of clearance after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)',\n",
       "        'Mean time for 90% reduction in parasitaemia at a dose of 3.16 mg/kg/day after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)',\n",
       "        'Percent parasitaemia before treatment at a dose of 10 mg/kg/day after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)',\n",
       "        'Mean time for 50% reduction in parasitaemia at a dose of 10 mg/kg/day after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)',\n",
       "        'Percent parasitaemia before treatment at a dose of 3.16 mg/kg/day after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)',\n",
       "        'Mean time for 50% reduction in parasitaemia at a dose of 3.16 mg/kg/day after oral administration on Plasmodium knowlesi in rhesus monkeys (7-day treatment)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum ItG assessed as inhibition of parasite growth after 48 to 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        \"Antimalarial activity against chloroquine-sensitive Plasmodium vinckei infected in mice (Mus musculus) assessed as reduction in parasitemia at 30 mg/m'2, intraperitoneally qd for 5 days administered 2 hrs post infection measured on day 5\",\n",
       "        \"Antimalarial activity against chloroquine-sensitive Plasmodium yoelii 17X infected in mice (Mus musculus) assessed as reduction in parasitaemia at 15 mg/m'2, intraperitoneal daily for 5 days administered 2 hrs post infection measured on day 5\",\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite growth after 48 to 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 assessed as inhibition of parasite growth after 48 to 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 at 5 uM',\n",
       "        'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of FabZ',\n",
       "        'Inhibition of Plasmodium falciparum FabZ by spectrophotometric analysis',\n",
       "        'Inhibition of FabI',\n",
       "        'Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Inhibition of Plasmodium falciparum FabG by spectrophotometric analysis',\n",
       "        'Inhibition of Plasmodium falciparum ENR using NADH substrate',\n",
       "        'Inhibition of Plasmodium falciparum ENR in presence of triclosan',\n",
       "        'Inhibition of Plasmodium falciparum ENR',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Inhibition of FabG'], dtype=object),\n",
       " array(['Parasite growth in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro antiplasmodial activity against Plasmodium falciparum D10',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Parasite growth in chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Inhibition of hematin polymerization',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity of compound against Plasmodium berghei infected in mice (Mus musculus) model. Compound active at given dose.',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei infected in mice (Mus musculus) model. Compound active at given dose.'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-sensitive Plasmodium falciparum D-8',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum D-8'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-sensitive Plasmodium falciparum D-8',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum D-8',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity of compound against Plasmodium berghei infected in mice (Mus musculus) model. Compound active at given dose.',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCR3 Gambia as 24 hrs [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Toxicity in patient with malaria assessed as incidence of abdominal pain at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of increase in serum creatinine at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antiplasmodial activity against Plasmodium cynomolgi sporozoites infected in Rhesus monkey assessed as duration for detection of parasites in blood at 0.316 mg/kg/day, po administered for three consecutive days before infection (Rvb = 8 days)',\n",
       "        'Toxicity in patient with malaria assessed as incidence of vertigo at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of vortex keratopathy at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of viral infection at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of insomnia at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abnormal coordination at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of tremor at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of musculoskeletal injury at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against sporozoites stage of Plasmodium cynomolgi infected in Rhesus monkey assessed as delay in patency at 0.316 mg/kg/day, po administered one day before infection, on day of infection and one day post infection',\n",
       "        'Toxicity in patient with malaria assessed as incidence of vomiting at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against Plasmodium cynomolgi infected in rhesus monkey assessed as delay in patency time at 0.316 mg/kg, po administered one day before infection, on day of infection followed by 1 day post infection',\n",
       "        'Toxicity in patient with malaria assessed as incidence of arthralgia at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abnormal dreams at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of gastroentertis at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against mefloquine-resistant Plasmodium falciparum CDC Sierra Leone 1 D6 after 48 hrs by [3H]hypoxanthine uptake assay',\n",
       "        'Toxicity in patient with malaria assessed as incidence of decrease in hematocrit at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antimalarial activity against mefloquine-susceptible Plasmodium falciparum CDC Indochina 3 W2 after 48 hrs by [3H]hypoxanthine uptake assay',\n",
       "        'OSM: Late stage gametocytes. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       "        'Toxicity in patient with malaria assessed as incidence of fungal dermatitis at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of rash at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of back pain at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'In vitro antimalarial activity dosed at 10 mg/kg against exoerythrocytic Plasmodium yoelii in mice (Mus musculus) hepatocytes',\n",
       "        'Toxicity in patient with malaria assessed as incidence of phayngitis at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of diarrhea at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of anxiety at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'In vitro antimalarial activity dosed at 1 mg/kg against exoerythrocytic Plasmodium yoelii in mice (Mus musculus) hepatocytes',\n",
       "        'Toxicity in patient with malaria assessed as incidence of somnolence at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of depression at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of decrease in hematocrit at 250 mg, perorally for 3 days and weekly 250 mg, perorally maintenance dose for 26 +/- 4 weeks relative to baseline',\n",
       "        'Toxicity in patient with malaria assessed as incidence of nausea at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Antiplasmodial activity against Plasmodium cynomolgi sporozoites infected in Rhesus monkey assessed as delay in detection of parasites in blood at 0.316 mg/kg/day, po administered for three consecutive days before infection',\n",
       "        'Toxicity in patient with malaria assessed as incidence of abnormal retinal fluoroscein at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of upper respiratory tract infection at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of headache at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of dizziness at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of agitation at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of paroniria at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of pigmentation of retinal epithelium at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of euphoria at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Prophylatic antimalarial activity against Plasmodium berghei infected Exoerythrocytic mouse model',\n",
       "        'Toxicity in patient with malaria assessed as incidence of amnesia at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks',\n",
       "        'Toxicity in patient with malaria assessed as incidence of increase in bilirubin at 200 mg, perorally for 3 days and weekly 200 mg, perorally maintenance dose for 26 +/- 4 weeks'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 2uM compound concentration.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity as change in MST against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 20 mg/kg subcutaneous dose after 72h',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity as change in MST for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 80mg/kg subcutaneous dose over 72h',\n",
       "        'Antimalarial activity as change in MST for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72hr',\n",
       "        'Antimalarial activity as change in MST against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72h',\n",
       "        'Difference in mean survival time against drug-sensitive Plasmodium berghei in mice (Mus musculus) after 320 mg/kg subcutaneous dose for 72 hrs as survivors 60 days post infection',\n",
       "        'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 80 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 40 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 20 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 80 mg/kg; 4 survived after 60 days of post infection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 40 mg/kg; 1 survived after 60 days of postinfection',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice'],\n",
       "       dtype=object),\n",
       " array(['Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 1 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 4 toxic deaths after 2-5 days of injection'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 1.25 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 40 mg/kg; 3 survived after 60 days of post infection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Trophozoite-induced Plasmodium berghei infected mice (Mus musculus) after 160 mg/kg subcutaneous dose; 60 days survival',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 3 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 20 mg/kg; 3 survived after 60 days of post infection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 20 mg/kg; 2 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg; 3 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 80 mg/kg; 1 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 1 survived after 160 days of post infection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 3 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg; 4 survived after 60 days of post infection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg; 3 survived after 60 days of postinfection'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 20 mg/kg; 4 survived after 60 days of postinfection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 10 mg/kg; 1 survived after 60 days of post infection',\n",
       "        'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg',\n",
       "        'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-susceptible Plasmodium berghei ANKA assessed as inhibition of trophozoite extract-mediated mouse hemoglobin hydrolysis at 10 mM after 18 hrs by SDS-PAGE',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) erythrocytes at 10 uM after 18 hrs as reduced hemoglobin hydrolysis',\n",
       "        'Antiparasitic activity against Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) after 18 hrs as reduced hemoglobin proteolysis',\n",
       "        'Inhibition of Plasmodium falciparum plasmepsin-2 expressed in Escherichia coli BL21 (DE3) at 1 uM after 30 min by FRET assay',\n",
       "        'Inhibition of Plasmodium falciparum plasmepsin-2 expressed in Escherichia coli BL21 (DE3) assessed as residual activity at 1 uM measured after overnight dialysis by spun column chromatography',\n",
       "        'Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 10 uM',\n",
       "        'Antimicrobial activity against wild type Plasmodium falciparum HB3 infected in erythrocytes assessed as growth inhibition after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimicrobial activity against leupeptin resistant-Plasmodium falciparum HB3-leuR1 mutant infected in erythrocytes assessed as growth inhibition after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'Antimalarial activity as inhibition of chloroquine-resistant Plasmodium falciparum mediated mice (Mus musculus) hemoglobin hydrolysis at 5 mM after 18 hrs',\n",
       "        'Inhibition of Plasmodium falciparum plasmepsin-2 by FRET assay',\n",
       "        'Inhibition of Plasmodium falciparum plasmepsin-2 expressed in Escherichia coli BL21 (DE3) at 1 uM after 1 to 2 hrs'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH reporter assay',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 25 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 40 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 40 mg/kg.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose'],\n",
       "       dtype=object),\n",
       " array(['Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei vinckeii V52 after 10 mg/kg intraperitoneally dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei vinckeii V52 at 15 mg/kg intraperitoneally dose ',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 30 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei vinckeii V52 at 20 mg/kg intraperitoneally dose '],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose.'],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 60 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose.'],\n",
       "       dtype=object),\n",
       " array(['Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 10 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose; Toxic',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose; Toxic',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 10 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose'],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 50 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose.',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose.',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose.',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 10 mg/kg',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 30 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 10 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 60 mg/kg',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 30 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 15 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 75 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 30 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 30 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 20 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 100 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 60 mg/kg',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 20 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 50 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as increase in mean survival time at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 30 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 40 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 75 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 100 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckeii V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 25 mg/kg dose',\n",
       "        'Oral antimalarial activity against Plasmodium vinckei in mice (Mus musculus) measured as increase in mean survival time at 150 mg/kg dose',\n",
       "        'Parenteral antimalarial activity against Plasmodium vinckei vinckei in mice (Mus musculus) measured as % cured and increase in MST (days) at 15 mg/kg dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 30 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei vinckei V52 after intraperitoneal administration at dose 25 mg/kg',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 70 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 15 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 60 mg/kg',\n",
       "        'Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 50 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose ',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity was evaluated against Plasmodium vinckei V52 after intraperitoneal administration at dose 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Increase in mean survival days of Plasmodium inoculated mice (Mus musculus) after 70 mg/Kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 10 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 on 70 mg/kg intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium vinckei V52 after 20 mg/kg intraperitoneal dose '],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['Mean reduction in parasitaemia of Plasmodium berghei ANKA suppressive test in mice (Mus musculus) (in vivo) at 10 mg/kg scheduled for 2 days',\n",
       "        'Growth inhibition of Plasmodium falciparum',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectrophotometric assay',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Inhibitory activity against Plasmodium berghei Ghana',\n",
       "        'Inhibitory activity against Plasmodium berghei 3D7',\n",
       "        'Inhibitory activity against Plasmodium berghei W2',\n",
       "        'Antiparasitic activity against Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) as reduced parasitaemia'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2mef assessed as suppression of parasitemia by microscopic analysis',\n",
       "        'Growth inhibition of Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 12 wk old C57BL/6 mouse assessed as prepatent period at 20 mg/kg, ip administered once daily via a regimen of day 1 pre-infection, on the day of infection followed by day 1 postinfection for 3 days by microscopic analysis',\n",
       "        'Inhibition of Plasmodium vivax FPPS',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 12 wk old BALB/c mouse assessed as prepatent period at 5 mg/kg, ip administered once daily on the day of infection followed by day 1 postinfection for 2 days by microscopic analysis',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 8 wk old C57BL/6 mouse assessed as prepatent period at 20 mg/kg, ip administered once daily via a regimen of day 1 pre-infection, on the day of infection followed by day 1, 2 and 3 days postinfection for 4 days by microscopic analysis',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 8 wk old C57BL/6 mouse assessed as prepatent period at 20 mg/kg, ip administered once daily via regimen of 2 and 1 day post infection, on the day of infection followed by day 1 postinfection for 4 days by microscopic analysis',\n",
       "        \"Antiplasmodial activity against 5 X 10'6 blood stream Plasmodium berghei NK65 infected in 12 wk old C57BL/6 mouse assessed as parasitemia at 20 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 5 days by microscopic analysis\",\n",
       "        'Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectrophotometric assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 12 wk old BALB/c mouse assessed as prepatent period at 17 mg/kg, ip administered once daily on the day of infection followed by day 1 postinfection for 2 days by microscopic analysis',\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 12 wk old BALB/c mouse assessed as prepatent period at 20 mg/kg, ip administered once daily via regimen of 1 preinfection, on day of infection followed by regimen of 1 day post infection for 3 days by microscopic analysis',\n",
       "        'Inhibition of Plasmodium vivax GGPPS',\n",
       "        'Antiplasmodial activity against 3000 Plasmodium berghei NK65 liver stage sporozoites infected in 12 wk old C57BL/6 mouse assessed as delay in prepatent period at 20 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 5 days by microscopic analysis',\n",
       "        'Inhibition of Plasmodium falciparum 3D7 in erythrocytes',\n",
       "        \"Antiplasmodial activity against 5 X 10'6 blood stream Plasmodium berghei NK65 infected in 12 wk old C57BL/6 mouse assessed as delay in prepatent period at 20 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 5 days by microscopic analysis\",\n",
       "        'Antiplasmodial activity against Plasmodium berghei NK65 infected in 12 wk old BALB/c mouse assessed as prepatent period assessed as complete suppression of parasitemia at 20 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 2 days by microscopic analysis',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as suppression of parasitemia by microscopic analysis',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in human HepG2 cells after 48 hrs by RT-PCR',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        \"Antiplasmodial activity against 5 X 10'6 blood stream Plasmodium berghei NK65 infected in 12 wk old C57BL/6 mouse assessed as prepatent period at 20 mg/kg, ip administered once daily via a regimen of day 2, 1 pre-infection, on the day of infection followed by day 1 and 2 postinfection for 5 days by microscopic analysis\"],\n",
       "       dtype=object),\n",
       " array(['Mean reduction in parasitaemia of Plasmodium berghei ANKA suppressive test in mice (Mus musculus) (in vivo) at 25 mg/kg scheduled for 4 days',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Inhibition of Plasmodium falciparum 3D7 in erythrocytes'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectrophotometric assay',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Inhibitory activity against Plasmodium berghei 3D7',\n",
       "        'Inhibitory activity against Plasmodium berghei W2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Mean reduction in parasitaemia of Plasmodium berghei ANKA suppressive test in mice (Mus musculus) (in vivo) at 10 mg/kg scheduled for 4 days',\n",
       "        'Growth inhibition of Plasmodium falciparum',\n",
       "        'Inhibitory activity against Plasmodium berghei Ghana'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectrophotometric assay',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Inhibition of Plasmodium falciparum 3D7 in erythrocytes',\n",
       "        'Growth inhibition of Plasmodium falciparum',\n",
       "        'Mean reduction in parasitaemia of Plasmodium berghei ANKA suppressive test in mice (Mus musculus) (in vivo) at 25 mg/kg scheduled for 4 days',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectrophotometric assay',\n",
       "        'Growth inhibition of Plasmodium falciparum',\n",
       "        'Antiparasitic activity against Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) as reduced parasitaemia',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes as [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected human erythrocytes as [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium falciparum cyclin dependent protein kinase, Pfmrk',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Binding constant for PFPK5(P.falciparum) kinase domain',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Inhibition of GST-fused Plasmodium falciparum recombinant CDPK1 expressed in Escherichia coli Rosetta 2 assessed as inhibition of [gamma-33P]ATP incorporation into substrate peptide by scintillation counting',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Inhibition of Plasmodium falciparum cyclin-dependent kinase',\n",
       "        'Binding constant for PFCDPK1(P.falciparum) kinase domain'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine, mefloquine and halofantrine-resistant Plasmodium yoelii nigeriensis infected in Swiss mouse assessed as suppression of parasitemia at 24 mg/kg, po administered for 4 days measured on day 4',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against the chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum D6 (Sierra Leone) relative to QHS',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 24 mg/kg/day orally',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity against Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 48 mg/kg peroral dose over 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia against multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 48 mg/kg peroral dose at day 4',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 48 mg/kg peroral dose over 4 days',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and halofantrine-resistant Plasmodium yoelii nigeriensis infected in Swiss mouse assessed as suppression of parasitemia at 48 mg/kg, po administered for 4 days measured on day 4',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 48 mg/kg/day orally',\n",
       "        'Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum W2 Indochina relative to QHS',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis infected in Swiss mice (Mus musculus) assessed as suppression of parasitaemia at 48 mg/kg, peroral for 4 days relative to control',\n",
       "        'Antimalarial activity against multi drug-resistant Plasmodium yoelii nigeriensis infected in Swiss mice (Mus musculus) assessed as suppression of parasitaemia level at 24 mg/kg, perorally daily for 4 days',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 24 mg/kg/day peroral dose after 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum African D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and halofantrine-resistant Plasmodium yoelii nigeriensis infected in Swiss mouse assessed as protection against parasite-induced mortality at 24 mg/kg, po administered for 4 days measured on day 28',\n",
       "        'Antimalarial activity against Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 24 mg/kg peroral dose over 4 days',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 (Indochina)',\n",
       "        'Antimalarial activity against chloroquine, mefloquine and halofantrine-resistant Plasmodium yoelii nigeriensis infected in Swiss mouse assessed as protection against parasite-induced mortality at 48 mg/kg, po administered for 4 days measured on day 28',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum W-2',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum D6',\n",
       "        'Antimalarial activity as cures against multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 48 mg/kg peroral dose over 4 days',\n",
       "        'Antimalarial activity against multi drug-resistant Plasmodium yoelii nigeriensis infected in Swiss mice (Mus musculus) assessed as suppression of parasitaemia level at 48 mg/kg, perorally daily for 4 days',\n",
       "        'In vivo antimalarial activity against Plasmodium chabaudi in mice (Mus musculus) and its survival rate reported',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) as reduced parasitaemia after peroral 48 mg/kg dose for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity as reduced parasitaemia (%) against multidrug-resistant Plasmodium yoelii infected Swiss mice (Mus musculus) at 24 mg/kg peroral dose after 4 days',\n",
       "        'In vitro antimalarial activity against mefloquine-resistant Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 48 mg/kg/day peroral dose over 4 days',\n",
       "        'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered intravenously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 48 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'In vitro inhibitory activity against Plasmodium falciparum (sierra leone clone)',\n",
       "        'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered subcutaneously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       "        'Antimalarial activity as reduced parasitemia day 4 against multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 24 mg/kg/day peroral dose over 4 days',\n",
       "        'Antimalarial activity in multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mouse assessed as disease cure at 24 mg/kg, po two devided dose daily for 4 days by 28 day survival assay',\n",
       "        'Antimalarial activity against chloroquine-, mefloquine-, halofantrine-resistant Plasmodium yoelii nigeriensis blood stream schizonts infected in Swiss mouse assessed as suppression of parasitemia at 6 mg/kg, im administered once daily for 4 days relative to control',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 10 against Plasmodium berghei NK65 infected Swiss Webster mice (Mus musculus) at 10 mg/kg/day intraperitoneal dose for 3 days',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis infected in Swiss mice (Mus musculus) assessed as suppression of parasitaemia at 24 mg/kg, peroral for 4 days relative to control',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Blood schizonticidal activity in mice model with Plasmodium berghei k-173 infection was determined',\n",
       "        'Antimalarial activity against chloroquine-, mefloquine-, halofantrine-resistant Plasmodium yoelii nigeriensis blood stream schizonts infected in Swiss mouse assessed as suppression of parasitemia at 3 mg/kg, im administered once daily for 4 days relative to control',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium yoelii N-67 infected in Swiss mouse assessed as reduction in parasitemia at 3 mg/kg/day, im administered for 3 days measured on day 4 relative to control',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium yoelii N-67 infected in Swiss mouse assessed as mean survival time at 3 mg/kg/day, im administered for 3 days (Rvb = 9.20 +/- 0.44 days)',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 17 against Plasmodium berghei NK65 infected Swiss Webster mice (Mus musculus) at 10 mg/kg/day intraperitoneal dose for 3 days',\n",
       "        'Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity in multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mouse assessed as supression of parasitaemia at 24 mg/kg, po two devided dose daily for 4 days',\n",
       "        'Reduced parasitemia in multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mice (Mus musculus) at 48 mg/kg peroral dose after 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia (%) against multidrug-resistant Plasmodium yoelii infected Swiss mice (Mus musculus) at 48 mg/kg peroral dose after 4 days',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 24 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Antimalarial activity in multidrug-resistant Plasmodium yoelii nigeriensis infected Swiss mouse assessed as supression of parasitaemia at 48 mg/kg, po two devided dose daily for 4 days'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 48 mg/kg/day intramuscular.',\n",
       "        'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 24 mg/kg/day after 10 days',\n",
       "        'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 24 (mg/kg/day) after 7 days',\n",
       "        'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 24 (mg/kg/day) after 4 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 48 (mg/kg/day) after 10 days',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 24 mg/kg/day intramuscular.',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 96 mg/kg/day intramuscular.',\n",
       "        'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 48 (mg/kg/day) after 7 days'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity a survival time in Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 30 mg/kg/day peroral dose over 4 days',\n",
       "        'Antimalarial activity as survival time against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 3 mg/kg/day subcutaneous dose over 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 10 mg/kg/day peroral dose over 4 days',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity after 36 hrs against chloroquine-sensitive Plasmodium falciparum FCA 20 in human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in Kunming mouse assessed as reduction of parasitemia at 10 mg/kg, ip for 4 days measured on day 5',\n",
       "        'Antimalarial activity as survival time in Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 30 mg/kg subcutaneous dose after 3 days',\n",
       "        'Antiplasmodial activity in chloroquine-nonsensitive Plasmodium yoelii infected intraperitoneally dosed BALB/c mice (Mus musculus) assessed as inhibition of parasitaemia administered daily once for 4 days',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'In vitro inhibition of Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition after 72 hrs of Plasmodium falciparum D6 by HRPII ELISA',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity in chloroquine-nonsensitive Plasmodium yoelii infected BALB/c mice (Mus musculus) assessed as inhibition of parasitaemia at 3 mg/kg, intraperitoneally daily once for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 10 mg/kg treated for 4 days',\n",
       "        'Growth inhibition after 72 hrs of Plasmodium falciparum W2 by HRPII ELISA',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum MRC-02 infected in human erythrocyte assessed as inhibition of schizont maturation after 24 hrs',\n",
       "        'Growth inhibition after 72 hrs of Plasmodium falciparum 3D7 by HRPII ELISA',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte after 48 h by SYBR-Green-1 assay',\n",
       "        'Growth inhibition after 72 hrs of Plasmodium falciparum D6 by SYBR green I assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in Swiss albino mice (Mus musculus) assessed as suppression of parasitemia at 8 mg/kg/day, perorally for 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 5 against Plasmodium berghei ANKA infected in BALB/c mice (Mus musculus) at 10 mg/kg/day intraperitoneal dose over 4 days',\n",
       "        'In vitro growth inhibition as IC50 against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Parasitaemia for Plasmodium falciparum in human erythrocytes after 3 hrs incubation with 100 uM compound',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected in Swiss mice (Mus musculus) assessed as suppression of parasitaemia at 5 mg/kg, perorally for 4 days measured on day 5 relative to control',\n",
       "        'Antiplasmodial activity in chloroquine-nonsensitive Plasmodium yoelii infected BALB/c mice (Mus musculus) assessed as inhibition of parasitaemia at 10 mg/kg, intraperitoneally daily once for 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 30 mg/kg subcutaneous dose after 3 days',\n",
       "        'In vitro inhibition of Plasmodium falciparum F32',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcM29 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by LDH activity',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition after 72 hrs of Plasmodium falciparum W2 by SYBR green I assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7A infected erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 10 mg/kg/day subcutaneous dose over 4 days',\n",
       "        'In vitro antiplasmodial concentration against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum RKL9 infected in human erythrocyte after 48 h by SYBR-Green-1 assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       "        'Normalized IC50 as product of antiplasmodial IC50 and vacuolar accumulation IC50',\n",
       "        'In vitro inhibition of Plasmodium falciparum FcB1',\n",
       "        'In vitro antiplasmodial activity for Plasmodium falciparum',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 (Thailand) assessed as growth inhibition by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 by LDH assay',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 30 mg/kg/day peroral dose over 4 days',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'In vitro growth inhibition as IC50 against chloroquine-resistant Plasmodium falciparum FcB2',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum Nigerian by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum Nigerian by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'Growth inhibition after 72 hrs of Plasmodium falciparum 3D7 by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected in Swiss mice (Mus musculus) assessed as parasitaemia at 5 mg/kg, perorally for 4 days measured on day 5',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against Plasmodium falciparum FCB2',\n",
       "        'In vitro inhibition as IC50 against Plasmodium falciparum by [3H]hypoxanthine uptake',\n",
       "        'In vivo activity against Plasmodium berghei parasitaemia',\n",
       "        'Antiplasmodial activity after 36 hrs against chloroquine-resistant Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity in chloroquine-nonsensitive Plasmodium yoelii infected BALB/c mice (Mus musculus) assessed as inhibition of parasitaemia at 1 mg/kg, intraperitoneally daily once for 4 days',\n",
       "        'Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 by LDH reporter assay',\n",
       "        'In vitro inhibitory activity against Plasmodium berghei',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity as survival time in Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 100 mg/kg peroral dose after 3 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei in untreated mice (Mus musculus)',\n",
       "        'Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 10 mg/kg for 4 days',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum MRC2 infected in human erythrocytes after 24 hrs by Giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitaemia in mice (Mus musculus) at 10 mg/kg treated for 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 3 mg/kg/day subcutaneous dose over 4 days',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 infected human erythrocytes assessed by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity in chloroquine-sensitive Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) assessed as mean parasitemia at 10 mg/kg, intraperitoneally daily once for 4 days',\n",
       "        'Antimalarial activity as survival time against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 10 mg/kg/day peroral dose over 4 days',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum RKL9 after 24 hrs by Giemsa staining',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FcM29 after 72 hrs by [3H]hypoxanthine uptake',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3 after 48 hrs by LDH reporter activity',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3-A infected erythrocytes as [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity in chloroquine-sensitive Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) assessed as inhibition of parasitemia at 10 mg/kg, intraperitoneally daily once for 4 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH assay',\n",
       "        'Antimalarial activity as survival time against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 10 mg/kg/day subcutaneous dose over 4 days',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'In vitro inhibitory activity against Plasmodium falciparum FcB1',\n",
       "        'In vitro inhibition of Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum RKL09 infected in human erythrocyte assessed as inhibition of schizont maturation after 24 hrs',\n",
       "        'Antimalarial activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum T9-96 by LDH reporter assay',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 100 mg/kg peroral dose after 3 days'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite growth after 48 to 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        \"Antimalarial activity against chloroquine-sensitive Plasmodium vinckei infected in mice (Mus musculus) assessed as reduction in parasitemia at 15 mg/m'2, intraperitoneally qd for 5 days administered 2 hrs post infection measured on day 5\",\n",
       "        'Antimalarial activity against Plasmodium falciparum ItG assessed as inhibition of parasite growth after 48 to 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        \"Antimalarial activity against chloroquine-sensitive Plasmodium yoelii 17X infected in mice (Mus musculus) assessed as reduction in parasitaemia at 15 mg/m'2, intraperitoneal daily for 5 days administered 2 hrs post infection measured on day 5\",\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 assessed as inhibition of parasite growth after 48 to 96 hrs by [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Compound was tested in vitro Antimalarial activity against Plasmodium berghei in infected mice (Mus musculus) administered intraperitoneally',\n",
       "        'In vitro antimalarial activity against Plasmodium berghei'],\n",
       "       dtype=object),\n",
       " array(['Compound was tested in vitro Antimalarial activity against Plasmodium berghei in infected mice (Mus musculus) administered per orally',\n",
       "        'Compound was tested in vitro Antimalarial activity against Plasmodium berghei in infected mice (Mus musculus) administered intraperitoneally',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'Antimicrobial activity against Plasmodium falciparum 3D7 assessed as gametocytes per 1000 RBCs at 100 uM after 2 days by Giemsa staining relative to control',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of recombinant Plasmodium falciparum DHODH',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef at 10 uM after 48 hrs by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Inhibition of ubiquinone binding site of Plasmodium falciparum dihydroorotate dehydrogenase',\n",
       "        'Inhibition of Plasmodium falciparum DHODH expressed in Escherichia coli BL21 (DE3) using L-dihydroorotate as substrate after 10 mins by DCIP dye reduction assay'],\n",
       "       dtype=object),\n",
       " array(['PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-sensitive Plasmodium falciparum D-10',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum FAC8',\n",
       "        'Antimalarial activity against Plasmodium falciparum FAC8',\n",
       "        'In vitro inhibition chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O positive erythrocytes after 48 hrs by SYBR green-I based fluorescence assay',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in Swiss mouse assessed as inhibition of parasitemia at 50 mg/kg, ip administered 2 hrs postinfection daily for 4 days measured on day 5',\n",
       "        'Antiplasmodial potency relative to chloroquine',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O positive erythrocytes after 48 hrs by SYBR green-I based fluorescence assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vitro activity against Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vitro activity against Plasmodium falciparum D6'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6'], dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei NK65 infected in Swiss mouse assessed as inhibition of parasitemia at 50 mg/kg, ip administered 2 hrs postinfection daily for 4 days measured on day 5',\n",
       "        'Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O positive erythrocytes after 48 hrs by SYBR green-I based fluorescence assay'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against ferriprotoporphyrin in biomineralisation assay (FBIT)',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine',\n",
       "        'Antiplasmodial potency relative to chloroquine in ferriprotoporphyrin biomineralisation assay',\n",
       "        'Inhibitory concentration against ferriprotoporphyrin in biomineralisation assay (FBIT)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vitro activity against Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O positive erythrocytes after 48 hrs by SYBR green-I based fluorescence assay',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine'], dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O positive erythrocytes after 48 hrs by SYBR green-I based fluorescence assay',\n",
       "        'Antiplasmodial potency relative to chloroquine in ferriprotoporphyrin biomineralisation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in Swiss mouse assessed as inhibition of parasitemia at 50 mg/kg, ip administered 2 hrs postinfection daily for 4 days measured on day 5',\n",
       "        'In vitro inhibitory concentration against ferriprotoporphyrin in biomineralisation assay (FBIT)',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antiplasmodial potency relative to chloroquine',\n",
       "        'Inhibitory concentration against ferriprotoporphyrin in biomineralisation assay (FBIT)'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O positive erythrocytes after 48 hrs by SYBR green-I based fluorescence assay',\n",
       "        'Antiplasmodial potency relative to chloroquine',\n",
       "        'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in Swiss mouse assessed as inhibition of parasitemia at 50 mg/kg, ip administered 2 hrs postinfection daily for 4 days measured on day 5'],\n",
       "       dtype=object),\n",
       " array(['In vitro activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum IMT Vol assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'Terminal half life in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally by two compartment model assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FC27',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Tlag in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'In vitro activity against Plasmodium falciparum W-2',\n",
       "        'Half life in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum C2 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'AUC (3 to 20 days) in children with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Antiparasitic activity as survival at day 30 against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 20-30 mg/kg intraperitoneal dose 64 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 Y184F, S1034C, N1042D, D1246Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum by Peters 4 day test',\n",
       "        'Antimalarial activity against ring stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 harboring D10 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Terminal half-life in human with uncomplicated malaria at 32 mg/kg, perorally after 35 days',\n",
       "        'Apparent steady-state volume of distribution with respect to bioavailability in human with uncomplicated malaria at 32 mg/kg, perorally after 35 days',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Cmax in Plasmodium falciparum-infected patient at 320 mg/kg, po',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum clinical isolate after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Apparent oral clearance in human with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Apparent peripheral volume of distribution with respect to bioavailability in human with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Apparent steady-state volume of distribution with respect to bioavailability in human with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring mdr1 N86Y/D1246Y/Y184F mutant gene by ELISA',\n",
       "        'Apparent clearance with respect to bioavailability in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum HB3 by ELISA',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum W2 by ELISA',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured after 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy harboring Ppcrt K76T, A220S, N326D and I371R mutant gene, Pmdr1 T184FN, 1042D and D1246Y, mutant gene and Pfmrp H191Y and S437A mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium vivax with >50% parasites at ring stage infected in human erythrocytes assessed as growth inhibition after 30 to 50 hrs by microscopic analysis using giemsa staining',\n",
       "        'AUC (3 to 20 days) in uncomplicated malaria patient at 31 mg/kg, perorally once daily for 3 days',\n",
       "        'Plasma concentration in human with uncomplicated malaria at 31 mg/kg, perorally once daily for 3 days measured at day 20',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 34-1/E',\n",
       "        'AUC (0 to infinity) in Plasmodium falciparum-infected patient at 320 mg/kg, po',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 harboring parental pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium malariae trophozoite stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum trophozoites infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E mutant gene, Pmdr1 N86Y mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 S1034C, N1042D mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 harboring Ppcrt I371R mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6 isolated from po dosed patient with malaria after 7 days',\n",
       "        'Plasma concentration in Plasmodium falciparum-infected patient at 320 mg/kg, po after 28 days',\n",
       "        'In vitro activity against Plasmodium falciparum D6',\n",
       "        'Half life in Plasmodium falciparum-infected patient at 320 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 harboring Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'AUC (0 to 63 days) in human with uncomplicated malaria at 31 mg/kg, perorally once daily for 3 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiparasitic activity as parasitaemia against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 30 mg/kg intraperitoneal dose 64 hrs post infection',\n",
       "        'Plasma concentration in human with uncomplicated malaria at 31 mg/kg, perorally at day 28',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'AUC in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiparasitic activity as parasitaemia after 36 hrs against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 90 mg/kg intraperitoneal dose 64 hrs post infection',\n",
       "        'Plasma concentration in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection measured after 2 to 7 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Terminal half-life in human with uncomplicated malaria at 35 mg/kg, perorally after 35 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 harboring Ppcrt I371R mutant gene and Pfmdr1 Y184F mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Apparent volume of distribution with respect to bioavailability in human with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 harboring Pfcrt Q271E mutant gene and Ppcrt I371R mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum at the ring stage infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Apparent clearance with respect to bioavailability in Cambodian children with malaria',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Volume of distribution at steady state with respect to bioavailability in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'AUC (0 to infinity) in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10354 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum C3 harboring Dd2 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Initial half life in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally by two compartment model assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'Plasma concentration in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection measured after 60 days',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured within 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured within 30 hrs by microscopy',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Plasma concentration in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection measured after 30 days',\n",
       "        'Plasma concentration in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection measured after 36 hrs',\n",
       "        'Apparent oral clearance in human with uncomplicated malaria at 35 mg/kg, perorally after 35 days',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured after 30 hrs by microscopy',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type pfcrt-76 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Absorption half life in Papua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum by [3H]hypoxanthine incorporation',\n",
       "        'Apparent steady-state volume of distribution with respect to bioavailability in human with uncomplicated malaria at 35 mg/kg, perorally after 35 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 106/1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum T996',\n",
       "        'AUC (0 to 42 days) in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 isolated from po dosed patient with malaria after 7 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium malariae ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against Plasmodium ovale ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against Plasmodium vivax infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium vivax by Giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10354 harboring Ppcrt M74I, N75E, K76T, A220S mutant gene, Pmdr1 D1246Y mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 harboring Pfcrt Q271E mutant gene and Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum C6harboring 7G8 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Apparent oral clearance in human with uncomplicated malaria at 31 mg/kg, perorally after 63 days',\n",
       "        'AUC (0 to 60 days) in human adult with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Terminal half-life in human with uncomplicated malaria at 31 mg/kg, perorally after 63 days',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 harboring 7G8 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Plasma concentration in human with uncomplicated malaria at 31 mg/kg, perorally four-dose treatment regimen measured at day 20',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum TM6 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antiparasitic activity as survival at day 30 against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 30 mg/kg intraperitoneal dose 64 hrs post infection',\n",
       "        'AUC (3 to 20 days) in human adult with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'AUC (0 to 63 days) in uncomplicated malaria patient at 31 mg/kg, perorally four-dose treatment regimen',\n",
       "        'Distribution half life in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antiparasitic activity as survival at day 30 against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 10 mg/kg intraperitoneal dose 64 hrs post infection',\n",
       "        'Absorption half life in Cambodian children with malaria',\n",
       "        'Apparent volume of distribution in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection',\n",
       "        'Apparent clearance in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 harboring Ppcrt M74I, N75E, K76T, A220H, Q271E, N326S and I356T mutant gene, Pmdr1 Y184F, N1042D, D1246Y mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'AUC (3 to 20 days) in uncomplicated malaria patient at 31 mg/kg, perorally four-dose treatment regimen',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation by beta counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 S1034C, N1042D mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 7G8-mdr7G8',\n",
       "        'AUC (0 to 60 days) in children with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 harboring Ppcrt I371R mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Tmax in Plasmodium falciparum-infected patient at 320 mg/kg, po',\n",
       "        'Volume of distribution at steady state with respect to bioavailability in Cambodian children with malaria',\n",
       "        'AUC in Plasmodium falciparum-infected patient at 320 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 harboring Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against ring stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Antimalarial activity against Plasmodium ovale trophozoite stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       "        'Antimalarial activity against Plasmodium vivax trophozoites infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium vivax at the ring stage infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       "        'Antimicrobial activity against Plasmodium falciparum by ELISA',\n",
       "        'Elimination half life in Cambodian children with malaria',\n",
       "        'Apparent intercompartmental clearance with respect to bioavailability in human with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfcrt-76 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum RSA11',\n",
       "        'Antiplasmodial activity against multidrug-sensitive Plasmodium falciparum 3D7 after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium vivax assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 20% human serum',\n",
       "        'Antimalarial activity against trophozoites stage of Plasmodium falciparum assessed as parasites growth inhibition using giemsa staining after 24 to 56 hrs by microscopic analysis in presence of 10% human serum',\n",
       "        'Terminal half-life in human with uncomplicated malaria at 31 mg/kg, perorally',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Plasma concentration in Swiss mice (Mus musculus) infected with Plasmodium berghei ANKA at 90 mg/kg, intraperitoneally administered 64 hrs after infection measured after 2 hrs',\n",
       "        'Apparent steady-state volume of distribution with respect to bioavailability in human with uncomplicated malaria at 31 mg/kg, perorally after 63 days',\n",
       "        'Elimination half life in Paua New Guinean children with uncomplicated malaria at 20 mg/kg daily for 3 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum K1 by ELISA',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D6 by ELISA',\n",
       "        'Apparent oral clearance in human with uncomplicated malaria at 32 mg/kg, perorally after 35 days',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of choline kinase in Plasmodium falciparum NF54 assessed as incorporation of [methlyl-14C]choline into phosphocholine at 10 uM',\n",
       "        'Growth inhibition of schizont Plasmodium falciparum NF54 at 10 uM',\n",
       "        'Inhibition of Plasmodium falciparum NF54 ring stage at 30 uM',\n",
       "        'Antimalarial activity against intraperitoneal inoculated Plasmodium yoelii N67 in Swiss mice (Mus musculus) at 20 mg/kg intraperitoneal dose on day 4',\n",
       "        'Antimalarial activity at day 4 against intravenously inoculated Plasmodium yoelii N67 in Swiss mice (Mus musculus) at 20 mg/kg intraperitoneal dose',\n",
       "        'Inhibition of Plasmodium falciparum NF54 as [3H]hypoxanthine uptake at 10 uM',\n",
       "        'Antimalarial activity against intraperitoneal inoculated Plasmodium yoelii N67 in Swiss mice (Mus musculus) at 5 mg/kg intraperitoneal dose on day 4',\n",
       "        'Antimalarial activity against intravenously inoculated Plasmodium yoelii N67 in Swiss mice (Mus musculus) at 10 mg/kg intraperitoneal dose on day 4',\n",
       "        'In vitro activity against Plasmodium falciparum',\n",
       "        'Inhibition of Plasmodium falciparum NF54 as [3H]hypoxanthine uptake at 20 uM',\n",
       "        'Inhibition of Plasmodium falciparum NF54 trophozoite at 10 uM',\n",
       "        'Antimalarial activity against intravenously inoculated Plasmodium yoelii N67 in Swiss mice (Mus musculus) at 5 mg/kg intraperitoneal dose on day 4',\n",
       "        'Inhibition of phosphocholine biosynthesis in Plasmodium falciparum NF54 as intracellular free choline at 10 uM',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Inhibition of Plasmodium falciparum choline kinase at 50 uM in presence of 100 uM ATP',\n",
       "        'Inhibition of Plasmodium falciparum choline kinase at 100 uM',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against intraperitoneal inoculated Plasmodium yoelii N67 in Swiss mice (Mus musculus) at 10 mg/kg intraperitoneal dose on day 4',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Inhibitory activity against Plasmodium falciparum'], dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum W2mef at 10 uM after 48 hrs by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef ring form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef assessed as DNA positive erythrocytes by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef schizont form by hoechst 33342-thiazole orange stain based flow cytometry assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14'],\n",
       "       dtype=object),\n",
       " array(['In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9'],\n",
       "       dtype=object),\n",
       " array(['In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 50 mg/kg/day (percent suppression on day 4)',\n",
       "        'Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 100 mg/kg/day (percent suppression on day 4)',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 40 mg/kg',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 20 mg/kg',\n",
       "        'In vitro total parasite growth inhibition for chloroquine-sensitive Plasmodium falciparum FSH 14',\n",
       "        'In vitro schizont maturation inhibition for chloroquine-sensitive Plasmodium falciparum FJB D9',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 80 mg/kg',\n",
       "        'Mean survival time of mice (Mus musculus) infected with Plasmodium berghei after administration of compound at the dose of 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 100 mg/kg/day (percent suppression on day 4)',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 100 mg/kg/day (percent suppression on day 4)',\n",
       "        'Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 50 mg/kg/day (percent suppression on day 4)',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 6.25 mg/kg/day (percent suppression on day 4)',\n",
       "        'Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 12.5 mg/kg/day (percent suppression on day 4)',\n",
       "        'Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 50 mg/kg/day (percent suppression on day 4)',\n",
       "        'Antimalarial activity of compound against multidrug-resistant strain of Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 25 mg/kg/day (percent suppression on day 4)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum K1 in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of ferriprotoporphyrin 9 biomineralization at 1 mg/ml'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of ferriprotoporphyrin 9 biomineralization at 1 mg/ml',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 in [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against parasitemia in Plasmodium berghei ANKA infected NMRI mice (Mus musculus) at 20 mg/kg intraperitoneal dose after 4 days',\n",
       "        'Antiplasmodial activity as survival against Plasmodium berghei ANKA infection in NMRI mice (Mus musculus) at 20 mg/kg intraperitoneal dose for 4 days',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 in [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum assessed as resistant isolates',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 harboring Ppcrt I371R mutant gene and Pfmdr1 Y184F mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011017 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 assessed as [G-3H]hypoxanthine uptake after 24 hrs by scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolates assessed as parasite growth inhibition after 72 hrs by ELISA based histidine-rich protein 2 in vitro drug susceptibility assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 Indochina',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       "        'Antiplasmodial activity against drug resistant Plasmodium falciparum Dd2 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011008 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum HB3 by ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by microculture radioisotope assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6 infected in RBCs by parasitic LDH release assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by microculture radioisotope assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 harboring 7G8 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 isolated from po dosed patient with malaria',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by microculture radioisotope technique',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011003 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 harboring Pfcrt Q271E mutant gene and Ppcrt I371R mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10354 harboring Ppcrt M74I, N75E, K76T, A220S mutant gene, Pmdr1 D1246Y mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum W2 infected in human A positive erythrocytes after 72 hrs by SYBR Green I assay',\n",
       "        'Antimalarial activity against chloroquine, mefloquine, pyrimethamine and atovaquone-resistant Plasmodium falciparum TM90-C2B infected in human A positive erythrocytes after 72 hrs by SYBR Green I assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity after 42 hrs against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity after 24 hrs against Plasmodium falciparum K1 by [G-3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 S1034C, N1042D mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity as parasitaemia against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 30 mg/kg intraperitoneal single dose 64 hrs post infection (Rvb=2.5%+/-0.5%)',\n",
       "        'Toxicity in Plasmodium berghei ANKA infected Swiss mice (Mus musculus) assessed as median time for adverse effect at 30 mg/kg, intraperitoneally administered as single dose 64 hrs after infection measured after 24 hrs',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against chloroquine-, mefloquine-, pyrimethamine-,atovaquone-resistant ring stage Plasmodium falciparum TM90-C2B infected in human A positive erythrocytes after 72 hrs by SYBR green 1-based fluorescence assay',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum K1 by ELISA',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 harboring pfATP6 263E mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M3 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 harboring pfATP6 263E mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Inhibition of Plasmodium falciparum in HRP2 ELISA',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 infected in RBCs by parasitic LDH release assay',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum W2 by ELISA',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1 assessed as [G-3H]hypoxanthine uptake after 24 hrs by scintillation counting',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 after 42 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 after 24 hrs by [G-3H]hypoxanthine uptake assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Apparent oral clearance in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6 isolated from po dosed patient with malaria',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum W2 Indochina relative to QHS',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 after 24 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 harboring Ppcrt I371R mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]-hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Apparent volume of distribution in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum clinical isolate after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of Plasmodium falciparum AZ10011022 isolate in HRP2 ELISA',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Half life in in adults with uncomplicated falciparum malaria at 32 to 35 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E mutant gene, Pmdr1 N86Y mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone 1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay',\n",
       "        'Antimalarial activity against multidrug-resistance Plasmodium falciparum K1 assessed as growth inhibition by microdilution radioisotope technique',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S and I356T mutant gene, Pmdr1 N86Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy harboring Ppcrt K76T, A220S, N326D and I371R mutant gene, Pmdr1 T184FN, 1042D and D1246Y, mutant gene and Pfmrp H191Y and S437A mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 harboring Ppcrt M74I, N75E, K76T, A220H, Q271E, N326S and I356T mutant gene, Pmdr1 Y184F, N1042D, D1246Y mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'AUC (0 to infinity) in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Half life in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 by lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against multidrug-sensitive Plasmodium falciparum 3D7 after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 harboring D10 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity as parasitaemia nadir after 24 hrs against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 30 mg/kg intraperitoneal single dose 64 hrs post infection',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'Tmax in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1 assessed as [3H]hypoxanthine incorporation after 24 hrs by microtiter plate scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 harboring Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone 2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against chloroquine-, pyrimethamine-resistant ring stage Plasmodium falciparum W2 infected in human A positive erythrocytes after 72 hrs by SYBR green 1-based fluorescence assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 by lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by micro culture radioisotope technique',\n",
       "        'Intrinsic equimolar activity against Plasmodium falciparum D6 (Sierra Leone) relative to QHS',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 harboring Ppcrt I371R mutant gene and Pfnhe-1 ms4760 microsatellite mutant assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum C6harboring 7G8 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M3 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 assessed as reduction in uptake of [3H]-hypoxanthine by microculture radioisotope technique',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M4 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone M1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by microculture radioisotope technique',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfcrt-76 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antiparasitic activity as parasitaemia against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) at 30 mg/kg intraperitoneal dose 64 hrs post infection',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to hypoxanthine addition measured after 18 hrs by liquid scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 harboring Pfcrt Q271E mutant gene and Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone 1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone 2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 clone 1 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 7G8 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimicrobial activity against Plasmodium falciparum by ELISA',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D6 by ELISA',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Antimalarial activity against asexual erythrocyte stage of chloroquine-resistant Plasmodium falciparum Dd2 by parasite lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 harboring Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 Y184F, S1034C, N1042D, D1246Y mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'AUC in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Compound was tested in vivo for antimalarial activity against Plasmodium berghei in the mice (Mus musculus) model.',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum TM6 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum C2 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'In vitro antimalarial activity against Plasmodium berghei',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum C3 harboring Dd2 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Ppcrt I371R mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Half life in in children with uncomplicated falciparum malaria at 32 to 35 mg/kg, po',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 assessed as [3H]-hypoxanthine uptake after 24 hrs by scintillation counting',\n",
       "        'In vitro inhibitory activity against Plasmodium falciparum (sierra leone clone)',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against asexual erythrocyte stage of chloroquine-sensitive Plasmodium falciparum D10 by parasite lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 harboring pfATP6 L263 mutant assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone M2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antimalarial activity against Plasmodium falciparum D10 clone 1 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 harboring Ppcrt M74I, N75E, K76T, A220S, Q271E, N326S mutant gene, Pmdr1 S1034C, N1042D mutant gene and Pfmrp H191Y and S437A mutant gene assessed as incorporation of [3]H hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasite growth inhibition after 48 hrs by [3H]hypoxanthin incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Cmax in Plasmodium falciparum-infected patient at 40 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation by beta counting',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10354 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 harboring parental pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against dihydropteroic acid synthase (SYN) from Plasmodium berghei',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after oral administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF 54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after oral administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration',\n",
       "        'In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after oral administration',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54',\n",
       "        'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after subcutaneous administration'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum W-2 (Indochina)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone relative to artemisinin',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6 Sierra Leone',\n",
       "        'In vitro antimalarial activity relative to artemisinin against Plasmodium falciparum W-2 (Indochina)'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Bre1',\n",
       "        'Antiplasmodial activity against Plasmodium berghei ANKA infected in C57BL/6 mice (Mus musculus) assessed as parasitemia at 40 ug/g, intraperitoneally on days 2,4 and 6',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against Plasmodium berghei ANKA infected in C57BL/6 mice (Mus musculus) assessed as parasitemia at 0.5 ug/g, intraperitoneal on day 2, 1 ug/g, intraperitoneal on day 4 followed by 2 ug/g on day 6',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antiplasmodial activity against Plasmodium berghei ANKA infected in C57BL/6 mice (Mus musculus) assessed as parasitemia at 2 ug/g, intraperitoneally on days 2,4 and 6',\n",
       "        'Antimalarial activity against Plasmodium falciparum infected in mouse assessed as parasitemia at 40 mg/kg, ip, qd administered 3 days post infection for 6 days measured after 6 days (Rvb =8.0+/-1.6 %)',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against Plasmodium berghei ANKA infected in C57BL/6 mice (Mus musculus) assessed as parasitemia at 100 ug/g, perorally on days 1,3 and 5',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCR3',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum IMT031'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against the Plasmodium falciparum FCR3'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against the Plasmodium falciparum FCR3',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against the Plasmodium falciparum FCR3',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition of Plasmodium falciparum at 10 nM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum at 10 nM',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day',\n",
       "        'Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day',\n",
       "        'Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day',\n",
       "        'Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 in parasite LDH assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 in parasite LDH assay'],\n",
       "       dtype=object),\n",
       " array(['Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day',\n",
       "        'Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['Antiparasitic activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 20 mg/kg/day',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 65 in mice (Mus musculus) at 50 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against Plasmodium falciparum as [3H]hypoxanthine (50 uL) incorporation at 37C',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 at 100 uM by SYBR green assay',\n",
       "        \"Inhibitory constant against Plasmodium falciparum deoxyuridine 5'-triphosphate nucleotidohydrolase expressed in Escherichia coli BL21 (DE3) cells\",\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 after 48 hrs by SYBR green assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium falciparum isolate 208432 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       "        'Displacement of bis-ANS from Plasmodium falciparum 3D7 Hsp90 expressed in Escherichia coli BL21(DE3) assessed as reduction in fluorescence at 100 uM after 30 min by fluorescent monochromator spectrophotometry'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'In vitro sensitivity for Plasmodium falciparum FcB1R'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium falciparum Zinc-aminopeptidase PfA-M1 at 10 uM',\n",
       "        'Inhibitory activity against Plasmodium falciparum FcB1',\n",
       "        'Inhibitory activity for Plasmodium falciparum Zinc aminopeptidase'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK173 infected mice (Mus musculus) administered intraperitoneal. at the end of 4 day',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK 173 infected mice (Mus musculus) administered i.p. at the end of 4 day',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCB1'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei NK173 infected mice (Mus musculus) administered intraperitoneally. at the end of 4 day',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCB1',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei NK173 infected mice (Mus musculus) administered intraperitoneal. at the end of 4 day'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of parasitaemia in ring-form development assay',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of falcipain activity',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 50-90%'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in ring-form development assay',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 50-90%'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of parasitaemia in ring-form development assay',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of falcipain activity',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 0-10%'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in ring-form development assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 10-50%',\n",
       "        'Inhibition of parasitaemia in ring-form development assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of falcipain activity',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 10-50%',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of parasitaemia in ring-form development assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in ring-form development assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 50-90%',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles; 10-50%',\n",
       "        'Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in ring-form development assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles',\n",
       "        'Inhibition of parasitaemia in ring-form development assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of parasitaemia in [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of hemoglobin degradation as percentage of organisms with dark swollen food vacuoles',\n",
       "        'Inhibition of falcipain activity',\n",
       "        'Inhibition of parasitaemia in ring-form development assay'],\n",
       "       dtype=object),\n",
       " array(['In vivo inhibition of Plasmodium falciparum infected male Swiss albino mice (Mus musculus) by intraperitoneal dose',\n",
       "        'In vivo inhibition of Plasmodium falciparum infected male Swiss albino mice (Mus musculus) by oral dose',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vivo inhibition of Plasmodium falciparum infected male Swiss albino mice (Mus musculus) by intraperitoneal dose',\n",
       "        'In vivo inhibition of Plasmodium falciparum infected male Swiss albino mice (Mus musculus) by oral dose',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro antiplasmodial activity for Plasmodium falciparum',\n",
       "        'In vitro antiplasmodial concentration against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 50 mg/kg treated for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei in untreated mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 50 mg/kg treated for 4 days',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Normalized IC50 as product of antiplasmodial IC50 and vacuolar accumulation IC50',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 50 mg/kg dose for 4 days'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Anti-infective activity against Plasmodium falciparum W2 in erythrocytes',\n",
       "        'Anti-infective activity against Plasmodium falciparum D6 infected red blood cells',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 (mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 640(mg/kg); Experiment II; Survival beyond 60 days is considered curative (C)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 (mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg); Survival beyond 60 days is considered curative; Experiment II; active(A)',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 640(mg/kg); Experiment I; not active',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg); Experiment I',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg); Experiment II',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 640(mg/kg); Experiment II; Survival beyond 60 days is considered curative (C).',\n",
       "        'Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg); Experiment I',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 20(mg/kg); Experiment I',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg); Survival beyond 60 days is considered curative; Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 320(mg/kg); Survival beyond 60 days is considered curative; Experiment II; active(A)',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 (mg/kg); Experiment I',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 40(mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 160 (mg/kg); Experiment II',\n",
       "        'Mean survival time of the treated mice (Mus musculus) beyond that of the control animals against Plasmodium berghei at dose 80(mg/kg); Experiment II'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of Plasmodium falciparum falcipain 3',\n",
       "        'Inhibition of beta-hematin formation by BHIA assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive ring stage Plasmodium falciparum 3D7 infected in human red blood cells after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Inhibition of Plasmodium falciparum falcipain 2',\n",
       "        'Antiplasmodial activity against chloroquine-resistant ring stage Plasmodium falciparum W2 infected in human red blood cells after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive, mefloquine-resistant ring stage Plasmodium falciparum D6 infected in human red blood cells after 48 hrs',\n",
       "        'In vitro antiplasmodial activity for Plasmodium falciparum',\n",
       "        'Antiparasitic activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei yoelii infected Swiss albino mice (Mus musculus) at 50 mg/kg/day peroral dose for 4 days',\n",
       "        'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for chloroquine and pyrimethamine-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine and pyrimethamine-resistant ring stage Plasmodium falciparum V1/S infected in human red blood cells after 48 hrs',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei infected Swiss albino mice (Mus musculus) at 50 mg/kg/day peroral dose for 4 days'],\n",
       "       dtype=object),\n",
       " array(['Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Evaluated for the percentage of subcutaneously to Plasmodium berghei infected mice on days 3, 4, and 5 post infection.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 100 mg/kg/day peroral dose after 4 days',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against early trophozoite-stage Plasmodium falciparum 3D7 infected in erythrocyte assessed as reduction in parasite hemoglobin content at 5 times IC50 after 8 hrs',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 30 mg/kg/day peroral dose after 4 days'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'MMV: Inhibition of Plasmodium falciparum K1 (EC50).',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).'],\n",
       "       dtype=object),\n",
       " array(['Change in the mean survival time of the treated mice infected with Plasmodium berghei, dosed at 40 mg/kg',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum THAI',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcB1R/Colombia by [3H]hypoxanthine uptake',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'Antimalarial activity on Plasmodium berghei in mice (Mus musculus) dosed at 40 mg/kg at day 4'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity on Plasmodium berghei in mice (Mus musculus) dosed at 40 mg/kg at day 4',\n",
       "        'Change in the mean survival time of the treated mice infected with Plasmodium berghei, dosed at 40 mg/kg',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcB1R/Colombia by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity as reduced parasitaemia in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 40 mg/kg/day peroral dose then intraperitoneal for 4 days',\n",
       "        'Antimalarial activity as increased MST in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 40 mg/kg peroral dose day 1 followed by intraperitoneal dose for 4 days',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum THAI'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity on Plasmodium berghei in mice (Mus musculus) dosed at 40 mg/kg at day 7',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'Antimalarial activity as reduced parasitaemia in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 40 mg/kg/day peroral dose then intraperitoneal for 4 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum THAI/Thailand as [3H]hypoxanthine uptake after 24 hrs by semi-automated micro dilution',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum THAI',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum K1/Thailand by [3H]hypoxanthine uptake',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity as increased MST in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 40 mg/kg peroral dose day 1 followed by intraperitoneal dose for 4 days',\n",
       "        'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcB1R/Colombia by [3H]hypoxanthine uptake',\n",
       "        'Change in the mean survival time of the treated mice infected with Plasmodium berghei, dosed at 40 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity on Plasmodium berghei in mice (Mus musculus) dosed at 40 mg/kg at day 4',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'Inhibitory activity against chloroquine-resistant Plasmodium falciparum THAI'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in human erythrocytes after 48 hrs',\n",
       "        'Inhibition of beta-hematin formation after 16 hrs',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium berghei infected in mice (Mus musculus) assessed as suppression of parasitaemia at 100 mg/kg, po',\n",
       "        'Inhibitory activity I50 against chloroquine-sensitive Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye',\n",
       "        'ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['In vitro antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'In vitro antiplasmodial activity against Plasmodium falciparum D10',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Indochina I by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'In vitro antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Indochina I',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 by [3H]hypoxanthine uptake',\n",
       "        'In vitro antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Haiti 135',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum GCO3 after 72 hrs by SYBR green assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCB after 72 hrs by SYBR green assay',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum Haiti 135 by [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against drug resistant Plasmodium falciparum Dd2 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 assessed as inhibition of [3H] hypoxanthine uptake by liquid scintillation counting',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 in human erythrocytes by DAPI stain',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'Antiparasitic activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       "        'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'In vitro antiplasmodial activity against Plasmodium falciparum D10',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 in human erythrocytes by DAPI stain',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['Percent growth inhibition of Plasmodium falciparum 3D7 in erythrocytes at 20 uM',\n",
       "        'Growth inhibition of Plasmodium falciparum 3D7 infected red blood cells',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase',\n",
       "        'Effective dose against Plasmodium falciparum'], dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control; range 1 mg/kg to 3 mg/kg',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum; range 3 nM to 10 nM',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum infected in mice (Mus musculus) assessed as inhibition of parasitaemia at 30 mg/kg, subcutaneous for 4 days',\n",
       "        'Antiplasmodial activity against Plasmodium vivax infected in mice (Mus musculus) assessed as inhibition of parasitaemia at 30 mg/kg, subcutaneous for 4 days',\n",
       "        'In vitro inhibitory activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei N on oral administration.'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei N on oral administration.',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered subcutaneously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       "        'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered intravenously each day for 4 days to five mice (Mus musculus) per dose regimen'],\n",
       "       dtype=object),\n",
       " array(['Reaction velocity for Plasmodium falciparum 68 neutral proteinase.',\n",
       "        'Substrate affinity for Plasmodium falciparum 68 neutral proteinase.'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei N on oral administration.',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered subcutaneously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       "        'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered intravenously each day for 4 days to five mice (Mus musculus) per dose regimen'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered subcutaneously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       "        'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered intravenously each day for 4 days to five mice (Mus musculus) per dose regimen'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity after 120 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 as delayed first replication cycle at IC50 after 48-120 hrs by giemsa stain',\n",
       "        'Antiplasmodial activity as ED50 against parasite growth after 48 hrs for Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity after 48 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antiplasmodial activity as ED50 against parasite growth after 96 hrs for Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity after 96 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity',\n",
       "        'Antiplasmodial activity after 72 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum falcipain 2 assessed as benzyloxycarbonyl-Phe-Leu-7-amino-4-methylcoumarin substrate hydrolysis after 30 mins by spectrofluorometry analysis',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 by FACS-based assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by FACS-based assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in erythrocytes assessed as inhibition of sorbitol-induced hemolysis after 15 mins',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 by FACS-based assay'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum 3D7'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'MMV: Inhibition of Plasmodium falciparum K1 (EC50).',\n",
       "        'MMV: CRC and MIC90 against Mtb (nonreplicating)',\n",
       "        'MMV: CRC and MIC90 against Mtb (replicating)',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Cytotoxicity CRC and LD50 against HepG2',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against the Plasmodium falciparum FCR3',\n",
       "        'Compound was tested for antimalarial activity against mice (Mus musculus) malaria parasite Plasmodium berghei in vivo and the samples were administrated intraperitoneally.',\n",
       "        'In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       "        'Antimalarial activity against Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Compound was tested for antimalarial activity against mice (Mus musculus) malaria parasite Plasmodium berghei in vivo and the samples were administrated intraperitoneally.',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3',\n",
       "        'In vitro antimalarial activity against the Plasmodium falciparum FCR3'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against the Plasmodium falciparum FCR3',\n",
       "        'In vivo antimalarial activity at >100mg/kg intraperitoneal dose',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'Compound was tested for antimalarial activity against mice (Mus musculus) malaria parasite Plasmodium berghei in vivo mice (Mus musculus) and the samples were administrated intraperitoneally.',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcB1 by [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 25 mg/kg for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 12.5 mg/kg for 4 days'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 20 mg/kg for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 20 mg/kg for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 20 mg/kg for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 20 mg/kg for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA ',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1-10 uM DEEA'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium berghei (ANKA) in mice at a dose of 20 mg/kg for 4 days',\n",
       "        'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA ',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA'],\n",
       "       dtype=object),\n",
       " array(['Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1-10 uM DEEA ',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA '],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA ',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA'],\n",
       "       dtype=object),\n",
       " array(['Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA ',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       "        'Concentration required to reduce chloroquine IC50 by 50%',\n",
       "        'In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against multidrug-resistant Plasmodium falciparum W2 Indochina',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA'],\n",
       "       dtype=object),\n",
       " array(['The compound was tested for the dose required to cause 50% suppression of Plasmodium berghei growth in mice.',\n",
       "        'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 1.0 mg/kg/day after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.5-mg/kg/day for 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.1-mg/kg/day for 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 5 mg/kg/day after 4 days',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 2 mg/kg/day after 4 days',\n",
       "        'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 10 mg/kg/day after 4 days'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 trophozoites infected in human erythrocytes assessed as [3H]hypoxanthine incorporation into nucleic acid after 30 hrs by beta-scintillation counting',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 20 uM',\n",
       "        'Inhibition of Plasmodium falciparum recombinant plasmepsin-2 expressed in Escherichia coli BL21 (DE3)',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum assessed as inhibition of parasite growth at 20 uM',\n",
       "        'Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum',\n",
       "        'Binding affinity for Plasmodium falciparum plasmepsin-2.'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 trophozoites infected in human erythrocytes assessed as [3H]hypoxanthine incorporation into nucleic acid after 30 hrs by beta-scintillation counting',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'Inhibition of Plasmodium falciparum plasmepsin-2',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of aspartic protease plasmepsin-1 (Plm) of Plasmodium falciparum.',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'Growth inhibition of Plasmodium falciparum infected human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'In vitro inhibition of aspartic protease plasmepsin (Plm) II of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum plasmepsin-2 at 10 uM',\n",
       "        'Inhibitory concentration for Plasmodium falciparum plasmepsin-1.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum 3D7 recombinant GCN5 by HAT assay at 100 uM',\n",
       "        'Antimalarial activity against chloroquine-susceptible Plasmodium falciparum D10',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 7G8',\n",
       "        'Binding affinity to Plasmodium falciparum ATPase6',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCK2',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum MP14',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCK by [3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Inhibition of Plasmodium falciparum 3D7 recombinant GCN5 by HAT assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity as parasitemia at day 17 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha treated to day 10; range 25-30%',\n",
       "        'Hemozoin formation in chloroquine-resistant Plasmodium yoelii',\n",
       "        'Evaluated for the Hemeoxygenase in chloroquine-sensitive Plasmodium yoelii',\n",
       "        'Heme content in chloroquine-sensitive Plasmodium berghei',\n",
       "        'Heme content in chloroquine-sensitive Plasmodium yoelii',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 100 uM',\n",
       "        'In vivo resistance reversal at day 10 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha at 10 mg/kg; range 20-22%',\n",
       "        'In vivo antimalarial activity as pretreatment parasitemia in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 1-2%',\n",
       "        'In vivo resistance reversal in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus); range is 1-2%',\n",
       "        'In vivo resistance reversal agent in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus). Parasitemia observed on day 6-10 of treatment in Group IV;range is 80-70%',\n",
       "        'Evaluated for the Hemeoxygenase (Values are mean +/- SD of 4 separate observations. Specific activity in nmol/h/mg protein) in chloroquine-sensitive Plasmodium berghei',\n",
       "        'In vivo antimalarial activity as parasitemia at day 6 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 70-80%',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 50 uM',\n",
       "        'Heme content after 10 days in chloroquine-resistant Plasmodium yoelii at 15 mg/kg',\n",
       "        'In vivo pretreatment parasitemia in chloroquine-resistant Plasmodium berghei infected Mastomys coucha; range 4-5%',\n",
       "        'In vivo antimalarial activity as parasitemia at day 10 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha at 15 mg/kg; range 20-22%',\n",
       "        'Hemozoin formation in chloroquine-resistant Plasmodium yoelii at 15 mg/kg for 10 days',\n",
       "        'In vivo antimalarial activity as parasitemia at day 10 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha at 10 mg/kg; range 15-17%',\n",
       "        'Evaluated for the Hemeoxygenase (Values are mean +/- SD of 4 separate observations. Specific activity in nmol/h/mg protein) in chloroquine-resistant Plasmodium berghei',\n",
       "        'In vivo antimalarial activity as parasitaemia at day 17 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha treated to day 10; range 25-30%',\n",
       "        'In vivo resistance reversal at day 10 against chloroquine-resistant Plasmodium berghei infected Mastomys coucha at 10 mg/kg; range 20-22',\n",
       "        'Heme content in chloroquine-resistant Plasmodium berghei at 15 mg/kg for 10 days',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Plasmodium yoelii (host) at concentration 50 uM',\n",
       "        'Heme content in chloroquine-resistant Plasmodium berghei',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Plasmodium yoelii (host) at concentration 100 uM',\n",
       "        'Hemozoin formation in chloroquine-sensitive Plasmodium berghei',\n",
       "        'Inhibition of Glutathione S-transferase in Plasmodium yoelii nigeriensis isolated from infected mice (Mus musculus) (oral)',\n",
       "        'Hemozoin formation in chloroquine-sensitive Plasmodium yoelii',\n",
       "        'In vivo antimalarial activity as parasitemia at days 6-10 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 70-80%',\n",
       "        'In vivo resistance reversal at day 10 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha at 10 mg/kg; range 20-22',\n",
       "        'In vivo antimalarial activity as pretreatment parasitaemia in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus); range 1-2%',\n",
       "        'In vivo antimalarial activity as parasitemia at day 10 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha; range 20-22%',\n",
       "        'Hemozoin formation in chloroquine-resistant Plasmodium berghei',\n",
       "        'Evaluated for the Hemeoxygenase in chloroquine-resistant Plasmodium yoelii',\n",
       "        'Inhibition of heme oxygenase in Plasmodium yoelii nigeriensis isolated from infected mice (Mus musculus) (oral)',\n",
       "        'Heme content in chloroquine-resistant Plasmodium yoelii',\n",
       "        'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 10 uM',\n",
       "        'Hemozoin formation in chloroquine-resistant Plasmodium berghei at 15 mg/kg for 10 days',\n",
       "        'In vivo antimalarial activity as parasitaemia at day 17 in chloroquine-resistant Plasmodium berghei infected Mastomys coucha treated to day 10; range >25-30%'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase',\n",
       "        'Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase at 10 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase',\n",
       "        'Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase at 10 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase at 10 uM',\n",
       "        'Inhibition of Plasmodium falciparum AM1 using Leu-pNA as substrate preincubated for 10 mins',\n",
       "        'Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana in human erythrocytes after 72 hrs by Malstat assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana',\n",
       "        'Inhibition of beta-hematin formation after 18 hrs by microtiter plate assay'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana in human erythrocytes after 72 hrs by Malstat assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of beta-hematin formation after 18 hrs by microtiter plate assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 after 72 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-sensitive Plasmodium falciparum T996',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei infected Swiss albino mice (Mus musculus) at 50 mg/kg/day peroral dose for 4 days',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei yoelii infected Swiss albino mice (Mus musculus) at 50 mg/kg/day peroral dose for 4 days'],\n",
       "       dtype=object),\n",
       " array(['In vitro anti-malarial activity against Plasmodium berghei',\n",
       "        'Inhibitory concentration against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against KB 3-1',\n",
       "        'Compound was tested for antimalarial activity against human epidermoid carcinoma KB 3-1',\n",
       "        'In vitro anti-malarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of beta-hematin formation after 18 hrs by microtiter plate assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana in human erythrocytes after 72 hrs by Malstat assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as [35S]Met/Cys incorporation by SYBR green based fluorescence assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'HARVARD: Cytotoxicity in HepG2 cell line'], dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum NF54 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum NF54',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       "        'In vitro inhibitory activity against Plasmodium falciparum (Sierra leone clone)'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of beta-hematin formation',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 after 24 hrs',\n",
       "        'Inhibition of beta-hematin formation at 5 mM',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       "        'HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       "        'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       "        'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation at 200 uM ',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation at 200 uM '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation at 200 uM '],\n",
       "       dtype=object),\n",
       " array(['Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation at 200 uM ',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against schizonts of chloroquine-sensitive Plasmodium berghei ANKA 2.34 assessed as chemosuppression of schizont numbers at 200 uM after 16 hrs relative to control',\n",
       "        'Antimalarial activity against schizonts of chloroquine-sensitive Plasmodium berghei ANKA 2.34 after 16 hrs'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum FcB1/Columbia erythrocytes infected human MRC5 cells',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Antimalarial activity of compound (20 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 4',\n",
       "        'Antimalarial activity of compound (40 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 11',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FcB1',\n",
       "        'Antimalarial activity of compound (40 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 4',\n",
       "        'Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation at 200 uM '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Inhibition of 1-monooleoyl glycerol (MOG) induced beta-hematin formation at 200 uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye',\n",
       "        'MMV: Inhibition of Plasmodium falciparum K1 (EC50).',\n",
       "        'ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei in mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'MMV: Inhibition of Plasmodium falciparum K1 (EC50).',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) erythrocytes at 10 uM after 18 hrs as reduced hemoglobin hydrolysis',\n",
       "        'Antimicrobial activity against leupeptin resistant-Plasmodium falciparum HB3-leuR1 mutant infected in erythrocytes assessed as growth inhibition after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       "        'Inhibition of Cysteine protease falcipain-3 in Plasmodium falciparum HB3-leuR1 mutant infected erythrocytes by Z-Phe-Arg-AMC substrate hydrolysis assay',\n",
       "        'Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 10 uM',\n",
       "        'Antimalarial activity against chloroquine-susceptible Plasmodium berghei ANKA assessed as inhibition of trophozoite extract-mediated mouse hemoglobin hydrolysis at 10 mM after 18 hrs by SDS-PAGE',\n",
       "        'Inhibition of Cysteine protease falcipain-3 in Plasmodium falciparum HB3 infected erythrocytes by Z-Phe-Arg-AMC substrate hydrolysis assay',\n",
       "        'Antimalarial activity as inhibition of chloroquine-resistant Plasmodium falciparum mediated mice (Mus musculus) hemoglobin hydrolysis at 5 mM after 18 hrs',\n",
       "        'Antiparasitic activity against Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) after 18 hrs as reduced hemoglobin proteolysis',\n",
       "        'Inhibitory concentration against recombinant Falcipain-2',\n",
       "        'Inhibition of Cysteine protease falcipain-2 in Plasmodium falciparum HB3 infected erythrocytes by Z-Phe-Arg-AMC substrate hydrolysis assay',\n",
       "        'Inhibition of Cysteine protease falcipain-2 in Plasmodium falciparum HB3-leuR1 mutant infected erythrocytes by Z-Phe-Arg-AMC substrate hydrolysis assay',\n",
       "        'Antimicrobial activity against wild type Plasmodium falciparum HB3 infected in erythrocytes assessed as growth inhibition after 72 hrs by SYBR Green I-based fluorescence assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in mice (Mus musculus) after 6 days',\n",
       "        'Dose required for 100%, 31 day survival of Plasmodium berghei inoculated mice (Mus musculus).',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Inhibition of WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum W2',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Binding affinity to recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant by competitive binding assay',\n",
       "        'Binding affinity to wild type Plasmodium falciparum DHFR by competitive binding assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay',\n",
       "        'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       "        'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       "        'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       "        'Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in mice (Mus musculus) after 6 days',\n",
       "        'Dose required for 100%, 31 day survival of Plasmodium berghei inoculated mice (Mus musculus).'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro',\n",
       "        'DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       "        'PUBCHEM_BIOASSAY: Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       "        'PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       "        'PUBCHEM_BIOASSAY: Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against KB 3-1',\n",
       "        'In vitro anti-malarial activity against Plasmodium berghei',\n",
       "        'In vitro anti-malarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro anti-malarial activity against Plasmodium falciparum',\n",
       "        'In vitro anti-malarial activity against Plasmodium berghei',\n",
       "        'In vitro antimalarial activity against KB 3-1'], dtype=object),\n",
       " array(['In vitro antimalarial activity against KB 3-1',\n",
       "        'In vitro anti-malarial activity against Plasmodium berghei',\n",
       "        'In vitro anti-malarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro anti-malarial activity against Plasmodium berghei',\n",
       "        'In vitro anti-malarial activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity against KB 3-1'], dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro efficacy for chloroquine-resistant Plasmodium falciparum F32',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Percentage excess MST, when used as the chlorohydrate in mice infected with Plasmodium berghei (i.p., 40 mg/kg)',\n",
       "        'Effective dose against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum D6',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum Thai strain',\n",
       "        'Parasitaemia (%) on day 4 in Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['In vitro efficacy for chloroquine-resistant Plasmodium falciparum D6',\n",
       "        'Effective dose against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Effect on protein of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 30 nM',\n",
       "        'Effect on glutathione reductase activity of chloroquine-resistant Plasmodium falciparum K1 in culture after 24 hrs treatment at 30 nM conc',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum Thai strain',\n",
       "        'Effect on glutathione content of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 500 nM',\n",
       "        'Effect on protein of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 500 nM',\n",
       "        'Effect on glutathione S-transferase (GST) activity of chloroquine-resistant Plasmodium falciparum K1 in culture after 24 hrs treatment at 500 nM conc',\n",
       "        'Percentage of parasitaemia on day 11 in mice infected with Plasmodium berghei (ip, 40 mg/kg)',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro efficacy for chloroquine-resistant Plasmodium falciparum F32',\n",
       "        'Effect on nucleic acid of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 150 nM',\n",
       "        'Effect on glutathione content of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 150 nM',\n",
       "        'Effect on nucleic acid of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 30 nM',\n",
       "        'Effect on protein of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 150 nM',\n",
       "        'Effect on glutathione content of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 30 nM',\n",
       "        'Effect on nucleic acid of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 500 nM',\n",
       "        'Percentage of parasitaemia on day 18 in mice infected with Plasmodium berghei (ip, 40 mg/kg)',\n",
       "        'Effect on glutathione reductase activity of chloroquine-resistant Plasmodium falciparum K1 in culture after 24 hrs treatment at 150 nM conc',\n",
       "        'Percentage of parasitaemia on day 4 in mice infected with Plasmodium berghei (ip, 40 mg/kg)',\n",
       "        'Effect on glutathione S-transferase (GST) activity of chloroquine-resistant Plasmodium falciparum K1 in culture after 24 hrs treatment at 30 nM conc',\n",
       "        'Effect on glutathione reductase activity of chloroquine-resistant Plasmodium falciparum K1 culture after 24 hrs at 500 nM',\n",
       "        'Effect on glutathione S-transferase (GST) activity of chloroquine-resistant Plasmodium falciparum K1 in culture after 24 hrs treatment at 150 nM conc',\n",
       "        'Percentage excess MST, when used as the chlorohydrate in mice infected with Plasmodium berghei (i.p., 40 mg/kg)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       "        'In vivo effective dose for antimalarial activity by peroral dose',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3'],\n",
       "       dtype=object),\n",
       " array(['Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Inhibitory activity against Plasmodium falciparum NF54',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Effective subcutaneous dose ED50 against Plasmodium yoelii sspNS',\n",
       "        'Effective dose ED90 against Plasmodium yoelii sspNS on subcutaneous dose',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Effective subcutaneous dose ED50 against Plasmodium yoelii sspNS',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum NF54',\n",
       "        'Effective dose ED90 against Plasmodium yoelii sspNS on subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       "        'In vivo effective dose for antimalarial activity by intraperitoneal dose'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose for antimalarial activity by peroral dose',\n",
       "        'In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FCR3'],\n",
       "       dtype=object),\n",
       " array(['Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Effective dose ED90 against Plasmodium yoelii sspNS on subcutaneous dose',\n",
       "        'Inhibitory activity against Plasmodium falciparum K1',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Effective subcutaneous dose ED50 against Plasmodium yoelii sspNS',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum K1',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Effective dose ED90 against Plasmodium yoelii sspNS on subcutaneous dose',\n",
       "        'Inhibitory activity against Plasmodium falciparum NF54',\n",
       "        'Effective subcutaneous dose ED50 against Plasmodium yoelii sspNS'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Percent suppression of Plasmodium berghei N infection in mice (Mus musculus) malaria model after peroral dose',\n",
       "        'Percent suppression of Plasmodium berghei NS infection in mice (Mus musculus) malaria model after 10 mg/kg peroral dose',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Effective dose against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration'],\n",
       "       dtype=object),\n",
       " array(['Effective subcutaneous dose ED90 in SSV against Plasmodium yoelii sspNS',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Effective dose after oral administration against Plasmodium yoelii sspNS for 50%inhibition in presence of DMSO',\n",
       "        'Inhibitory activity against Plasmodium falciparum D6',\n",
       "        'Effective dose after oral administration against Plasmodium yoelii sspNS for 90%inhibition in presence of DMSO',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Inhibitory activity against Plasmodium falciparum W2',\n",
       "        'Inhibitory activity against Plasmodium falciparum K1',\n",
       "        'Effective dose ED50 against Plasmodium berghei N in mice (Mus musculus) malaria model after peroral administration',\n",
       "        'Effective dose ED90 against Plasmodium berghei N in mice (Mus musculus) malaria model after subcutaneous administration',\n",
       "        'Effective subcutaneous dose ED50 in SSV against Plasmodium yoelii sspNS'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of [3H]hypoxanthine incorporation in Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum 3D7'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum 3D7 infected red blood cells',\n",
       "        'Percent growth inhibition of Plasmodium falciparum 3D7 in erythrocytes at 20 uM'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum 3D7 infected red blood cells',\n",
       "        'Percent growth inhibition of Plasmodium falciparum 3D7 in erythrocytes at 20 uM'],\n",
       "       dtype=object),\n",
       " array(['Percent growth inhibition of Plasmodium falciparum 3D7 in erythrocytes at 20 uM',\n",
       "        'Growth inhibition of Plasmodium falciparum 3D7 infected red blood cells'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum IMT L1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum W2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCM29 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Voll infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K14 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10354 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 8425 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum W2 by ELISA',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D6 by ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum K1 by ELISA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum by ELISA',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum L1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Bres infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum PA infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       "        'Antimicrobial activity against Plasmodium falciparum harboring mdr1 N86Y/D1246Y/Y184F mutant gene by ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum HB3 by ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as parasite growth inhibition after 48 hrs by [3H]hypoxanthin incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Plasma concentration in children with uncomplicated malaria assessed as desethylamodiaquine at 10 mg/kg, po administered as single dose measured on day 3',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as resistant isolates'],\n",
       "       dtype=object),\n",
       " array(['Drug level in malaria patient whole blood assessed as desethychloroquine level on day 4',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by SYBR green assay',\n",
       "        'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes by SYBR green assay',\n",
       "        'Drug level in malaria patient whole blood assessed as desethychloroquine level on day 14',\n",
       "        'Parasite growth in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum',\n",
       "        'Parasite growth in chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'Drug level in malaria patient whole blood assessed as desethychloroquine level on day 1',\n",
       "        'Inhibition of hematin polymerization',\n",
       "        'AUC (0 to infinity) in Paua New Guinean children with uncomplicated malaria',\n",
       "        'AUC (0 to 42 days) in Paua New Guinean children with uncomplicated malaria',\n",
       "        'Elimination half life in Paua New Guinean children with uncomplicated malaria'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum 3D7 infected red blood cells',\n",
       "        'Percent growth inhibition of Plasmodium falciparum 3D7 in erythrocytes at 20 uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii yoelii',\n",
       "        'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O+ erythrocytes after 72 hrs by SYBR Green-1 fluorescence based assay',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of parasitemia after 48 hrs by Giemsa staining',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 3 times 30 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 10 mg/kg, perorally administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 30 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 30 mg/kg, perorally administered as single dose measured up to 30 days postinfection',\n",
       "        'Binding affinity to wild type Plasmodium falciparum DHFR by competitive binding assay',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 60 mg/kg, perorally administered as single dose measured up to 30 days postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 30 mg/kg, perorally administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 100 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 15 mg/kg, perorally administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 15 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 10 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 30 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 60 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 15 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 3 times 100 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 3 times 30 mg/kg, perorally',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 15 mg/kg, perorally administered as single dose measured up to 30 days postinfection',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 3 times 60 mg/kg, perorally measured up to 30 days postinfection',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 10 mg/kg, perorally administered as single dose measured up to 30 days postinfection',\n",
       "        'Binding affinity to recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant by competitive binding assay',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in perorally dosed NMRI mice (Mus musculus) assessed as reduction in parasitemia administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 3 times 30 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 10 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 60 mg/kg, perorally administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as survival rate at 100 mg/kg, perorally administered as single dose',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 3 times 60 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 3 times 100 mg/kg, perorally measured up to 30 days postinfection',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1/S harboring S108N, N51I, C59R, I164L mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 3 times 30 mg/kg, perorally measured up to 30 days postinfection',\n",
       "        'Toxicity in NMRI mice (Mus musculus) infected with Plasmodium berghei ANKA at 100 mg/kg, perorally administered as single dose measured up to 30 days postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 3 times 60 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 60 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitemia at 3 times 100 mg/kg, perorally measured on day 3 postinfection',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as cure rate at 100 mg/kg, perorally administered as single dose measured on day 3 postinfection',\n",
       "        'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I mutation in DHFR assessed as decrease in parasitaemia'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 infected human erythrocytes assessed by [3H]hypoxanthine uptake',\n",
       "        'Toxicity in Plasmodium berghei N-infected TSW mice (Mus musculus) assessed as mortality before day 5 at 9 mg/kg, perorally administered 3 hrs after infection daily for 4 consecutive days',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 4 against Plasmodium berghei N infected TSW mice (Mus musculus) at 3 mg/kg peroral dose 3 hrs post infection then daily',\n",
       "        'Antimalarial activity as reduced parasitaemia at day 4 against Plasmodium berghei N infected TSW mice (Mus musculus) perorally dosed 3 hrs post infection then daily',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated by the percent viability of FM3A cells',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum Smith',\n",
       "        'In Vivo antimalarial activity of compound was tested in Plasmodium berghei infected mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial potency was evaluated by the increase of life span of mice (Mus musculus) at 1 mg/kg',\n",
       "        'In Vivo antimalarial activity of compound was tested in Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimalarial activity was evaluated by the percent viability of FM3A cells'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 48 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Percent suppression against Plasmodium yoelii in mice (Mus musculus) at 24 mg/kg/day orally on day 4',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 24 mg/kg/day orally',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 48 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'Percent suppression against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'Inhibition of hematin polymerization',\n",
       "        'Parasite growth in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Parasite growth in chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimalarial activity was evaluated by the percent viability of FM3A cells'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated by the percent viability of cells',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated by the percent viability of FM3A cells',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated by the percent viability of FM3A cells',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was evaluated by the percent viability of FM3A cells',\n",
       "        'Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimalarial activity was evaluated by the percent viability of cells',\n",
       "        'Antimalarial activity was evaluated by the percent viability of FM3A cells'],\n",
       "       dtype=object),\n",
       " array(['Anti-malarial activity as growth inhibition of chloroquine-resistant Plasmodium falciparum',\n",
       "        'Antimalarial activity was evaluated by the percent viability of FM3A cells'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 96 mg/kg/day peroral dose after 4 days',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression',\n",
       "        'Antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in mice (Mus musculus) at 96 mg/kg/day peroral dose after 4 days',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day intramuscularly on day 4 expressed as percent suppression',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day intramuscularly',\n",
       "        'Mean survival time against Plasmodium yoelii in mice (Mus musculus) which died during 28-day observation period at 96 mg/kg/day orally',\n",
       "        'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 96 mg/kg/day orally on day 4 expressed as percent suppression'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei infected mice (Mus musculus) after intramuscular administration at a dose 100 mg/kg/day',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium berghei infected mice (Mus musculus) after intraperitoneal administration at a dose 100 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'Antimalarial activity against Plasmodium falciparum assessed as [35S]Met/Cys incorporation by SYBR green based fluorescence assay',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei infected mice (Mus musculus) after intramuscular administration at a dose 100 mg/kg/day',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium berghei infected mice (Mus musculus) after intraperitoneal administration at a dose 100 mg/kg/day'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei NK-65 infected in ICR mouse assessed as survival days at 100 mg/kg, po administered as single dose (Rvb = 6 days)',\n",
       "        'Antimalarial activity against chloroquine and pyrimethamine resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium berghei NK-65 infected in ICR mouse assessed as inhibition of parasitemia at 100 mg/kg, po administered as single dose on day 1 measured on day 4',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity as reduced parasitaemia against Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 10 mg/kg peroral dose',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum FcB1',\n",
       "        'Antiplasmodial activity as reduced parasitaemia against Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 50 mg/kg peroral dose',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity as reduced parasitaemia against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum HB',\n",
       "        'Antimalarial activity as ED100 in peripheral blood at day 23 against Plasmodium yoelii 17X infected CD1 mice (Mus musculus)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'In vivo antimalarial activity against Plasmodium chabaudi in mice (Mus musculus) and its survival rate reported',\n",
       "        'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 4',\n",
       "        'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 5',\n",
       "        'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 3',\n",
       "        'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 1',\n",
       "        'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 2'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii NS peroral dosage',\n",
       "        'In vitro antimalarial activity against Plasmodium yoelii NS in peter 4-day assay',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human RBCs after 72 hrs by parasite lactate dehydrogenase assay',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) perorally dosed daily over 4 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human RBCs after 72 hrs by parasite lactate dehydrogenase assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1R after 24 hrs by semiautomated micro dilution assay',\n",
       "        'Antimalarial activity as reduced parasitaemia against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) perorally dosed daily for 4 days',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 as LDH activity',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Thai after 24 hrs by semiautomated micro dilution assay',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 as LDH reporter activity',\n",
       "        'Antimalarial activity as minimal concentration for parasite elimination at day 23 against Plasmodium yoelii 17X peroral inoculated CD1 mice (Mus musculus) dosed 1 hrs post infection then daily for 4 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum HB',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 24 hrs by semiautomated micro dilution assay'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity as reduced parasitaemia against Plasmodium berghei ANKA infected CD1 mice (Mus musculus) after 4 days',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 in human erythrocytes after 48 hrs by [3H]hypoxanthine uptake',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum HB'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound',\n",
       "        'In vitro activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against blood-stage of Plasmodium cynomolgi M infected in rhesus macaque assessed as reduction of parasitemia administered intramuscularly twice daily for 8 consecutive days measured on day 28 (Rvb = 6.1%)',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibition of Plasmodium falciparum',\n",
       "        'Antimalarial activity against blood-stage of Plasmodium cynomolgi M infected in rhesus macaque assessed as reduction of peak parasitemia days administered intramuscularly twice daily measured after 2nd dose (Rvb = 3.5%)'],\n",
       "       dtype=object),\n",
       " array(['PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against drug-resistant Plasmodium falciparum W-2',\n",
       "        'In vitro antimalarial activity against drug-resistant Plasmodium falciparum D6',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'Compound was tested in vivo for antimalarial activity against Plasmodium berghei in the mice (Mus musculus) model.'],\n",
       "       dtype=object),\n",
       " array(['Antimicrobial activity against Plasmodium falciparum harboring mdr1 N86Y/D1246Y/Y184F mutant gene by ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Cmax in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 5 days coadministered with 20 mg artemether measured after 7 days by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 9881 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCM29 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10336 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Inhibition against Plasmodium falciparum Dd2 in erythrocytes in semiautomated micro dilution assay',\n",
       "        'Clearance in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Apparent peripheral volume of distribution in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Cmax in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 4 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type and mutant pfcrt-76 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Tlag in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether measured after 7 days by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 in erythrocytes',\n",
       "        'Cmax in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 4 days coadministered with 20 mg artemether measured after 7 days by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Apparent volume of distribution in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in C57BL/6 mouse assessed as host survival at 18 mg/kg, po administered 24 hrs post-infection (Rvb = 6.8 days)',\n",
       "        'Cmax in venous plasma of pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 5 days coadministered with 20 mg artemether measured on 7 days by two-compartment population pharmacokinetic model',\n",
       "        'Volume of distribution at steady state in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antimicrobial activity against Plasmodium falciparum by ELISA',\n",
       "        'Drug concentration in pregnant human with uncomplicated multidrug-resistant Plasmodium falciparum malaria infection at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether',\n",
       "        'AUC (0 to infinity) in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfcrt-76 and mutant pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Intercompartmental clearance in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Cmax in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum W2 by ELISA',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 8425 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured within 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Anti-malarial activity against Plasmodium falciparum Dd2',\n",
       "        'Antimicrobial activity against Plasmodium vivax at the ring stage measured after 30 hrs by microscopy',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Terminal elimination half-life in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K14 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'Antiplasmodial activity against multidrug-sensitive Plasmodium falciparum 3D7 after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT K2 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum 106/1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D6 by ELISA',\n",
       "        'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT L1 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum K1 by ELISA',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT A4 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum HB3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT 31 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Guy assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfcrt-76 and wild type pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum PA assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Absorption rate constant in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Drug concentration in pregnant human patient with reappeared uncomplicated multidrug-resistant Plasmodium falciparum malaria infection at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether',\n",
       "        'Drug concentration in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured within 30 hrs by microscopy',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimicrobial activity against Plasmodium vivax trophozoites measured after 30 hrs by microscopy',\n",
       "        'Cmax in Ugandan children patient with uncomplicated malaria administered twice daily for 3 days as 20/120 mg tablets containing artemether-lumefantrine combination',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum clinical isolate after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Cmax in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 5 days coadministered with 20 mg artemether by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against Plasmodium falciparum D6 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antimalarial activity against Plasmodium falciparum FCR3 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type pfcrt-76 and mutant pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type pfcrt-76 and wild type pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in C57BL/6 mouse assessed as decrease in parasitemia at 18 mg/kg, po administered 24 hrs post-infection measured after 3 days by Giemsa microscopy relative to vehicle treated control',\n",
       "        'Drug concentration in pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 3 days coadministered with 20 mg artemether measured after 7 days by two-compartment population pharmacokinetic model',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium vivax by Giemsa staining',\n",
       "        'Antimalarial activity against Plasmodium falciparum IMT Bres assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       "        'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes by semiautomated micro dilution',\n",
       "        'AUC (0-120 hrs) in Ugandan children patient with uncomplicated malaria assessed as dihydroartemisin administered twice daily for 3 days as 20/120 mg tablets containing artemether-lumefantrine combination',\n",
       "        'Half life in Ugandan children patient with uncomplicated malaria administered twice daily for 3 days as 20/120 mg tablets containing artemether-lumefantrine combination',\n",
       "        'AUC (0-infinity) in Ugandan children patient with uncomplicated malaria administered twice daily for 3 days as 20/120 mg tablets containing artemether-lumefantrine combination',\n",
       "        'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum HB3 by ELISA',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring wild type and mutant pfmdr-1-86 gene after 18 hrs by [3H]hypoxanthine incorporation assay',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2mef infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by beta liquid scintillation counting method',\n",
       "        'Cmax in capillary plasma of pregnant human patient with uncomplicated multidrug-resistant Plasmodium falciparum malaria at 120 mg, po administered as 4 tablets BID for 5 days coadministered with 20 mg artemether measured on 7 days by two-compartment population pharmacokinetic model',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum harboring mutant pfcrt-76 gene after 18 hrs by [3H]hypoxanthine incorporation assay'],\n",
       "       dtype=object),\n",
       " array(['Compound was tested in vivo for antimalarial activity against Plasmodium berghei in the mice (Mus musculus) model.',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3'],\n",
       "       dtype=object),\n",
       " array(['Compound was tested in vivo for antimalarial activity against Plasmodium berghei in the mice (Mus musculus) model.',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity of compound (20 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 4',\n",
       "        'Antimalarial activity of compound (40 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 4',\n",
       "        'Antimalarial activity against Plasmodium falciparum FcB1/Columbia erythrocytes infected human MRC5 cells',\n",
       "        'Antimalarial activity of compound (20 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 11',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity of compound (20 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 4',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum FcB1',\n",
       "        'Growth inhibition against chloroquine-sensitive Plasmodium falciparum F32',\n",
       "        'Antimalarial activity of compound (20 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 11',\n",
       "        'Antimalarial activity of compound (5 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 4',\n",
       "        'Antimalarial activity of compound (5 mg/kg) was determined against Plasmodium berghei infected intraperitoneally in mice (Mus musculus) at day 11',\n",
       "        'Growth inhibition against chloroquine-sensitive Plasmodium falciparum K1',\n",
       "        'Growth inhibition against chloroquine-sensitive Plasmodium falciparum FcB1',\n",
       "        'In vitro inhibition of beta-hematin formation',\n",
       "        'Antimalarial activity against Plasmodium falciparum FcB1/Columbia erythrocytes infected human MRC5 cells'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 as parasite DNA microfluorimetric assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 50 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 50 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 50 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 50 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Effective dose was determined in vivo for 90% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg',\n",
       "        'Effective dose was determined in vivo for 50% parasite (Plasmodium berghei) reduction in the male albino mice after subcutaneous administration',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Effective dose was determined in vivo for 50% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 50 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 50 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 50 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 50 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 50 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 50 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Effective dose was determined in vivo for 50% parasite (Plasmodium berghei) reduction in the male albino mice after subcutaneous administration',\n",
       "        'Effective dose was determined in vivo for 50% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration',\n",
       "        'Effective dose was determined in vivo for 90% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 10 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 10 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after oral administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Growth inhibition of Plasmodium berghei was tested in vivo in male albino mice (Mus musculus) after subcutaneous administration of a dose of 100 mg/kg',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ',\n",
       "        'PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells   Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) '],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei. Activity expressed as ED90.',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei. Activity expressed as ED50.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['Antimalarial potency was evaluated by the increase of life span of mice (Mus musculus) at 3 mg/kg',\n",
       "        'In Vivo antimalarial activity of compound was tested in Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In Vivo antimalarial activity of compound was tested in Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'Antimalarial potency was evaluated by the increase of life span of mice (Mus musculus) at 3 mg/kg',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum',\n",
       "        'In Vivo antimalarial activity of compound was tested in Plasmodium berghei infected mice (Mus musculus)',\n",
       "        'Antimalarial potency was evaluated by the increase of life span of mice (Mus musculus) at 3 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against Plasmodium falciparum (sierra leone clone)',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory activity against Plasmodium falciparum (sierra leone clone)',\n",
       "        'Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 40 mg/Kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 160 mg/kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 640 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 40 mg/Kg',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 640 mg/kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 160 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 640 mg/kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 160 mg/kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 40 mg/Kg',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 640 mg/kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 40 mg/Kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 160 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 640 mg/kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 40 mg/Kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 160 mg/kg',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6'],\n",
       "       dtype=object),\n",
       " array(['Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 160 mg/kg',\n",
       "        'In vitro antimalarial activity against Plasmodium falciparum D6',\n",
       "        'In vivo antimalarial activity against Plasmodium falciparum W-2',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 40 mg/Kg',\n",
       "        'Compound was evaluated for (T-C) survival time of the treated mice (Mus musculus) against Plasmodium berghei at 640 mg/kg'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium yoelii when administered subcutaneously',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei when administered perorally',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei',\n",
       "        'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       "        'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei when administered subcutaneously'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 32 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'Inhibition of beta-hematin formation',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 4 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 8 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 64 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 8 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 32 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 16 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 4 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 16 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Inhibition of beta-hematin formation at 5 mM',\n",
       "        'Inhibition of beta-hematin formation at 10 mM',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 1 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 8 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 32 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 16 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 64 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 4 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 16 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 8 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 32 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at a dose of 4 uM/well through Schizonts maturation assay over 24 hr',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 64u M/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 2 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 2 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 64 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro growth inhibition against Plasmodium falciparum at a dose of 20 uM/well through total parasite growth inhibition assay over 72 hr',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 40 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Anti-malarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 20 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 160 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 80 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 80 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 160 mg/kg',\n",
       "        'Anti-malarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 20 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 40 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 500 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 500 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 40 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Anti-malarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 20 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 160 mg/kg',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 0.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 80 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 25 uM/well dose at 72 hrs in total parasite growth assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 160 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 40 mg/kg',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 0.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Anti-malarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 20 mg/kg',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 500 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 80 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for chloroquine-resistant Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Anti-malarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 20 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 40 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 160 mg/kg',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 80 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial activity for Plasmodium falciparum at 50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.25 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.50 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 1 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 160 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 2.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 20 uM/well dose at 72 hrs in total parasite growth assay; Not determined',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 100 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 80 mg/kg',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 10 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 100 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 0.10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'Antimalarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 40 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 1.0 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'Anti-malarial activity against Plasmodium berghei evaluated in terms of mean survival time for mice (Mus musculus) at a dose of 20 mg/kg',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 10 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 20 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro antimalarial activity for Plasmodium falciparum at 2.5 uM/well dose at 24 hrs in Schizont maturation assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 0.25 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 5 uM/well dose at 72 hrs in total parasite growth assay',\n",
       "        'In vitro inhibition of Plasmodium falciparum at 50 uM/well dose at 72 hrs in total parasite growth assay'],\n",
       "       dtype=object),\n",
       " array(['Binding affinity for Plasmodium falciparum plasmepsin-2.',\n",
       "        'Binding affinity for Plasmodium falciparum plasmepsin-1.',\n",
       "        'Percent inhibition against Plasmodium falciparum infected red blood cells at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.1 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry',\n",
       "        'Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry'],\n",
       "       dtype=object),\n",
       " array(['Binding affinity for Plasmodium falciparum plasmepsin-2.',\n",
       "        'Binding affinity for Plasmodium falciparum plasmepsin-1.',\n",
       "        'Percent inhibition of Plasmodium falciparum in erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Binding affinity for Plasmodium falciparum plasmepsin-1.',\n",
       "        'Percent inhibition of Plasmodium falciparum in red blood cells at 5 uM',\n",
       "        'Binding affinity for Plasmodium falciparum plasmepsin-2.'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibition of Plasmodium falciparum 3D7 infected red blood cells',\n",
       "        'Percent growth inhibition of Plasmodium falciparum 3D7 in erythrocytes at 20 uM'],\n",
       "       dtype=object),\n",
       " array(['Effective dose for antimalarial activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       "        'Tested for parasite (malaria)-based antiproliferative assay',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro antiprotozoal activity against Plasmodium falciparum infected erythrocytes',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in mice (Mus musculus)',\n",
       "        'Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef ring form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef at 10 uM after 48 hrs by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef assessed as DNA positive erythrocytes by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Binding constant for PFCDPK1(P.falciparum) kinase domain',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef schizont form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Binding constant for PFPK5(P.falciparum) kinase domain'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity was assessed against Plasmodium berghei in mice (Mus musculus). Increase in mean survival time in days was reported, at 80 mg/kg dosage of the compound.',\n",
       "        'Antimalarial activity was assessed against Plasmodium berghei in mice (Mus musculus). Increase in mean survival time in days was reported at 160 mg/kg dosage of the compound.',\n",
       "        'Antimalarial activity was assessed against Plasmodium berghei in mice (Mus musculus) at 320 mg/kg dosage of the compound; Toxic',\n",
       "        'Increase in mean survival time in mice innoculated with Plasmodium berghei days was reported following 40 mg/kg.',\n",
       "        'Antimalarial activity was assessed against Plasmodium berghei in mice (Mus musculus). Increase in mean survival time in days was reported at 320 mg/kg dosage of the compound.',\n",
       "        'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       "        'Antimalarial activity was assessed against Plasmodium berghei in mice (Mus musculus) at 640 mg/kg dosage of the compound; Cure',\n",
       "        'Antimalarial activity was assessed against Plasmodium berghei in mice (Mus musculus) at 640 mg/kg dosage of the compound; Toxic'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       "        'PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 320 mg/kg dosage',\n",
       "        'In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP '],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP '],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 320 mg/kg dosage',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage',\n",
       "        'In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP '],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP ',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP ',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 320 mg/kg dosage',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 640 mg/kg dosage',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 320 mg/kg dosage',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP ',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage'],\n",
       "       dtype=object),\n",
       " array(['Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP ',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 640 mg/kg dosage',\n",
       "        'Antimalarial activity in vitro against Plasmodium falciparum and potency (ID50) was determined against multidrug-resistant Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Effective in vivo dose ED90 against Plasmodium berghei N on oral administration',\n",
       "        'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after oral dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'In vitro antimalarial activity in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after subcutaneous dose at 1,3,10 or 30 mg/kg/day, n=5'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum TM91C235',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 640 mg/kg dosage',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 160 mg/kg dosage',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 40 mg/kg dosage',\n",
       "        'In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP '],\n",
       "       dtype=object),\n",
       " array(['In vitro antimalarial potency against multidrug-resistant Plasmodium falciparum Vietnam Smith strain',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 160 mg/kg administration',\n",
       "        'Increase in mean survival time in Plasmodium berghei inoculated mice (Mus musculus) following 40 mg/kg administration',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 640 mg/kg dosage',\n",
       "        'In vivo antimalarial activity against Plasmodium berghei in the mice (Mus musculus) at 80 mg/kg dosage',\n",
       "        'In vitro antimalarial potency against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum CAMP '],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen'], dtype=object),\n",
       " array(['Effective in vivo dose ED50 against Plasmodium berghei N after subcutaneous dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after oral dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'Effective in vivo dose ED90 against Plasmodium berghei N on oral administration',\n",
       "        'In vitro antimalarial activity in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen'], dtype=object),\n",
       " array(['Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen'], dtype=object),\n",
       " array(['Antimalarial activity in primary screen',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Antimalarial activity in primary screen'], dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Effective in vivo dose ED90 against Plasmodium berghei N on oral administration',\n",
       "        'In vitro antimalarial activity in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after oral dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after subcutaneous dose at 1,3,10 or 30 mg/kg/day, n=5'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection'],\n",
       "       dtype=object),\n",
       " array(['Effective in vivo dose ED90 against Plasmodium berghei N on oral administration',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after oral dose at 1,3,10 or 30 mg/kg/day, n=5',\n",
       "        'In vitro antimalarial activity in chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration',\n",
       "        'Effective in vivo dose ED50 against Plasmodium berghei N after subcutaneous dose at 1,3,10 or 30 mg/kg/day, n=5'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average of 6.2 days) versus treated mice (Mus musculus) 72 hrs after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 640 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 320 mg/kg subcutaneous dose',\n",
       "        'Difference in mean survival time in mice (Mus musculus) (control = 6.2 days) after single 40mg/kg subcutaneous dose 72hr post infection',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 2.5 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Difference in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 10 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) on 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 320 mg/kg subcutaneous dose',\n",
       "        'Antimalarial activity in primary screen',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 2.5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) 72 hrs after 1.25 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 160 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time in control (average 6.2 days) versus treated mice (Mus musculus) after 80 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time of Plasmodium berghei infected mice (Mus musculus) after 5 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       "        'Change in mean survival time for control (average 6.2 days) versus treated mice (Mus musculus) after 40 mg/kg subcutaneous dose'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum',\n",
       "        'In vitro percent inhibition of Plasmodium falciparum 3D7 in human erythrocyte at 5 uM',\n",
       "        'Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum',\n",
       "        'Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum',\n",
       "        'Percent inhibition for Plasmodium falciparum at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum',\n",
       "        'Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum',\n",
       "        'In vitro percent inhibition of Plasmodium falciparum 3D7 in human erythrocyte at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition constant against plasmepsin-4 of Plasmodium falciparum',\n",
       "        'In vitro percent inhibition of Plasmodium falciparum 3D7 in human erythrocyte at 5 uM',\n",
       "        'Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum',\n",
       "        'Inhibition constant against plasmepsin-1 of Plasmodium falciparum, 10 min using 3 uM of DABCYL-Glu-Arg-Nle-Phe-Le u-Ser-Phe-Pro-EDANS as substrate',\n",
       "        'Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum',\n",
       "        'Inhibition constant against plasmepsin-2 of Plasmodium falciparum 10 min using 3 uM of DABCYL-Glu-Arg-Nle-Phe-Le u-Ser-Phe-Pro-EDANS as substrate'],\n",
       "       dtype=object),\n",
       " array(['In vitro percent inhibition of Plasmodium falciparum 3D7 in human erythrocyte at 5 uM',\n",
       "        'Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum',\n",
       "        'Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum',\n",
       "        'In vitro percent inhibition of Plasmodium falciparum 3D7 in human erythrocyte at 5 uM',\n",
       "        'Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro percent inhibition of Plasmodium falciparum 3D7 in human erythrocyte at 5 uM',\n",
       "        'Inhibitory activity against protease plasmepsin-1 (Plm I) of Plasmodium falciparum',\n",
       "        'Inhibitory activity against protease plasmepsin-2 (Plm II) of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum W2mef assessed as DNA positive erythrocytes by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef schizont form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef at 10 uM after 48 hrs by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef ring form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vitro minimum inhibiting concentration for schizont maturation from ring stage parasite over 40 hrs'],\n",
       "       dtype=object),\n",
       " array(['In vitro minimum inhibiting concentration for schizont maturation from ring stage parasite over 40 hrs',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum D6 assessed as growth inhibition after 72 hrs by SYBR Green 1-based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium knowlesi infected in rhesus monkey RBC assessed as [3H]-hypoxanthine incorporation after 12 hrs by scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in C57BL/6 mouse assessed as decrease in parasitemia at 15 mg/kg, po administered 24 hrs post-infection measured after 3 days by Giemsa microscopy relative to vehicle treated control',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in C57BL/6 mouse assessed as host survival at 18 mg/kg, po administered 24 hrs post-infection (Rvb = 6.8 days)',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in O-positive human RBC assessed as [3H]-hypoxanthine incorporation after 48 hrs by scintillation counting',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected mouse assessed as survival at 30 mg/kg, po',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in mouse at 30 mg/kg, po',\n",
       "        'Antimalarial activity against Plasmodium falciparum C235 containing mdr1 transporter gene assessed as growth inhibition after 72 hrs by SYBR Green 1-based fluorescence assay',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in C57BL/6 mouse assessed as host survival at 15 mg/kg, po administered 24 hrs post-infection (Rvb = 6.8 days)',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in O-positive human RBC assessed as [3H]-hypoxanthine incorporation after 48 hrs by scintillation counting',\n",
       "        'Antimalarial activity against Plasmodium berghei ANKA infected in C57BL/6 mouse assessed as decrease in parasitemia at 18 mg/kg, po administered 24 hrs post-infection measured after 3 days by Giemsa microscopy relative to vehicle treated control',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in O-positive human RBC assessed as [3H]-hypoxanthine incorporation after 48 hrs by scintillation counting in presence of BSA',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in O-positive human RBC assessed as [3H]-hypoxanthine incorporation after 48 hrs by scintillation counting in presence of BSA',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected mouse assessed as reduction in parasitemia at 30 mg/kg, po measured on day 3 postinfection relative to control'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase by scintillation proximity assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 after more than 40 hrs by Giemsa staining-based light microscopic analysis',\n",
       "        'Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasitemia at 50 ug/ml after more than 40 hrs by Giemsa staining-based light microscopy'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 after more than 40 hrs by Giemsa staining-based light microscopic analysis',\n",
       "        'Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasitemia at 50 ug/ml after more than 40 hrs by Giemsa staining-based light microscopy'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasitemia at 50 ug/ml after more than 40 hrs by Giemsa staining-based light microscopy',\n",
       "        'Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 after more than 40 hrs by Giemsa staining-based light microscopic analysis'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Growth inhibitory concentration against chloroquine-resistant Plasmodium falciparum',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM',\n",
       "        'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       "        'In vitro inhibition of beta-hematin formation in Plasmodium falciparum at 100 uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium berghei infected in human Hepa 1-6 cells assessed as inhibition of host cell sporozoite invasion at 10 uM preincubated for 10 mins measured after 1 hr',\n",
       "        'Antimalarial activity against liver stages of Plasmodium yoelii 17XNL expressing GFP infected in human HepG2 cells transfected with CD81 assessed as growth inhibition of hepatic parasite after 40 hrs by flow cytometry',\n",
       "        'Antiparasitic activity against Plasmodium falciparum',\n",
       "        'Antimalarial activity against liver stages of Plasmodium berghei infected in human HepG2 cells assessed as growth inhibition of hepatic parasite before invasion of hepatocytes incubated for 48 hrs followed by compound wash out measured after 3 days by RT-PCR analysis',\n",
       "        'Antimalarial activity against liver stages of Plasmodium berghei assessed as human HepG2 cells assessed as inhibition of hepatic parasite growth after invasion of hepatocytes incubated for 48 hrs followed by compound wash out measured after 2 days by RT-PCR analysis',\n",
       "        'Inhibition of Plasmodium falciparum falcipain-2'], dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552]',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'MMV: Screen against Mtb, single point, replicating, at 25uM',\n",
       "        'MMV: Inhibition of Plasmodium falciparum K1 (EC50).',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'MMV: Screen against Mtb, single point, nonreplicating, at 25uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.',\n",
       "        'MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).',\n",
       "        'MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).',\n",
       "        'MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity (100 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (100 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Antiparasitic effect against Plasmodium berghei infected mice (Mus musculus) after 100 mg/kg per oral (SSV) dose after 3 days',\n",
       "        'Antiparasitic effect against Plasmodium berghei in mice (Mus musculus) after 4 days at 100 mg/kg/day (T/A Tween 80) peroral dose in Peters suppressive assay',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Anti-parasitic effect against Plasmodium berghei in mice (Mus musculus) after 4 days at 100 mg/kg/day (T/A Tween 80) peroral dose in Peters suppressive assay',\n",
       "        'Antiparasitic effect against Plasmodium berghei infected mice (Mus musculus) after 100 mg/kg per oral (T/A Tween-80) dose after 3 days',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (100 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity (100 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity (100 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake',\n",
       "        'Antimalarial activity (100 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon peroral dose was determined'],\n",
       "       dtype=object),\n",
       " array(['Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Antimalarial activity (100 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Antimalarial activity (100 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg peroral dose was determined'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 100 mg/kg upon subcutaneous dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vitro inhibition of chloroquine-sensitive Plasmodium falciparum NF54',\n",
       "        'Antimalarial activity (10 mg/kg, peroral) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitaemia on day 3 post infection',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg peroral dose was determined',\n",
       "        'Survival of mice to 30-day postinfection with Plasmodium berghei upon 10 mg/kg upon subcutaneous dose was determined',\n",
       "        'Antimalarial activity (10 mg/kg, subcutaneously) given 1 day post infection of mice (Mus musculus) with Plasmodium berghei is its ability to reduce parasitemia on day 3 post infection'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'Percentage inhibition of parasite growth in human erythrocytes at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Percentage inhibition of parasite growth in human erythrocytes at 5 uM',\n",
       "        'Inhibitory concentration against the plasmepsin-2 of Plasmodium falciparum',\n",
       "        'Inhibitory concentration against the plasmepsin-1 of Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against sporozoite stage of Plasmodium berghei infected in human HepG2 cells assessed as inhibition of sporozoite infectivity at 2 uM after 40 hrs',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 assessed as reduction of number of complex trails up to 10 uM relative to untreated control',\n",
       "        'Antimalarial activity against Plasmodium yoelii 17XNL infected through mosquito bite in Swiss-Webster mouse liver assessed as increase of average prepatent period at 50 mg/kg, ip administered first dose 15 mins before infection and second and third doses given 6 hrs and 12 hrs postinfection measured up to 22 days (Rvb = 2.66 +/- 0.57 days)',\n",
       "        'Antimalarial activity against Plasmodium berghei NK65 infected in human HepG2 cells assessed as inhibition of sporozoite invasion after 1 hr',\n",
       "        'Inhibition of PKG in Plasmodium falciparum 3D7 microgametes'],\n",
       "       dtype=object),\n",
       " array(['PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       "        'Antimicrobial activity against Plasmodium falciparum',\n",
       "        'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       "        'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]'],\n",
       "       dtype=object),\n",
       " array(['In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 25 mg/kg treated for 4 days',\n",
       "        'In vitro antiplasmodial activity for Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 25 mg/kg treated for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei in untreated mice (Mus musculus)',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 25 mg/kg dose for 4 days'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 3.125 mg/kg dose for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 6.25 mg/kg treated for 4 days',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 6.25 mg/kg treated for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 25 mg/kg treated for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei in untreated mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 25 mg/kg treated for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 12.5 mg/kg treated for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 12.5 mg/kg treated for 4 days',\n",
       "        'In vitro antiplasmodial concentration against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'In vitro antiplasmodial activity for Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 3.125 mg/kg treated for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 25 mg/kg dose for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 3.125 mg/kg treated for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 6.25 mg/kg dose for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 12.5 mg/kg dose for 4 days',\n",
       "        'Normalized IC50 as product of antiplasmodial IC50 and vacuolar accumulation IC50'],\n",
       "       dtype=object),\n",
       " array(['In vitro antiplasmodial concentration against multidrug-resistant Plasmodium falciparum K1',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 50 mg/kg treated for 4 days',\n",
       "        'In vitro antiplasmodial activity for Plasmodium falciparum',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 50 mg/kg treated for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei in untreated mice (Mus musculus)',\n",
       "        'Normalized IC50 as product of antiplasmodial IC50 and vacuolar accumulation IC50',\n",
       "        'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 50 mg/kg dose for 4 days'],\n",
       "       dtype=object),\n",
       " array(['Mean survival time taken as number of days before illness due to Plasmodium berghei when mice (Mus musculus) treated with 25 mg/kg dose for 4 days',\n",
       "        'Mean survival time taken as number of days before illness due to Plasmodium berghei in untreated mice (Mus musculus)',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei was determined as suppression of parasitemia in mice (Mus musculus) at 25 mg/kg treated for 4 days',\n",
       "        'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) at dose of 25 mg/kg treated for 4 days',\n",
       "        'In vitro antiplasmodial activity for Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound',\n",
       "        'In vitro inhibition of Plasmodium falciparum'], dtype=object),\n",
       " array(['In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound',\n",
       "        'In vitro inhibition of Plasmodium falciparum'], dtype=object),\n",
       " array(['In vitro inhibition of Plasmodium falciparum',\n",
       "        'In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound',\n",
       "        'Lethal dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of Plasmodium falciparum',\n",
       "        'In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound',\n",
       "        'Lethal dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibition of Plasmodium falciparum',\n",
       "        'In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of hemozoin formation in Plasmodium berghei infected mice (Mus musculus) at 5 uM',\n",
       "        'Inhibitory concentration against recombinant Falcipain-2',\n",
       "        'Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       "        'Antimalarial activity against Plasmodium falciparum'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum PFT',\n",
       "        'Effective dose against Plasmodium falciparum 3D7'], dtype=object),\n",
       " array(['In vitro inhibition of Plasmodium falciparum',\n",
       "        'In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM',\n",
       "        'Inhibition of hemozoin formation in Plasmodium berghei infected mice (Mus musculus) at 5 uM',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in FACS'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Antiplasmodial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Inhibition of Plasmodium falciparum PFT',\n",
       "        'Effective dose against Plasmodium falciparum 3D7'], dtype=object),\n",
       " array(['Inhibitory concentration against recombinant Falcipain-2',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       "        'Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM',\n",
       "        'Inhibition of hemozoin formation in Plasmodium berghei infected mice (Mus musculus) at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against recombinant Falcipain-2',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       "        'Inhibition of hemozoin formation in Plasmodium berghei infected mice (Mus musculus) at 5 uM',\n",
       "        'Antimalarial activity against Plasmodium falciparum',\n",
       "        'Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Effective dose against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase'],\n",
       "       dtype=object),\n",
       " array(['In vivo effective dose against Plasmodium vinckei in mice (Mus musculus) after intraperitoneal administration of the compound',\n",
       "        'In vitro inhibition of Plasmodium falciparum'], dtype=object),\n",
       " array(['Antiplasmodial activity against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Inhibition of Plasmodium falciparum PFT',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Effective dose against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM',\n",
       "        'Inhibition of hemozoin formation in Plasmodium berghei infected mice (Mus musculus) at 5 uM',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in FACS'],\n",
       "       dtype=object),\n",
       " array(['Effective dose against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase'],\n",
       "       dtype=object),\n",
       " array(['Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       "        'Inhibition of hemozoin formation in Plasmodium berghei infected mice (Mus musculus) at 5 uM',\n",
       "        'Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of hemoglobin hydrolysis in mice (Mus musculus) infected with Plasmodium berghei at 5 uM',\n",
       "        'Inhibitory concentration against Plasmodium falciparum in FACS'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Effective dose against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase'],\n",
       "       dtype=object),\n",
       " array(['Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay',\n",
       "        'Effective dose against Plasmodium falciparum 3D7',\n",
       "        'Antimalarial activity against Plasmodium falciparum K1',\n",
       "        'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       "        'Inhibition of biotinylated lamin B peptide farnesylation by Plasmodium falciparum farnesyltransferase',\n",
       "        'Inhibition of Plasmodium falciparum protein farnesyltransferase by scintillation proximity assay'],\n",
       "       dtype=object),\n",
       " array(['Antimalarial activity against Plasmodium chabaudi infected rat malaria model',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mosquitoes assessed as reduction in number of oocysts',\n",
       "        'Antimalarial activity against Plasmodium berghei infected in mosquitoes assessed as reduction in number of sporozoites',\n",
       "        'Antimicrobial activity against Plasmodium falciparum infected in human erythrocytes assessed as growth inhibition',\n",
       "        'Antimalarial activity against Plasmodium falciparum gametocytes'],\n",
       "       dtype=object),\n",
       " array(['Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg'],\n",
       "       dtype=object),\n",
       " array(['Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Gametocytocidal activity as infected mosquitoes against Plasmodium berghei at 10 uM/kg'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg'],\n",
       "       dtype=object),\n",
       " array(['Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg'],\n",
       "       dtype=object),\n",
       " array(['Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg'],\n",
       "       dtype=object),\n",
       " array(['Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg'],\n",
       "       dtype=object),\n",
       " array(['Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Gametocytocidal activity as infected mosquitoes against Plasmodium berghei at 10 uM/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg'],\n",
       "       dtype=object),\n",
       " array(['Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 0 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 10 umol.1/kg',\n",
       "        'Percentage of Plasmodium berghei ANKA infected Anopheles stephensi mosquitos after treatment with the compound at a dosage of 50 umol.1/kg',\n",
       "        'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye',\n",
       "        'DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells.',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.'],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay '],\n",
       "       dtype=object),\n",
       " array(['GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       "        'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.'],\n",
       "       dtype=object),\n",
       " array(['NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       "        'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       "        'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)'],\n",
       "       dtype=object),\n",
       " array(['In vitro inhibitory concentration against chloroquine-resistant, pyrimethamine-resistant Plasmodium falciparum K1',\n",
       "        'Percent inhibition of Plasmodium falciparum beta-Ketoacyl-acyl carrier protein synthase III activity (MBP-pfKASIII) expressed in E. coli cells using [1-14C]acetyl-CoA as radioligand upon incubation at 37 degrees C for 15 minutes with compound dissolved in 2% DMSO at 10 uM'],\n",
       "       dtype=object),\n",
       " array(['Percent inhibition of Plasmodium falciparum beta-Ketoacyl-acyl carrier protein synthase III activity (MBP-pfKASIII) expressed in E. coli cells using [1-14C]acetyl-CoA as radioligand upon incubation at 37 degrees C for 15 minutes with compound dissolved in 2% DMSO at 10 uM',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant, pyrimethamine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " array(['Percent inhibition of Plasmodium falciparum beta-Ketoacyl-acyl carrier protein synthase III activity (MBP-pfKASIII) expressed in E. coli cells using [1-14C]acetyl-CoA as radioligand upon incubation at 37 degrees C for 15 minutes with compound dissolved in 2% DMSO at 10 uM',\n",
       "        'In vitro inhibitory concentration against chloroquine-resistant, pyrimethamine-resistant Plasmodium falciparum K1'],\n",
       "       dtype=object),\n",
       " ...]"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(units_df.query(\"no_units != 1\")[\"ASSAY_DESCRIPTION\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/mr/bl2q5rxs0t3d8d8tn7wdcxz80000gp/T/ipykernel_96627/1629321367.py:1: FutureWarning: The provided callable <built-in function sum> is currently using SeriesGroupBy.sum. In a future version of pandas, the provided callable will be used directly. To keep current behavior pass the string \"sum\" instead.\n",
      "  new_df[\"Agg Standard Val\"] = new_df[\"STANDARD_VALUE\"].aggregate(sum)\n"
     ]
    },
    {
     "ename": "TypeError",
     "evalue": "'DataFrameGroupBy' object does not support item assignment",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[36], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m \u001b[43mnew_df\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAgg Standard Val\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m]\u001b[49m \u001b[38;5;241m=\u001b[39m new_df[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mSTANDARD_VALUE\u001b[39m\u001b[38;5;124m\"\u001b[39m]\u001b[38;5;241m.\u001b[39maggregate(\u001b[38;5;28msum\u001b[39m)\n",
      "\u001b[0;31mTypeError\u001b[0m: 'DataFrameGroupBy' object does not support item assignment"
     ]
    }
   ],
   "source": [
    "new_df[\"Agg Standard Val\"] = new_df[\"STANDARD_VALUE\"].aggregate(mean)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>MOL_CHEMBL_ID</th>\n",
       "      <th>DOWNGRADED</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>STANDARD_INCHI</th>\n",
       "      <th>FULL_MWT</th>\n",
       "      <th>ALOGP</th>\n",
       "      <th>ACD_LOGP</th>\n",
       "      <th>ACD_LOGD</th>\n",
       "      <th>PSA</th>\n",
       "      <th>...</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "      <th>TARGET_CHEMBL_ID</th>\n",
       "      <th>JOURNAL</th>\n",
       "      <th>YEAR</th>\n",
       "      <th>TITLE</th>\n",
       "      <th>PUBMED_ID</th>\n",
       "      <th>DOI</th>\n",
       "      <th>DOC_TYPE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>0 rows Ã— 44 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [MOLREGNO, MOL_CHEMBL_ID, DOWNGRADED, CANONICAL_SMILES, STANDARD_INCHI, FULL_MWT, ALOGP, ACD_LOGP, ACD_LOGD, PSA, SRC_DESCRIPTION, ASSAY_DESCRIPTION, ASSAY_CATEGORY, ASSAY_ORGANISM, ASSAY_TAX_ID, ASSAY_STRAIN, ASSAY_CHEMBL_ID, ACTIVITY_ID, ASSAY_ID, DOC_ID, RECORD_ID, STANDARD_RELATION, PUBLISHED_VALUE, PUBLISHED_UNITS, STANDARD_VALUE, STANDARD_UNITS, STANDARD_FLAG, STANDARD_TYPE, ACTIVITY_COMMENT, PUBLISHED_TYPE, DATA_VALIDITY_COMMENT, POTENTIAL_DUPLICATE, PUBLISHED_RELATION, PCHEMBL_VALUE, TARGET_TYPE, PREF_NAME, ORGANISM, TARGET_CHEMBL_ID, JOURNAL, YEAR, TITLE, PUBMED_ID, DOI, DOC_TYPE]\n",
       "Index: []\n",
       "\n",
       "[0 rows x 44 columns]"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.query(\"ASSAY_CATEGORY == 'confirmation'\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0         PUBCHEM_BIOASSAY: qHTS for differential inhibi...\n",
       "1         PUBCHEM_BIOASSAY: qHTS for differential inhibi...\n",
       "2         PUBCHEM_BIOASSAY: qHTS for differential inhibi...\n",
       "3         PUBCHEM_BIOASSAY: qHTS for differential inhibi...\n",
       "4         PUBCHEM_BIOASSAY: Primary qHTS for delayed dea...\n",
       "                                ...                        \n",
       "532408    Growth inhibition after 72 hrs of Plasmodium f...\n",
       "532409    GSK_TCMDC: Inhibition of Plasmodium falciparum...\n",
       "532410    GSK_TCMDC: Inhibition of Plasmodium falciparum...\n",
       "532411    GSK_TCMDC: Inhibition Frequency Index (IFI). T...\n",
       "532412    Growth inhibition after 72 hrs of Plasmodium f...\n",
       "Name: ASSAY_DESCRIPTION, Length: 532413, dtype: object"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['ASSAY_DESCRIPTION']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "malaria",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
